molecule,CAS number,chemical name,name IUPAC,merck index ref,literature ref,patent date,Launched date,FDA approved,code ATC,solubility,Additional info type,Additional info detail,blood brain barrier,administration,absorption tissue,protein binding,metabolism tissue,metabolism metabolite,daily dose,side effect name,target type,target name,therapeutic class name,therapeutic effect name,Synonyms,T max,protein binding rate,bioavailability,half life time,absorption rate,distribution volume
"Azaguanine-8
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0119 -1.5014 0.0 0
M  V30 3 N -1.3227 -2.2522 0.0 0
M  V30 4 C 1.275 -2.2522 0.0 0
M  V30 5 C -1.3346 -3.7418 0.0 0
M  V30 6 N 2.705 -1.7755 0.0 0
M  V30 7 C 1.2631 -3.7418 0.0 0
M  V30 8 N -0.0476 -4.4806 0.0 0
M  V30 9 N -2.6812 -4.4806 0.0 0
M  V30 10 N 3.5749 -2.9791 0.0 0
M  V30 11 N 2.6931 -4.1946 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 8
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
",134-58-7,Azaguanine-8,"5-Amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol","MI, 12, 928",Cancer Res. 1975 Oct 35(10):2872-8,9/8/1964,,,Not yet attributed,DMSO,Pharmacological tool,,,,,,,,,,,,Oncology,Antineoplastic,,,,,,,
"Sulfaguanidine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O -0.4942 1.4238 0.0 0
M  V30 3 O 1.365 0.6119 0.0 0
M  V30 4 N 0.706 -1.3297 0.0 0
M  V30 5 C -1.4709 -0.3412 0.0 0
M  V30 6 C 2.1887 -1.3179 0.0 0
M  V30 7 C -1.9063 -1.7533 0.0 0
M  V30 8 C -2.5064 0.7531 0.0 0
M  V30 9 N 2.9535 -0.0353 0.0 0
M  V30 10 N 2.8947 -2.6358 0.0 0
M  V30 11 C -3.3772 -2.0945 0.0 0
M  V30 12 C -3.9773 0.4118 0.0 0
M  V30 13 C -4.4245 -1.0002 0.0 0
M  V30 14 N -5.8954 -1.3414 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 11 13
M  V30 13 1 13 14
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
",57-67-0,Sulfaguanidine,4-amino-N-[amino(imino)methyl]benzenesulfonamide,"MI, 13, 8993",Contact Dermatitis. 2002 Mar 46(3):186-7,5/23/1950,,,A07AB03,DMSO,Chemical classification (according ATC code),Sulfonamide,,Oral,,,,,4000,"Diarrhoea, Hepatic enzyme levels elevated, Hypersensitivity reactions, Nausea, Nephrotoxicity, Photosensitization",,,"Infectiology, Metabolism",Antibacterial,,,,,,,
"Nocodazole
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C -0.3087 -1.4369 0.0 0
M  V30 3 C 1.4726 0.2018 0.0 0
M  V30 4 C -1.6863 -2.0545 0.0 0
M  V30 5 C 0.9975 -2.1732 0.0 0
M  V30 6 C 2.102 -1.1519 0.0 0
M  V30 7 O -1.8288 -3.5508 0.0 0
M  V30 8 C -2.9214 -1.1994 0.0 0
M  V30 9 C -4.299 -1.817 0.0 0
M  V30 10 C -2.8027 0.2968 0.0 0
M  V30 11 C -5.5104 -0.95 0.0 0
M  V30 12 C -4.0259 1.1757 0.0 0
M  V30 13 N -6.983 -1.2707 0.0 0
M  V30 14 C -5.4154 0.5462 0.0 0
M  V30 15 C -7.7787 0.0118 0.0 0
M  V30 16 N -6.793 1.14 0.0 0
M  V30 17 N -9.2869 0.1543 0.0 0
M  V30 18 C -10.1538 -1.045 0.0 0
M  V30 19 O -9.5363 -2.387 0.0 0
M  V30 20 O -11.6739 -0.9025 0.0 0
M  V30 21 C -12.5528 -2.102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 20 21
M  V30 21 1 5 6
M  V30 22 1 12 14
M  V30 23 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
",31430-18-9,Nocodazole,Methyl (5-(2-thienylcarbonyl)-1H-benz-imidazole-2-YL-carbamate,,Mol Cancer Ther. 2011 Oct 10(10):1886-96,6/10/1983,,,Not yet attributed,DMSO 10mg/mL,,,,,,,,,,"Diarrhoea, Skin dryness",,,Oncology,Antineoplastic,,,,,,,
"Lymecycline
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 0.0 -1.4855 0.0 0
M  V30 3 C -1.3297 -2.2162 0.0 0
M  V30 4 C 1.2818 -2.2162 0.0 0
M  V30 5 C -2.6595 -1.4495 0.0 0
M  V30 6 C -1.3537 -3.7018 0.0 0
M  V30 7 C 2.5637 -1.4256 0.0 0
M  V30 8 C 1.2459 -3.7018 0.0 0 CFG=2
M  V30 9 O -2.6954 0.0838 0.0 0
M  V30 10 C -3.9893 -2.1923 0.0 0
M  V30 11 C -2.6835 -4.4445 0.0 0
M  V30 12 C -0.0718 -4.4325 0.0 0 CFG=1
M  V30 13 O 2.5397 0.1078 0.0 0
M  V30 14 C 3.8575 -2.1563 0.0 0 CFG=1
M  V30 15 C 2.5277 -4.4325 0.0 0
M  V30 16 C -4.0132 -3.6778 0.0 0
M  V30 17 O -1.4256 -5.1274 0.0 0
M  V30 18 C -0.0838 -5.9181 0.0 0
M  V30 19 O 3.7497 -0.6229 0.0 0
M  V30 20 C 5.1154 -1.3896 0.0 0
M  V30 21 C 3.8096 -3.6419 0.0 0 CFG=2
M  V30 22 O 5.1034 0.1437 0.0 0
M  V30 23 C 6.3973 -2.1324 0.0 0
M  V30 24 C 5.0914 -4.3726 0.0 0 CFG=2
M  V30 25 C 6.3733 -3.6059 0.0 0
M  V30 26 C 7.6911 -1.3657 0.0 0
M  V30 27 N 5.0675 -5.8582 0.0 0
M  V30 28 O 7.6552 -4.3487 0.0 0
M  V30 29 O 7.6671 0.1677 0.0 0
M  V30 30 N 8.973 -2.0964 0.0 0
M  V30 31 C 6.3493 -6.6009 0.0 0
M  V30 32 C 3.7377 -6.6009 0.0 0
M  V30 33 C 10.2548 -1.3297 0.0 0
M  V30 34 N 11.5367 -2.0725 0.0 0
M  V30 35 C 12.8185 -1.3058 0.0 0
M  V30 36 C 12.7946 0.2276 0.0 0
M  V30 37 C 14.1004 -2.0485 0.0 0
M  V30 38 O 14.0884 0.9943 0.0 0
M  V30 39 O 11.4648 0.9943 0.0 0
M  V30 40 C 15.3942 -1.2818 0.0 0
M  V30 41 C 16.6761 -2.0126 0.0 0
M  V30 42 C 17.958 -1.2459 0.0 0
M  V30 43 N 19.2398 -1.9886 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 8 15 CFG=1
M  V30 15 2 10 16
M  V30 16 1 12 17 CFG=1
M  V30 17 1 12 18
M  V30 18 1 14 19 CFG=3
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 2 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 2 23 25
M  V30 25 1 23 26
M  V30 26 1 24 27 CFG=3
M  V30 27 1 25 28
M  V30 28 2 26 29
M  V30 29 1 26 30
M  V30 30 1 27 31
M  V30 31 1 27 32
M  V30 32 1 30 33
M  V30 33 1 33 34
M  V30 34 1 34 35
M  V30 35 1 35 36
M  V30 36 1 35 37
M  V30 37 2 36 38
M  V30 38 1 36 39
M  V30 39 1 37 40
M  V30 40 1 40 41
M  V30 41 1 41 42
M  V30 42 1 42 43
M  V30 43 1 8 12
M  V30 44 1 11 16
M  V30 45 1 21 15 CFG=1
M  V30 46 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(5 8 12 14 21 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",992-21-2,Lymecycline,"(+)-N-(5-amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphtacene-2-carboxamide","MI, 13, 5648",Eur J Dermatol. 2003 Mar-Apr 13(2):130-5,2/24/1982,1992,,J01AA04Â ,,Chemical classification (according ATC code),Tetracycline,,Oral,,,,,600,"Blurred vision, Diarrhoea, Headache, Hypersensitivity reactions, Intracranial hypertension, Nausea, Photosensitization",,,Metabolism,Antibacterial,,3 - 4,,,8 - 10,,
"Alfadolone acetate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2922 -0.7329 0.0 0
M  V30 3 C 1.2922 -2.1602 0.0 0 CFG=2
M  V30 4 C 2.5267 0.0385 0.0 0
M  V30 5 C 0.0192 -2.8932 0.0 0 CFG=2
M  V30 6 C 2.546 -2.816 0.0 0 CFG=2
M  V30 7 C 3.7611 -0.6365 0.0 0 CFG=1
M  V30 8 C 0.0385 -4.3012 0.0 0 CFG=2
M  V30 9 C -1.2537 -2.1602 0.0 0
M  V30 10 C 0.0 -1.3694 0.0 0
M  V30 11 C 3.7997 -2.0445 0.0 0 CFG=1
M  V30 12 C 2.5653 -4.2819 0.0 0
M  V30 13 C 4.9955 0.1157 0.0 0 CFG=1
M  V30 14 C 3.7611 0.8872 0.0 0
M  V30 15 C -1.2344 -5.0341 0.0 0
M  V30 16 C 1.273 -5.0148 0.0 0
M  V30 17 C -2.5267 -2.8739 0.0 0
M  V30 18 C 6.23 -2.0445 0.0 0
M  V30 19 C 4.9763 1.6394 0.0 0
M  V30 20 C 6.2493 -0.5786 0.0 0
M  V30 21 C -2.5267 -4.3012 0.0 0 CFG=1
M  V30 22 O 3.6454 2.411 0.0 0
M  V30 23 C 6.23 2.4302 0.0 0
M  V30 24 O -3.8383 -5.0341 0.0 0
M  V30 25 O 7.5223 1.6973 0.0 0
M  V30 26 C 8.7953 2.4881 0.0 0
M  V30 27 O 8.7567 4.0119 0.0 0
M  V30 28 C 10.0876 1.7552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 3 2 CFG=1
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10 CFG=1
M  V30 10 1 6 11
M  V30 11 1 6 12 CFG=3
M  V30 12 1 7 13
M  V30 13 1 7 14 CFG=1
M  V30 14 1 8 15 CFG=1
M  V30 15 1 8 16
M  V30 16 1 9 17
M  V30 17 1 11 18 CFG=1
M  V30 18 1 13 19 CFG=1
M  V30 19 1 13 20
M  V30 20 1 15 21
M  V30 21 2 19 22
M  V30 22 1 19 23
M  V30 23 1 21 24 CFG=3
M  V30 24 1 23 25
M  V30 25 1 25 26
M  V30 26 2 26 27
M  V30 27 1 26 28
M  V30 28 1 7 11
M  V30 29 1 12 16
M  V30 30 1 17 21
M  V30 31 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 3 5 6 7 8 11 13 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",23930-37-2,Alfadolone acetate,"[2-[(3R,5S,8S,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-11-oxo-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate","MI, 13, 231",Anesthesiology. 1979 Apr 50(4):350-2,9/9/1987,Phase I,,Not yet attributed,,,,,,,,,,,,,,Central Nervous System,Anesthetic,,,,,,,
"Alfaxalone
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2744 -0.7254 0.0 0
M  V30 3 C 1.2744 -2.1567 0.0 0 CFG=2
M  V30 4 C 2.5293 0.0196 0.0 0
M  V30 5 C 0.0 -2.8626 0.0 0 CFG=2
M  V30 6 C 2.5097 -2.8626 0.0 0 CFG=2
M  V30 7 C 3.7449 -0.6862 0.0 0 CFG=1
M  V30 8 C 0.0 -4.2939 0.0 0 CFG=2
M  V30 9 C -1.2744 -2.1371 0.0 0
M  V30 10 C 0.0196 -1.3332 0.0 0
M  V30 11 C 3.7449 -2.0979 0.0 0 CFG=1
M  V30 12 C 2.5097 -4.2939 0.0 0
M  V30 13 C 4.9998 0.0588 0.0 0 CFG=1
M  V30 14 C 3.7253 0.8431 0.0 0
M  V30 15 C -1.2744 -5.0194 0.0 0
M  V30 16 C 1.2352 -4.9998 0.0 0
M  V30 17 C -2.5489 -2.843 0.0 0
M  V30 18 C 6.2154 -2.0979 0.0 0
M  V30 19 C 4.9802 1.5881 0.0 0
M  V30 20 C 6.235 -0.6274 0.0 0
M  V30 21 C -2.5685 -4.2743 0.0 0 CFG=1
M  V30 22 O 3.6469 2.3528 0.0 0
M  V30 23 C 6.2546 2.3724 0.0 0
M  V30 24 O -3.8822 -4.9998 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 3 2 CFG=1
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10 CFG=1
M  V30 10 1 6 11
M  V30 11 1 6 12 CFG=3
M  V30 12 1 7 13
M  V30 13 1 7 14 CFG=1
M  V30 14 1 8 15 CFG=1
M  V30 15 1 8 16
M  V30 16 1 9 17
M  V30 17 1 11 18 CFG=1
M  V30 18 1 13 19 CFG=1
M  V30 19 1 13 20
M  V30 20 1 15 21
M  V30 21 2 19 22
M  V30 22 1 19 23
M  V30 23 1 21 24 CFG=3
M  V30 24 1 7 11
M  V30 25 1 12 16
M  V30 26 1 17 21
M  V30 27 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 3 5 6 7 8 11 13 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",23930-19-0,Alfaxalone,"(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one","MI, 13, 233",Mol Pharmacol. 1980 Jul 18(1):144-7,9/9/1987,,,N01AX05,,Therapeutic classification (according ATC code),General anesthetic,,,,,,,,"Arrhythmia, Bradycardia, Dyspnea, Hypoxia, Seizure, Vomiting",,,Central Nervous System,Anesthetic,,,,,,,
"Azapropazone
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.4863 0.342 0.0 0
M  V30 3 N -2.6305 -0.6252 0.0 0
M  V30 4 C -2.0997 1.7458 0.0 0 CFG=2
M  V30 5 N -3.9517 0.1533 0.0 0
M  V30 6 C -2.6423 -2.1115 0.0 0
M  V30 7 C -3.6096 1.616 0.0 0
M  V30 8 C -1.3801 3.0552 0.0 0
M  V30 9 C -5.2611 -0.5662 0.0 0
M  V30 10 N -3.9753 -2.8311 0.0 0
M  V30 11 N -1.3801 -2.8311 0.0 0
M  V30 12 O -4.6241 2.7485 0.0 0
M  V30 13 C 0.0825 3.067 0.0 0
M  V30 14 C -5.2965 -2.0525 0.0 0
M  V30 15 C -6.5823 0.2005 0.0 0
M  V30 16 C -1.4037 -4.2938 0.0 0
M  V30 17 C -0.1179 -2.0643 0.0 0
M  V30 18 C 0.8021 4.3764 0.0 0
M  V30 19 C -6.6059 -2.7603 0.0 0
M  V30 20 C -7.8917 -0.5308 0.0 0
M  V30 21 C -7.9153 -1.9817 0.0 0
M  V30 22 C -9.2011 0.2477 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=3
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 2 15 20
M  V30 20 2 19 21
M  V30 21 1 20 22
M  V30 22 1 5 7
M  V30 23 1 10 14
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",13539-59-8,Azapropazone,"5-(dimethylamino)-9-methyl-2-propylpyrazolo[1,2-a][1,2,4]benzotriazine-1,3-dione","MI, 13, 733",Curr Med Res Opin. 1976 4(1):3-16,10/24/1967,1970,,M01AX04,,Therapeutic classification (according ATC code),NSAID,,Oral,GI tract,,,,750,"Depression, Dizziness, Drowsiness, Epigastric misery, Haematuria, Headache, Hypersensitivity reactions, Insomnia, Photosensitization, Tinnitus",,,"Central Nervous System, Metabolism","Analgesic, Anti-inflammatory",,,,,,,
"Meptazinol hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 4.3498 -5.9573 0.0 0
M  V30 3 C 3.1323 -5.0472 0.0 0
M  V30 4 C 1.7375 -5.5909 0.0 0
M  V30 5 C 3.286 -3.5342 0.0 0
M  V30 6 C 0.5437 -4.6689 0.0 0
M  V30 7 C 2.0685 -2.6122 0.0 0
M  V30 8 C 0.6973 -3.1796 0.0 0
M  V30 9 C -0.851 -5.2363 0.0 0 CFG=2
M  V30 10 C -1.1938 -3.7706 0.0 0
M  V30 11 C -1.8203 -6.3592 0.0 0
M  V30 12 C -0.2364 -6.5483 0.0 0
M  V30 13 N -2.5531 -3.085 0.0 0
M  V30 14 C -3.3332 -6.3237 0.0 0
M  V30 15 C 1.2292 -6.4774 0.0 0
M  V30 16 C -3.9242 -3.6878 0.0 0
M  V30 17 C -2.5767 -1.572 0.0 0
M  V30 18 C -4.2552 -5.1299 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 2 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 2 5 7
M  V30 6 2 6 8
M  V30 7 1 6 9
M  V30 8 1 9 10
M  V30 9 1 9 11
M  V30 10 1 9 12 CFG=3
M  V30 11 1 10 13
M  V30 12 1 11 14
M  V30 13 1 12 15
M  V30 14 1 13 16
M  V30 15 1 13 17
M  V30 16 1 14 18
M  V30 17 1 7 8
M  V30 18 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",59263-76-2,Meptazinol hydrochloride,3-(3-ethyl-1-methylazepan-3-yl)phenol hydrochloride,"MI, 13, 5888",Drugs. 1985 Oct 30(4):285-312,4/9/1970,1983,,N02AX05,,Chemical classification (according ATC code),Opioid,,,,,,,1200,"Constipation, Diarrhoea, Dizziness, Drowsiness, Epigastric misery, Headache, Nausea, Rash, Sweat",,,Central Nervous System,Analgesic,,0.4 - 1,,,,,
"Apramycin
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.2695 0.8046 0.0 0 CFG=2
M  V30 3 C 1.1265 0.7867 0.0 0 CFG=2
M  V30 4 O -3.5583 -0.2682 0.0 0
M  V30 5 C -1.3231 2.2708 0.0 0 CFG=2
M  V30 6 C 2.253 0.143 0.0 0 CFG=2
M  V30 7 C 1.0728 2.253 0.0 0 CFG=2
M  V30 8 C -5.7219 1.1443 0.0 0 CFG=1
M  V30 9 N -3.1291 2.5927 0.0 0
M  V30 10 C -0.1966 3.0576 0.0 0
M  V30 11 O 2.1814 -1.198 0.0 0
M  V30 12 C 3.3973 0.9119 0.0 0 CFG=2
M  V30 13 O 2.1993 3.0397 0.0 0
M  V30 14 C -7.0451 0.5364 0.0 0 CFG=2
M  V30 15 C -5.704 2.5927 0.0 0 CFG=1
M  V30 16 N 4.5238 0.2503 0.0 0
M  V30 17 C 3.3258 2.3781 0.0 0
M  V30 18 O -7.1881 -0.7688 0.0 0
M  V30 19 C -8.2788 1.4125 0.0 0 CFG=1
M  V30 20 N -4.3629 3.7907 0.0 0
M  V30 21 C -6.9378 3.451 0.0 0
M  V30 22 C 4.4523 -1.0728 0.0 0
M  V30 23 O 4.4523 3.1828 0.0 0
M  V30 24 O -9.5842 0.8225 0.0 0
M  V30 25 C -8.2788 2.8788 0.0 0 CFG=1
M  V30 26 C 4.3808 4.649 0.0 0 CFG=1
M  V30 27 N -9.5126 3.7371 0.0 0
M  V30 28 O 3.1112 5.4358 0.0 0
M  V30 29 C 5.5073 5.4358 0.0 0 CFG=2
M  V30 30 C 3.0397 6.902 0.0 0 CFG=1
M  V30 31 O 6.6338 4.7742 0.0 0
M  V30 32 C 5.4358 6.902 0.0 0 CFG=2
M  V30 33 C 4.1662 7.7067 0.0 0 CFG=2
M  V30 34 C 1.7702 7.7067 0.0 0
M  V30 35 O 6.5623 7.7067 0.0 0
M  V30 36 N 4.0947 9.1729 0.0 0
M  V30 37 O 1.6808 9.1729 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 1 CFG=1
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 8 4 CFG=1
M  V30 8 1 5 9 CFG=3
M  V30 9 1 5 10
M  V30 10 1 6 11 CFG=1
M  V30 11 1 6 12
M  V30 12 1 7 13 CFG=3
M  V30 13 1 8 14
M  V30 14 1 8 15
M  V30 15 1 12 16 CFG=1
M  V30 16 1 12 17
M  V30 17 1 14 18 CFG=3
M  V30 18 1 14 19
M  V30 19 1 15 20 CFG=3
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 17 23
M  V30 23 1 19 24 CFG=1
M  V30 24 1 19 25
M  V30 25 1 26 23 CFG=1
M  V30 26 1 25 27 CFG=3
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 29 1 28 30
M  V30 30 1 29 31 CFG=1
M  V30 31 1 29 32
M  V30 32 1 30 33
M  V30 33 1 30 34 CFG=3
M  V30 34 1 32 35 CFG=3
M  V30 35 1 33 36 CFG=1
M  V30 36 1 34 37
M  V30 37 1 7 10
M  V30 38 1 13 17
M  V30 39 1 21 25
M  V30 40 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(16 2 3 5 6 7 8 12 14 15 19 25 26 29 30 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",37321-09-8,Apramycin,"(2R,3R,4R,5S,6R)-5-amino-2- [((1R,2R,3R,4R,6R,8R)-8-amino-9- [(1R,2S,3R,4R,6R)-4,6-diamino-2,3- dihydroxy-cyclohexyl]oxy-2-hydroxy- 3-methylamino-5,10- dioxabicyclo[4.4.0]dec-4-yl)oxy]-6- (hydroxymethyl)oxane-3,4-diol","MI, 13, 757",Vet Q. 2001 Apr 23(2):62-6,4/8/1975,1980,,QJ01GB90,,"Veterinary use, Veterinary use, Veterinary use","Cattle, Rabbit, Swine",,Oral,GI tract,,,,,Hypersensitivity reactions,,,"Infectiology, Metabolism",Antibacterial,,,,,,0 - 5,
"Fursultiamine Hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 S 3.4429 -4.7818 0.0 0
M  V30 3 S 4.71 -4.0167 0.0 0
M  V30 4 C 2.1279 -4.0047 0.0 0
M  V30 5 C 5.9772 -4.7459 0.0 0
M  V30 6 C 0.8129 -4.734 0.0 0
M  V30 7 C 2.104 -2.4865 0.0 0
M  V30 8 C 7.2444 -3.9808 0.0 0 CFG=2
M  V30 9 N -0.502 -3.9689 0.0 0
M  V30 10 C 0.789 -6.2044 0.0 0
M  V30 11 C 3.3831 -1.7214 0.0 0
M  V30 12 O 8.4638 -4.7818 0.0 0
M  V30 13 C 7.6389 -2.5224 0.0 0
M  V30 14 C -0.526 -2.4506 0.0 0
M  V30 15 C -1.817 -4.6981 0.0 0
M  V30 16 O 4.6503 -2.4506 0.0 0
M  V30 17 C 9.6234 -3.8374 0.0 0
M  V30 18 C 9.1093 -2.4387 0.0 0
M  V30 19 O 0.7411 -1.6736 0.0 0
M  V30 20 C -3.144 -3.921 0.0 0
M  V30 21 C -4.447 -4.6503 0.0 0
M  V30 22 C -3.156 -2.3909 0.0 0
M  V30 23 N -5.762 -3.8852 0.0 0
M  V30 24 N -4.471 -6.1207 0.0 0
M  V30 25 N -4.471 -1.6258 0.0 0
M  V30 26 C -5.7979 -2.355 0.0 0
M  V30 27 C -7.1129 -1.578 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 1 3 5
M  V30 4 2 4 6
M  V30 5 1 4 7
M  V30 6 1 8 5 CFG=1
M  V30 7 1 6 9
M  V30 8 1 6 10
M  V30 9 1 7 11
M  V30 10 1 8 12
M  V30 11 1 8 13
M  V30 12 1 9 14
M  V30 13 1 9 15
M  V30 14 1 11 16
M  V30 15 1 12 17
M  V30 16 1 13 18
M  V30 17 2 14 19
M  V30 18 1 15 20
M  V30 19 2 20 21
M  V30 20 1 20 22
M  V30 21 1 21 23
M  V30 22 1 21 24
M  V30 23 2 22 25
M  V30 24 2 23 26
M  V30 25 1 26 27
M  V30 26 1 17 18
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",2105-43-3,Fursultiamine Hydrochloride,N-(4-Amino-2-methylpyrimidin-5-ylmethyl)-N-[4-hydroxy-1-methyl-2-[(tetrahydrofurfuryl)dithio]-1-butenyl]formamide monohydrochloride,"MI, 13, 4332",Med Sci Monit. 2004 Sep 10(9):RA199-203,10/11/1966,,,Not yet attributed,,,,,,,,,,,,,,Metabolism,Anti-Alzheimer,,,,,,,
"Gabexate mesilate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 28 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O -0.7578 1.3144 0.0 0
M  V30 3 O 0.746 -1.2907 0.0 0
M  V30 4 O 1.2907 0.746 0.0 0
M  V30 5 C -1.3144 -0.7578 0.0 0
M  V30 6 O -6.6314 -8.9998 0.0 0
M  V30 7 C -6.6432 -7.484 0.0 0
M  V30 8 O -7.9577 -6.7261 0.0 0
M  V30 9 C -5.3525 -6.7261 0.0 0
M  V30 10 C -9.2721 -7.4603 0.0 0
M  V30 11 C -5.3643 -5.2104 0.0 0
M  V30 12 C -4.0499 -7.4603 0.0 0
M  V30 13 C -10.5866 -6.7025 0.0 0
M  V30 14 C -4.0736 -4.4525 0.0 0
M  V30 15 C -2.7591 -6.7025 0.0 0
M  V30 16 C -2.771 -5.2104 0.0 0
M  V30 17 O -1.4802 -4.4525 0.0 0
M  V30 18 C -0.1894 -5.1867 0.0 0
M  V30 19 O -0.2013 -6.6788 0.0 0
M  V30 20 C 1.1012 -4.4288 0.0 0
M  V30 21 C 2.392 -5.163 0.0 0
M  V30 22 C 3.6828 -4.4051 0.0 0
M  V30 23 C 4.9735 -5.1393 0.0 0
M  V30 24 C 6.2761 -4.3814 0.0 0
M  V30 25 N 7.5669 -5.1156 0.0 0
M  V30 26 C 8.8577 -4.3578 0.0 0
M  V30 27 N 8.8458 -2.842 0.0 0
M  V30 28 N 10.1484 -5.092 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 6 7
M  V30 6 1 7 8
M  V30 7 1 7 9
M  V30 8 1 8 10
M  V30 9 2 9 11
M  V30 10 1 9 12
M  V30 11 1 10 13
M  V30 12 1 11 14
M  V30 13 2 12 15
M  V30 14 2 14 16
M  V30 15 1 16 17
M  V30 16 1 17 18
M  V30 17 2 18 19
M  V30 18 1 18 20
M  V30 19 1 20 21
M  V30 20 1 21 22
M  V30 21 1 22 23
M  V30 22 1 23 24
M  V30 23 1 24 25
M  V30 24 1 25 26
M  V30 25 2 26 27
M  V30 26 1 26 28
M  V30 27 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
",56974-61-9,Gabexate mesilate,ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate methanesulfonic acid,"MI, 13, 4343",J Pharmacol Exp Ther. 2003 Apr 305(1):298-305,8/7/1973,1978,,Not yet attributed,"H2O, EtOH, CHCl3",,,,,,,,,,,,,"Hematology, Metabolism",Anticoagulant,,,,,,,
"Pivampicillin
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C 0.8745 -1.2099 0.0 0
M  V30 3 C -1.4256 -0.4672 0.0 0 CFG=1
M  V30 4 C 0.0 -2.4079 0.0 0 CFG=1
M  V30 5 C 2.2162 -0.551 0.0 0
M  V30 6 C 1.8568 -2.324 0.0 0
M  V30 7 N -1.4375 -1.9527 0.0 0
M  V30 8 C -2.947 -0.4552 0.0 0 CFG=1
M  V30 9 C 0.4672 -3.8215 0.0 0
M  V30 10 C -2.959 -1.9407 0.0 0
M  V30 11 N -4.4564 -0.4552 0.0 0
M  V30 12 O -0.539 -4.9356 0.0 0
M  V30 13 O 1.9287 -4.109 0.0 0
M  V30 14 O -4.0252 -2.9949 0.0 0
M  V30 15 C -5.7742 0.3114 0.0 0
M  V30 16 C 3.2105 -3.3423 0.0 0
M  V30 17 O -5.7862 1.8209 0.0 0
M  V30 18 C -7.08 -0.4312 0.0 0 CFG=2
M  V30 19 O 4.4924 -4.0851 0.0 0
M  V30 20 N -7.092 -1.9167 0.0 0
M  V30 21 C -8.3858 0.3354 0.0 0
M  V30 22 C 5.7862 -3.3184 0.0 0
M  V30 23 C -9.6916 -0.4073 0.0 0
M  V30 24 C -8.3978 1.8448 0.0 0
M  V30 25 O 5.7742 -1.8089 0.0 0
M  V30 26 C 7.0681 -4.0372 0.0 0
M  V30 27 C -10.9974 0.3474 0.0 0
M  V30 28 C -9.7036 2.6116 0.0 0
M  V30 29 C 7.0561 -5.5466 0.0 0
M  V30 30 C 8.3499 -3.2944 0.0 0
M  V30 31 C 8.3379 -4.8158 0.0 0
M  V30 32 C -11.0094 1.8688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 1 CFG=1
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9 CFG=3
M  V30 9 1 7 10
M  V30 10 1 8 11 CFG=1
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 18 20 CFG=3
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 2 21 23
M  V30 23 1 21 24
M  V30 24 2 22 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 2 24 28
M  V30 28 1 26 29
M  V30 29 1 26 30
M  V30 30 1 26 31
M  V30 31 2 27 32
M  V30 32 1 4 7
M  V30 33 1 8 10
M  V30 34 1 28 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 4 8 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",33817-20-8,Pivampicillin,"2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate","MI, 13, 7596",Lancet. 1989 Aug 26 2(8661):469-73,10/10/1972,1971,,J01CA02,,Chemical classification (according ATC code),Penicillin with extended spectrum,,Oral,,,,"Ampicillin, pivalic acid, formaldehyde",1050,"Diarrhoea, Epigastric misery, Hypersensitivity reactions, Nausea, Rash",,,"Infectiology, Metabolism",Antibacterial,,,,,6,,
"R(-) Apomorphine hydrochloride hemihydrate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 Cl 2.4687 -1.3293 0.0 0
M  V30 3 O 6.8365 -7.5961 0.0 0
M  V30 4 C 8.1539 -8.3438 0.0 0
M  V30 5 C 9.4358 -7.5724 0.0 0
M  V30 6 C 8.1421 -9.8393 0.0 0
M  V30 7 C 9.4239 -6.0531 0.0 0
M  V30 8 C 10.7176 -8.3201 0.0 0
M  V30 9 O 6.8246 -10.5871 0.0 0
M  V30 10 C 9.4002 -10.5752 0.0 0
M  V30 11 C 10.7176 -5.2935 0.0 0
M  V30 12 C 8.1302 -5.2935 0.0 0
M  V30 13 C 10.7058 -9.8156 0.0 0
M  V30 14 C 11.9995 -7.5486 0.0 0
M  V30 15 C 10.7058 -3.7743 0.0 0
M  V30 16 C 11.9876 -6.0294 0.0 0 CFG=1
M  V30 17 C 8.1183 -3.7743 0.0 0
M  V30 18 C 9.4358 -3.0028 0.0 0
M  V30 19 C 11.9876 -3.0028 0.0 0
M  V30 20 N 13.2695 -5.2698 0.0 0
M  V30 21 C 13.2576 -3.7506 0.0 0
M  V30 22 C 14.5751 -6.0057 0.0 0
M  V30 23 O -7.2163 -7.786 0.0 0
M  V30 24 C -5.9107 -8.5338 0.0 0
M  V30 25 C -4.617 -7.7623 0.0 0
M  V30 26 C -5.9226 -10.0292 0.0 0
M  V30 27 C -4.6289 -6.2549 0.0 0
M  V30 28 C -3.3351 -8.51 0.0 0
M  V30 29 O -7.24 -10.7889 0.0 0
M  V30 30 C -4.6526 -10.7651 0.0 0
M  V30 31 C -3.3351 -5.4834 0.0 0
M  V30 32 C -5.9226 -5.4834 0.0 0
M  V30 33 C -3.347 -10.0055 0.0 0
M  V30 34 C -2.0533 -7.7385 0.0 0
M  V30 35 C -3.347 -3.9642 0.0 0
M  V30 36 C -2.0652 -6.2312 0.0 0 CFG=1
M  V30 37 C -5.9344 -3.9642 0.0 0
M  V30 38 C -4.617 -3.2046 0.0 0
M  V30 39 C -2.0652 -3.2046 0.0 0
M  V30 40 N -0.7833 -5.4597 0.0 0
M  V30 41 C -0.7952 -3.9405 0.0 0
M  V30 42 C 0.5222 -6.2074 0.0 0
M  V30 43 O 5.792 -0.0949 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 3 4
M  V30 2 2 4 5
M  V30 3 1 4 6
M  V30 4 1 5 7
M  V30 5 1 5 8
M  V30 6 1 6 9
M  V30 7 2 6 10
M  V30 8 2 7 11
M  V30 9 1 7 12
M  V30 10 2 8 13
M  V30 11 1 8 14
M  V30 12 1 11 15
M  V30 13 1 11 16
M  V30 14 2 12 17
M  V30 15 2 15 18
M  V30 16 1 15 19
M  V30 17 1 16 20 CFG=3
M  V30 18 1 19 21
M  V30 19 1 20 22
M  V30 20 1 23 24
M  V30 21 2 24 25
M  V30 22 1 24 26
M  V30 23 1 25 27
M  V30 24 1 25 28
M  V30 25 1 26 29
M  V30 26 2 26 30
M  V30 27 2 27 31
M  V30 28 1 27 32
M  V30 29 2 28 33
M  V30 30 1 28 34
M  V30 31 1 31 35
M  V30 32 1 31 36
M  V30 33 2 32 37
M  V30 34 2 35 38
M  V30 35 1 35 39
M  V30 36 1 36 40 CFG=3
M  V30 37 1 39 41
M  V30 38 1 40 42
M  V30 39 1 10 13
M  V30 40 1 14 16
M  V30 41 1 17 18
M  V30 42 1 20 21
M  V30 43 1 30 33
M  V30 44 1 34 36
M  V30 45 1 37 38
M  V30 46 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",41372-20-7,R(-) Apomorphine hydrochloride hemihydrate,"(6aR)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride hydrate","MI, 13, 751",Molecules. 2012 May 7 17(5):5289-309,2/20/1973,1951,Yes,N04BC07,H2O,,,,Parenteral,,,Liver,,20,"Confusion, Fatigue, Nausea, Orthostatic hypotension, Pruritus, Sweat",,,Central Nervous System,"Antiparkinsonian, Emetic",,,,,0.5,,
"Flucloxacillin sodium
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C -0.0242 1.5369 0.0 0
M  V30 3 C 1.2585 2.3235 0.0 0
M  V30 4 C -1.3553 2.3235 0.0 0
M  V30 5 C 1.2343 3.8725 0.0 0
M  V30 6 C 2.5413 1.5853 0.0 0
M  V30 7 C -1.3796 3.8725 0.0 0
M  V30 8 F 2.5171 4.6591 0.0 0
M  V30 9 C -0.0968 4.6591 0.0 0
M  V30 10 N 2.0451 0.1694 0.0 0
M  V30 11 C 4.0298 1.6095 0.0 0
M  V30 12 O 3.2432 -0.6655 0.0 0
M  V30 13 C 4.4776 0.1936 0.0 0
M  V30 14 C 5.3126 2.3961 0.0 0
M  V30 15 C 5.8814 -0.242 0.0 0
M  V30 16 O 5.2884 3.933 0.0 0
M  V30 17 N 6.5954 1.67 0.0 0
M  V30 18 C 8.0839 1.6337 0.0 0 CFG=2
M  V30 19 C 8.0597 0.1452 0.0 0
M  V30 20 C 9.5724 1.6579 0.0 0 CFG=2
M  V30 21 O 6.9585 -0.8834 0.0 0
M  V30 22 N 9.5603 0.1694 0.0 0
M  V30 23 S 10.9763 2.1662 0.0 0
M  V30 24 C 10.9641 -0.2662 0.0 0
M  V30 25 C 11.8476 0.9802 0.0 0
M  V30 26 C 11.424 -1.6821 0.0 0
M  V30 27 C 13.0335 0.0968 0.0 0
M  V30 28 C 13.0578 1.8394 0.0 0
M  V30 29 O 12.8762 -1.9604 0.0 0
M  V30 30 O 10.3954 -2.7713 0.0 0 CHG=-1
M  V30 31 Na 5.2279 7.0674 0.0 0 CHG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 18 17 CFG=1
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23 CFG=1
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 25 28
M  V30 28 2 26 29
M  V30 29 1 26 30
M  V30 30 1 7 9
M  V30 31 1 12 13
M  V30 32 1 20 22
M  V30 33 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 18 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",1847-24-1,Flucloxacillin sodium,"(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate sodium","MI, 13, 4137",Med J Aust. 1999 Mar 15 170(6):270-3,12/22/1970,1971,,J01CF05,H2O,Chemical classification (according ATC code),Beta-lactamase resistant penicillin,,Oral,,,,,2000,"Diarrhoea, Hypersensitivity reactions, Nausea, Purpura, Rash",,,"Infectiology, Metabolism",Antibacterial,,,,,,,
"Trapidil
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0 0.0 0.0 0
M  V30 2 C -1.3079 0.7659 0.0 0
M  V30 3 C 1.2843 0.7659 0.0 0
M  V30 4 C -1.3315 2.2741 0.0 0
M  V30 5 C -2.6158 0.0235 0.0 0
M  V30 6 N 2.6983 0.3299 0.0 0
M  V30 7 N 1.2725 2.2741 0.0 0
M  V30 8 C -0.0471 3.0282 0.0 0
M  V30 9 C 3.5585 1.5553 0.0 0
M  V30 10 N 2.663 2.7572 0.0 0
M  V30 11 N -0.0589 4.5365 0.0 0
M  V30 12 C -1.3786 5.3024 0.0 0
M  V30 13 C 1.2254 5.3024 0.0 0
M  V30 14 C -2.6865 4.5601 0.0 0
M  V30 15 C 2.5098 4.5719 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 7 8
M  V30 16 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
",15421-84-8,Trapidil,"N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine","MI, 13, 9650",Circulation. 1994 Dec 90(6):2710-5,2/1/1989,1979,,C01DX11,H2O,,,,,,,,,,"Anorexia, Diarrhoea, Dizziness, Epigastric misery, Headache, Hepatic enzyme levels elevated, Nausea",,,Cardiovascular,Vasodilator,,,,,,,
"Deptropine citrate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.5395 -0.6064 0.0 0
M  V30 3 O -1.7728 -2.1771 0.0 0
M  V30 4 C -2.8614 0.3732 0.0 0
M  V30 5 O -3.8411 -0.5909 0.0 0
M  V30 6 C -4.8519 1.2285 0.0 0
M  V30 7 C -1.073 1.0108 0.0 0
M  V30 8 C -4.9608 2.6592 0.0 0
M  V30 9 C -1.1196 2.7059 0.0 0
M  V30 10 O -6.2827 3.4368 0.0 0
M  V30 11 O -3.7011 3.4368 0.0 0
M  V30 12 O -2.6592 3.5456 0.0 0
M  V30 13 O 0.2954 3.6389 0.0 0
M  V30 14 O -1.8661 -7.8378 0.0 0
M  V30 15 C -1.8817 -6.4071 0.0 0
M  V30 16 C -0.6998 -8.5376 0.0 0
M  V30 17 C -3.1569 -5.7384 0.0 0
M  V30 18 C -0.6531 -5.785 0.0 0
M  V30 19 C 0.4354 -7.7289 0.0 0
M  V30 20 C -0.8553 -9.9061 0.0 0
M  V30 21 C -3.499 -4.3388 0.0 0
M  V30 22 C -4.2143 -6.6559 0.0 0
M  V30 23 C -0.3421 -4.3854 0.0 0
M  V30 24 C 0.3265 -6.7336 0.0 0
M  V30 25 C 1.7417 -8.1333 0.0 0 CFG=1
M  V30 26 C 0.1244 -10.8547 0.0 0 CFG=2
M  V30 27 C -4.8675 -3.8878 0.0 0
M  V30 28 C -2.6281 -3.2346 0.0 0
M  V30 29 C -5.5829 -6.2049 0.0 0
M  V30 30 C 0.9641 -3.95 0.0 0
M  V30 31 C -1.2441 -3.2502 0.0 0
M  V30 32 C 1.6484 -6.3138 0.0 0
M  V30 33 N -0.0466 -9.1285 0.0 0
M  V30 34 C 2.2082 -9.4085 0.0 0
M  V30 35 C 1.4773 -10.6215 0.0 0
M  V30 36 C -5.925 -4.8053 0.0 0
M  V30 37 C 1.9439 -4.8986 0.0 0
M  V30 38 C 1.1352 -9.8128 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 14 15
M  V30 14 1 14 16
M  V30 15 1 15 17
M  V30 16 1 15 18
M  V30 17 1 16 19
M  V30 18 1 16 20
M  V30 19 2 17 21
M  V30 20 1 17 22
M  V30 21 2 18 23
M  V30 22 1 18 24
M  V30 23 1 19 25
M  V30 24 1 20 26
M  V30 25 1 21 27
M  V30 26 1 21 28
M  V30 27 2 22 29
M  V30 28 1 23 30
M  V30 29 1 23 31
M  V30 30 2 24 32
M  V30 31 1 25 33 CFG=1
M  V30 32 1 25 34
M  V30 33 1 26 35
M  V30 34 2 27 36
M  V30 35 2 30 37
M  V30 36 1 33 38
M  V30 37 1 26 33 CFG=1
M  V30 38 1 28 31
M  V30 39 1 29 36
M  V30 40 1 32 37
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",2169-75-7,Deptropine citrate,"3-(6,11-dihydro-5H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane 2-hydroxypropane-1,2,3-tricarboxylic acid","MI, 13, 2929",Br J Dis Chest. 1977 Apr 71(2):101-4,1/11/1984,,,R06AX16,,,,,,,,,,2,"Anticholinergic effects, Blurred vision, Mouth dryness",,,"Allergology, Cardiovascular, Respiratory","Antihistaminic, Bronchodilator, Vasodilator",,,,,,,
"Sertraline
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C -0.732 -1.3442 0.0 0
M  V30 3 C 0.0133 -2.5287 0.0 0
M  V30 4 C -2.2093 -1.3309 0.0 0
M  V30 5 Cl 1.4906 -2.5154 0.0 0
M  V30 6 C -0.7187 -3.7798 0.0 0
M  V30 7 C -2.9413 -2.5686 0.0 0
M  V30 8 C -2.196 -3.7665 0.0 0
M  V30 9 C -4.4186 -2.5553 0.0 0 CFG=1
M  V30 10 C -5.1506 -3.833 0.0 0
M  V30 11 C -5.1506 -1.3176 0.0 0
M  V30 12 C -6.6679 -3.8197 0.0 0
M  V30 13 C -4.4053 -5.0708 0.0 0
M  V30 14 C -6.6679 -1.3043 0.0 0
M  V30 15 C -7.3999 -5.0974 0.0 0
M  V30 16 C -7.4398 -2.5686 0.0 0 CFG=2
M  V30 17 C -5.1773 -6.3219 0.0 0
M  V30 18 C -6.6679 -6.3219 0.0 0
M  V30 19 N -9.1434 -1.3575 0.0 0
M  V30 20 C -9.1567 0.2129 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 2 6 8
M  V30 8 1 9 7 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 15 18
M  V30 18 1 16 19 CFG=1
M  V30 19 1 19 20
M  V30 20 1 7 8
M  V30 21 1 14 16
M  V30 22 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",79617-96-2,Sertraline,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine","MI, 13, 8541",Expert Opin Pharmacother. 2001 May 2(5):883-92,3/2/1983,1990,Yes,N06AB06,"MeOH, DMSO",,,,Oral,,Plasmatic proteins,Liver,Desmethylsertraline,50,"Diarrhoea, Dizziness, Drowsiness, Erectile dysfunction, Fatigue, Headache, Insomnia, Mouth dryness, Nausea",Carrier,Serotonin transporter,Central Nervous System,"Antidepressant, CNS Stimulant",,4.5 - 8.4,98,,26,,
"Ethamsylate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 0.7359 1.3056 0.0 0
M  V30 3 O -0.7715 -1.2819 0.0 0
M  V30 4 O 1.2819 -0.7359 0.0 0
M  V30 5 C -1.3056 0.7477 0.0 0
M  V30 6 C -1.3175 2.267 0.0 0
M  V30 7 C -2.6113 0.0118 0.0 0
M  V30 8 O -0.0356 3.0267 0.0 0
M  V30 9 C -2.6231 3.0267 0.0 0
M  V30 10 C -3.9169 0.7715 0.0 0
M  V30 11 C -3.9288 2.2789 0.0 0
M  V30 12 O -5.2345 0.0356 0.0 0
M  V30 13 N -4.1781 7.1217 0.0 0
M  V30 14 C -5.4837 7.8695 0.0 0
M  V30 15 C -2.8961 7.8814 0.0 0
M  V30 16 C -6.7894 7.1336 0.0 0
M  V30 17 C -1.6142 7.1455 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 13 14
M  V30 13 1 13 15
M  V30 14 1 14 16
M  V30 15 1 15 17
M  V30 16 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
",2624-44-4,Ethamsylate,"2,5-dihydroxybenzenesulfonic acid N-ethylethanamine","MI, 13, 3757",Am J Ther. 2006 May-Jun 13(3):236-47,5/9/1962,1965,,B02BX01,,,,,Oral,GI tract,Plasmatic proteins,,,,"Diarrhoea, Fever, Headache, Nausea, Rash",,,"Cardiovascular, Hematology","Antiplatelet, Hemostatic",,4,95,,8,,
"Moxonidine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C -1.3041 0.7587 0.0 0
M  V30 3 N -2.6082 0.0237 0.0 0
M  V30 4 C -1.3159 2.2762 0.0 0
M  V30 5 C -3.9123 0.7824 0.0 0
M  V30 6 N -0.0355 3.0469 0.0 0
M  V30 7 C -2.6201 3.035 0.0 0
M  V30 8 N -3.9242 2.3 0.0 0
M  V30 9 C -5.2283 0.0474 0.0 0
M  V30 10 C 1.2567 2.3118 0.0 0
M  V30 11 O -2.6438 4.5407 0.0 0
M  V30 12 N 2.4422 3.2128 0.0 0
M  V30 13 N 1.6953 0.8891 0.0 0
M  V30 14 C -1.3515 5.2994 0.0 0
M  V30 15 C 3.6396 2.3355 0.0 0
M  V30 16 C 3.1773 0.901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 7 8
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
",75438-57-2,Moxonidine,"4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine","MI, 13, 6318",Cardiovasc Ther. 2012 Aug 30(4):199-208,11/15/1978,1991,,C02AC05,,,,,Oral,GI tract,Plasmatic proteins,,,"0,3","Asthenia, Dizziness, Insomnia, Mouth dryness, Pruritus, Somnolence",Protein,Imidazoline i1 receptor,Cardiovascular,Antihypertensive,,,7,88,2.6 - 2.8,90,1.8
"Etilefrine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O -0.6731 -4.2315 0.0 0
M  V30 3 C 0.613 -4.9648 0.0 0
M  V30 4 C 1.8993 -4.1593 0.0 0
M  V30 5 C 0.589 -6.4554 0.0 0
M  V30 6 C 3.1976 -4.8926 0.0 0
M  V30 7 C 1.8753 -7.1647 0.0 0
M  V30 8 C 3.1736 -6.4073 0.0 0
M  V30 9 C 4.4839 -4.0992 0.0 0 CFG=1
M  V30 10 O 4.4478 -2.5605 0.0 0
M  V30 11 C 5.7822 -4.8325 0.0 0
M  V30 12 N 7.0685 -4.0391 0.0 0
M  V30 13 C 8.3548 -4.7484 0.0 0
M  V30 14 C 9.6411 -3.955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 2 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 2 5 7
M  V30 6 2 6 8
M  V30 7 1 6 9
M  V30 8 1 9 10 CFG=1
M  V30 9 1 9 11
M  V30 10 1 11 12
M  V30 11 1 12 13
M  V30 12 1 13 14
M  V30 13 1 7 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",534-87-2,Etilefrine hydrochloride,2-Ethylamino-1-(3-hydroxyphenyl)ethanol monohydrochloride,"MI, 13, 3897",Urology. 2005 May 65(5):1002,1/6/1976,1957,,C01CA01,"H2O, EtOH",,,,Oral,,Albumin (8),,,50,"Anxiety, Facial flushing, Headache, Palpitations, Tachycardia",,,Cardiovascular,Vasoconstrictor,,,23,,,,2.1
"Alprostadil
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 0.0 -1.4954 0.0 0
M  V30 3 C 1.2106 -2.3619 0.0 0 CFG=1
M  V30 4 C -1.2343 -2.3619 0.0 0
M  V30 5 C 0.7358 -3.7861 0.0 0 CFG=2
M  V30 6 C 2.5043 -1.6023 0.0 0
M  V30 7 C -0.7714 -3.7861 0.0 0 CFG=2
M  V30 8 C 2.0295 -4.5339 0.0 0
M  V30 9 C 3.798 -2.3381 0.0 0
M  V30 10 O -1.6735 -4.9968 0.0 0
M  V30 11 C 3.3232 -3.7624 0.0 0
M  V30 12 C 5.1036 -1.5785 0.0 0
M  V30 13 C 4.617 -4.5101 0.0 0 CFG=1
M  V30 14 C 6.3973 -2.3144 0.0 0
M  V30 15 O 4.6051 -6.0056 0.0 0
M  V30 16 C 5.9107 -3.7387 0.0 0
M  V30 17 C 7.691 -1.5548 0.0 0
M  V30 18 C 7.2044 -4.4864 0.0 0
M  V30 19 C 8.9847 -2.2906 0.0 0
M  V30 20 C 8.5099 -3.7149 0.0 0
M  V30 21 C 10.2784 -1.531 0.0 0
M  V30 22 C 9.8037 -4.4627 0.0 0
M  V30 23 O 10.2665 -0.0118 0.0 0
M  V30 24 O 11.5721 -2.2669 0.0 0
M  V30 25 C 11.0974 -3.6912 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6 CFG=3
M  V30 6 1 4 7
M  V30 7 1 5 8 CFG=1
M  V30 8 1 6 9
M  V30 9 1 7 10 CFG=3
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15 CFG=3
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 5 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 5 7 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",745-65-3,Alprostadil,"7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid","MI, 13, 7968",Expert Opin Pharmacother. 2008 Jun 9(8):1421-9,2/29/1972,1979,Yes,G04BE01,,,,,Parenteral,,Plasmatic proteins,Lung,"Inactive (15-oxo-13,14-dihydro-PGE1)","0,25","Hematoma, Priapism",,,Cardiovascular,"Erectile dysfunction treatment, Vasodilator",,,95,,0.1,,
"Tribenoside
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.2487 -0.8444 0.0 0
M  V30 3 C 1.1893 -0.8444 0.0 0 CFG=1
M  V30 4 O -2.7235 -0.3449 0.0 0
M  V30 5 C -0.8206 -2.2477 0.0 0 CFG=1
M  V30 6 C 0.6779 -2.2477 0.0 0 CFG=1
M  V30 7 C 2.5926 -0.3449 0.0 0 CFG=2
M  V30 8 C -3.0803 1.1655 0.0 0
M  V30 9 O -1.7363 -3.4371 0.0 0
M  V30 10 O 1.5342 -3.4371 0.0 0
M  V30 11 O 2.8781 1.1655 0.0 0
M  V30 12 C 3.6749 -1.3201 0.0 0
M  V30 13 C -4.555 1.6769 0.0 0
M  V30 14 C 2.997 -3.2349 0.0 0
M  V30 15 C 4.2815 1.6769 0.0 0
M  V30 16 O 5.0783 -0.8206 0.0 0
M  V30 17 C 3.8533 -4.4242 0.0 0
M  V30 18 C 4.5669 3.1873 0.0 0
M  V30 19 C 6.1606 -1.7958 0.0 0
M  V30 20 C 5.3043 -4.222 0.0 0
M  V30 21 C 3.1873 -5.7681 0.0 0
M  V30 22 C 5.9703 3.6868 0.0 0
M  V30 23 C 3.4133 4.222 0.0 0
M  V30 24 C 7.564 -1.2963 0.0 0
M  V30 25 C 6.1606 -5.3994 0.0 0
M  V30 26 C 4.0317 -6.9574 0.0 0
M  V30 27 C 6.2438 5.2091 0.0 0
M  V30 28 C 3.6749 5.7443 0.0 0
M  V30 29 C 8.6462 -2.2715 0.0 0
M  V30 30 C 7.8375 0.214 0.0 0
M  V30 31 C 5.5065 -6.7671 0.0 0
M  V30 32 C 5.0902 6.2557 0.0 0
M  V30 33 C 10.0377 -1.772 0.0 0
M  V30 34 C 9.2409 0.7254 0.0 0
M  V30 35 C 10.3232 -0.2497 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 1 CFG=3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9 CFG=1
M  V30 9 1 6 10 CFG=3
M  V30 10 1 7 11 CFG=3
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 1 20 25
M  V30 25 2 21 26
M  V30 26 1 22 27
M  V30 27 2 23 28
M  V30 28 2 24 29
M  V30 29 1 24 30
M  V30 30 2 25 31
M  V30 31 2 27 32
M  V30 32 1 29 33
M  V30 33 2 30 34
M  V30 34 2 33 35
M  V30 35 1 5 6
M  V30 36 1 26 31
M  V30 37 1 28 32
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 5 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",10310-32-4,Tribenoside,"(3R,4R,5R)-5-[1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxyoxolan-3-ol","MI, 13, 9682",Pharmacology. 1977 15(5):445-60,2/17/1981,,,C05CX01,,,,,,,,,,,"Diarrhoea, Hypersensitivity reactions, Nausea",,,Cardiovascular,,,,,,,,
"Amoxapine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C -1.4206 -0.3991 0.0 0
M  V30 3 C -2.5359 0.6339 0.0 0
M  V30 4 C -1.7728 -1.8315 0.0 0
M  V30 5 C -3.9565 0.1995 0.0 0
M  V30 6 C -3.2286 -2.2659 0.0 0
M  V30 7 C -4.931 1.3736 0.0 0
M  V30 8 C -4.3087 -1.2444 0.0 0
M  V30 9 N -6.4103 1.3853 0.0 0
M  V30 10 N -4.3557 2.7238 0.0 0
M  V30 11 O -5.7058 -1.9019 0.0 0
M  V30 12 C -7.373 0.2348 0.0 0
M  V30 13 C -2.8764 2.9233 0.0 0
M  V30 14 C -5.248 3.933 0.0 0
M  V30 15 C -7.056 -1.2092 0.0 0
M  V30 16 C -8.7936 0.7161 0.0 0
M  V30 17 C -2.3011 4.3205 0.0 0
M  V30 18 C -4.6844 5.3301 0.0 0
M  V30 19 C -8.1479 -2.2072 0.0 0
M  V30 20 C -9.9207 -0.2582 0.0 0
M  V30 21 N -3.2051 5.5415 0.0 0
M  V30 22 C -9.6037 -1.7375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 2 19 22
M  V30 22 1 6 8
M  V30 23 2 12 15
M  V30 24 1 18 21
M  V30 25 1 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
",14028-44-5,Amoxapine,"8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine","MI, 12, 616",Drugs. 1982 Jul 24(1):1-23,5/16/1972,1980,Yes,N06AA17Â ,MeOH,,,,Oral,,,Liver,"Active (7-hydroxy-amoxapine, 8-hydroxy-amoxapine)",150,"Blurred vision, Constipation, Drowsiness, Hot flushes, Mouth dryness, Orthostatic hypotension, Suicide, Weight gain",,,Central Nervous System,"Antidepressant, Antipsychotic",,,,,8 - 30,,
"Rimexolone
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2895 0.762 0.0 0
M  V30 3 C 2.5205 0.0586 0.0 0
M  V30 4 C 1.27 2.2274 0.0 0
M  V30 5 C 3.7515 0.8206 0.0 0
M  V30 6 C 2.501 2.9699 0.0 0
M  V30 7 C 3.7319 2.286 0.0 0 CFG=2
M  V30 8 C 4.9825 0.1367 0.0 0
M  V30 9 C 4.9629 3.0285 0.0 0 CFG=1
M  V30 10 C 3.6929 3.8101 0.0 0
M  V30 11 C 6.233 0.8792 0.0 0
M  V30 12 C 4.9238 4.494 0.0 0 CFG=1
M  V30 13 C 6.1744 2.3447 0.0 0 CFG=1
M  V30 14 O 3.5952 5.256 0.0 0
M  V30 15 C 6.1157 5.2755 0.0 0
M  V30 16 C 7.4249 3.0872 0.0 0 CFG=1
M  V30 17 C 7.3858 4.5526 0.0 0 CFG=1
M  V30 18 C 9.8868 3.0872 0.0 0
M  V30 19 C 8.6168 5.2951 0.0 0 CFG=2
M  V30 20 C 7.3272 6.0767 0.0 0
M  V30 21 C 9.8868 4.5721 0.0 0 CFG=2
M  V30 22 C 8.5972 6.8191 0.0 0
M  V30 23 C 9.9259 6.018 0.0 0
M  V30 24 C 11.1764 5.3342 0.0 0
M  V30 25 O 7.2881 7.6007 0.0 0
M  V30 26 C 9.8868 7.5812 0.0 0
M  V30 27 C 11.1569 6.8582 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10 CFG=1
M  V30 10 1 8 11
M  V30 11 1 9 12 CFG=1
M  V30 12 1 9 13
M  V30 13 1 12 14 CFG=1
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 1 16 18 CFG=1
M  V30 18 1 17 19
M  V30 19 1 17 20 CFG=1
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 23 CFG=3
M  V30 23 1 21 24 CFG=3
M  V30 24 2 22 25
M  V30 25 1 22 26
M  V30 26 1 26 27
M  V30 27 1 6 7
M  V30 28 1 13 11 CFG=3
M  V30 29 1 16 17
M  V30 30 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 7 9 12 13 16 17 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",49697-38-3,Rimexolone,"(8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","MI, 13, 8310",Int Ophthalmol. 2008 Aug 28(4):281-5,1/21/1975,1995,Yes,H02AB12,,Chemical classification (according ATC code),Glucocorticoid,,Topical,,,,,20,"Blurred vision, Glaucoma, Headache, Occular irritation, Optic nerve damage, Photophobia",Nuclear receptor,Glucocorticoid receptor,Metabolism,Anti-inflammatory,,,,,1 - 2,,
"Isradipine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 0.0 1.3766 0.0 0
M  V30 3 O 1.2762 2.1366 0.0 0
M  V30 4 C -1.3192 2.1652 0.0 0
M  V30 5 C 2.5237 1.4052 0.0 0
M  V30 6 C -1.3192 3.6853 0.0 0
M  V30 7 C -2.6528 1.4769 0.0 0 CFG=2
M  V30 8 C 3.8143 2.1652 0.0 0
M  V30 9 C 2.4807 -0.0573 0.0 0
M  V30 10 N -2.6385 4.4739 0.0 0
M  V30 11 C -0.0573 4.4453 0.0 0
M  V30 12 C -3.9721 2.2513 0.0 0
M  V30 13 C -2.6958 -0.3298 0.0 0
M  V30 14 C -3.9721 3.757 0.0 0
M  V30 15 C -5.3056 1.5343 0.0 0
M  V30 16 C -4.0294 -1.0467 0.0 0
M  V30 17 C -1.4196 -1.0611 0.0 0
M  V30 18 C -5.2913 4.5456 0.0 0
M  V30 19 O -5.3487 0.2724 0.0 0
M  V30 20 O -6.6249 2.3086 0.0 0
M  V30 21 N -5.4777 -0.5592 0.0 0
M  V30 22 C -4.0581 -2.5381 0.0 0
M  V30 23 C -1.4483 -2.5381 0.0 0
M  V30 24 C -7.9585 1.606 0.0 0
M  V30 25 O -6.3811 -1.7494 0.0 0
M  V30 26 N -5.5207 -2.9539 0.0 0
M  V30 27 C -2.7962 -3.2551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13 CFG=1
M  V30 13 1 10 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 15 20
M  V30 20 2 16 21
M  V30 21 1 16 22
M  V30 22 1 17 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 22 27
M  V30 27 2 12 14
M  V30 28 2 23 27
M  V30 29 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",75695-93-1,Isradipine,"3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","MI, 13, 5262",Drugs. 1995 Apr 49(4):618-49,8/21/1984,1989,Yes,C08CA03Â ,,"Chemical classification (according ATC code), New therapeutic use, Reference","Dihydropyridine derivatives, Antialzheimer, Biochim Biophys Acta. 2011 Dec 1812(12):1584-90",,Oral,GI tract,,Liver,,5,"Dizziness, Dyspnea, Facial flushing, Fatigue, Gingivitis, Headache, Oedema, Palpitations, Tachycardia, Urinary troubles",Ion channel,Voltage-gated L-type calcium channel,Cardiovascular,"Antianginal, Antihypertensive",,,95,16 - 18,8.4,90 - 95,3.77
"Isometheptene mucate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 34 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0318 -1.464 0.0 0
M  V30 3 O -1.3685 -2.1801 0.0 0
M  V30 4 C 1.2571 -2.1801 0.0 0
M  V30 5 O 1.2253 -3.6442 0.0 0
M  V30 6 C 2.5302 -1.4004 0.0 0
M  V30 7 O 2.4984 0.1273 0.0 0
M  V30 8 C 3.8033 -2.1165 0.0 0
M  V30 9 O 3.7715 -3.5806 0.0 0
M  V30 10 C 5.0765 -1.3367 0.0 0
M  V30 11 O 5.0446 0.1909 0.0 0
M  V30 12 C 6.3336 -2.0528 0.0 0
M  V30 13 O 7.6227 -1.2731 0.0 0
M  V30 14 O 6.3018 -3.5169 0.0 0
M  V30 15 N 16.0411 2.1642 0.0 0
M  V30 16 C 16.0092 0.7002 0.0 0
M  V30 17 C 17.3142 2.944 0.0 0
M  V30 18 C 14.6725 -0.0159 0.0 0
M  V30 19 C 17.2823 -0.0159 0.0 0
M  V30 20 C 13.3357 0.7638 0.0 0
M  V30 21 C 11.999 0.0477 0.0 0
M  V30 22 C 10.6463 0.8275 0.0 0
M  V30 23 C 10.6145 2.3552 0.0 0
M  V30 24 C 9.3095 0.1113 0.0 0
M  V30 25 N 15.7864 -3.0554 0.0 0
M  V30 26 C 15.7546 -4.5195 0.0 0
M  V30 27 C 17.0595 -2.2756 0.0 0
M  V30 28 C 14.4179 -5.2356 0.0 0
M  V30 29 C 17.0277 -5.2356 0.0 0
M  V30 30 C 13.0811 -4.4558 0.0 0
M  V30 31 C 11.7443 -5.1719 0.0 0
M  V30 32 C 10.4076 -4.3922 0.0 0
M  V30 33 C 10.3758 -2.8644 0.0 0
M  V30 34 C 9.0708 -5.1083 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 15 16
M  V30 15 1 15 17
M  V30 16 1 16 18
M  V30 17 1 16 19
M  V30 18 1 18 20
M  V30 19 1 20 21
M  V30 20 2 21 22
M  V30 21 1 22 23
M  V30 22 1 22 24
M  V30 23 1 25 26
M  V30 24 1 25 27
M  V30 25 1 26 28
M  V30 26 1 26 29
M  V30 27 1 28 30
M  V30 28 1 30 31
M  V30 29 2 31 32
M  V30 30 1 32 33
M  V30 31 1 32 34
M  V30 END BOND
M  V30 END CTAB
M  END
",7492-31-1,Isometheptene mucate,"(2S,3R,4S,5R)-2,3,4,5-tetrahydroxyhexanedioic acid N,6-dimethylhept-5-en-2-amine","MI, 13, 5204",Expert Rev Neurother. 2012 Feb 12(2):159-67,6/11/1985,Withdrawn,,A03AX10,H2O,,,,,,,,,,"Dizziness, Rash, Thrombosis",,,Cardiovascular,"Antimigraine, Vasoconstrictor",,,,,,,
"Nifurtimox
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 1.0967 0.9895 0.0 0
M  V30 3 O 0.5483 -1.359 0.0 0
M  V30 4 C -0.7272 -1.2994 0.0 0
M  V30 5 C -0.8106 1.2875 0.0 0
M  V30 6 C -2.2174 -1.3233 0.0 0 CFG=1
M  V30 7 C -2.3247 1.2398 0.0 0
M  V30 8 N -3.0281 -0.0357 0.0 0
M  V30 9 C -2.9446 -2.6227 0.0 0
M  V30 10 N -4.5302 -0.0834 0.0 0
M  V30 11 C -6.0442 -0.0715 0.0 0
M  V30 12 C -7.4868 -0.5126 0.0 0
M  V30 13 O -8.7147 0.3695 0.0 0
M  V30 14 C -7.9756 -1.9193 0.0 0
M  V30 15 C -9.9546 -0.4649 0.0 0
M  V30 16 C -9.5015 -1.8955 0.0 0
M  V30 17 N -11.3852 0.0119 0.0 0 CHG=1
M  V30 18 O -12.5177 -0.9537 0.0 0
M  V30 19 O -11.7309 1.5021 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9 CFG=3
M  V30 9 1 8 10
M  V30 10 2 10 11 CFG=2
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 7 8
M  V30 20 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",23256-30-6,Nifurtimox,"(E)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine","MI, 13, 6566",J Pharm Sci. 2012 Mar 101(3):888-94,5/27/1964,1965,,P01CC01,,Chemical classification (according ATC code),Nitrofuran derivative,,,,,,,700,"Anorexia, Dizziness, Headache, Nausea",,,Metabolism,,,,,,,,
"Letrozole
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0 0.0 0.0 0
M  V30 2 C 1.2935 0.7785 0.0 0
M  V30 3 C 2.5871 1.5571 0.0 0
M  V30 4 C 2.5752 3.0662 0.0 0
M  V30 5 C 3.8807 0.8144 0.0 0
M  V30 6 C 3.8688 3.8328 0.0 0
M  V30 7 C 5.1624 1.581 0.0 0
M  V30 8 C 5.1504 3.0902 0.0 0
M  V30 9 C 6.432 3.8568 0.0 0
M  V30 10 N 6.432 5.3899 0.0 0
M  V30 11 C 7.7256 3.1022 0.0 0
M  V30 12 N 7.5459 6.408 0.0 0
M  V30 13 C 5.1264 6.1565 0.0 0
M  V30 14 C 7.7136 1.6169 0.0 0
M  V30 15 C 9.0072 3.8688 0.0 0
M  V30 16 C 6.9231 7.7735 0.0 0
M  V30 17 N 5.4378 7.6298 0.0 0
M  V30 18 C 8.9952 0.8743 0.0 0
M  V30 19 C 10.3008 3.1261 0.0 0
M  V30 20 C 10.2888 1.6409 0.0 0
M  V30 21 C 11.5824 0.8863 0.0 0
M  V30 22 N 12.888 0.1317 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 2 18 20
M  V30 20 1 20 21
M  V30 21 3 21 22
M  V30 22 1 7 8
M  V30 23 1 16 17
M  V30 24 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
",112809-51-5,Letrozole,"4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile","MI, 13, 5469",Oncologist. 2011 16(12):1762-70,9/16/1987,1996,Yes,L02BG04,,Therapeutic classification (according ATC code),Aromatase inhibitor,,Oral,,Albumin (55%),Liver,Inactive,"2,5","Arthralgia, Bone weakness, Fatigue, Hot flushes, Hypercholesterolemia, Nausea, Sweat, Thrombosis",Coenzyme,Cytochrome P450 19A1,Oncology,Antineoplastic,,1 - 2,60,99,48,,1.87
"Arbutin
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2459 0.8069 0.0 0 CFG=1
M  V30 3 C 0.0474 -1.4832 0.0 0 CFG=1
M  V30 4 O 1.1866 2.3139 0.0 0
M  V30 5 C 2.575 0.1305 0.0 0 CFG=2
M  V30 6 C 1.3883 -2.1715 0.0 0 CFG=2
M  V30 7 C -1.2222 -2.2664 0.0 0
M  V30 8 C -0.1305 3.0021 0.0 0
M  V30 9 O 3.8447 0.9374 0.0 0
M  V30 10 C 2.6224 -1.3646 0.0 0 CFG=2
M  V30 11 O 1.4002 -3.6548 0.0 0
M  V30 12 O -2.575 -1.5544 0.0 0
M  V30 13 C -0.1898 4.5092 0.0 0
M  V30 14 C -1.3883 2.219 0.0 0
M  V30 15 O 3.9396 -2.0528 0.0 0
M  V30 16 C -1.5544 5.233 0.0 0
M  V30 17 C -2.7292 2.9309 0.0 0
M  V30 18 C -2.8004 4.438 0.0 0
M  V30 19 O -4.1532 5.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 4 8
M  V30 8 1 5 9 CFG=3
M  V30 9 1 5 10
M  V30 10 1 6 11 CFG=3
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 10 15 CFG=1
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 2 16 18
M  V30 18 1 18 19
M  V30 19 1 6 10
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 3 5 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",497-76-7,Arbutin,"(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol","MI, 13, 778",Phytomedicine. 2003 10 Suppl 4:58-60.,4/12/2004,Preclinical,,Not yet attributed,H2O,"New therapeutic use, Reference","Depigmentation treatment, J Cosmet Laser Ther. 2010 Jun 12(3):126-31",,,,,,,,,,,"Infectiology, Metabolism",Antibacterial,,,,,,,
"Tocainide hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 3.1327 -5.8857 0.0 0
M  V30 3 C 3.1089 -4.3668 0.0 0
M  V30 4 N 1.7799 -3.6073 0.0 0
M  V30 5 C 4.3786 -3.6073 0.0 0 CFG=1
M  V30 6 C 0.4627 -4.343 0.0 0
M  V30 7 N 4.343 -2.0884 0.0 0
M  V30 8 C 5.6483 -4.3312 0.0 0
M  V30 9 C -0.8543 -3.5836 0.0 0
M  V30 10 C 0.439 -5.8145 0.0 0
M  V30 11 C -2.1715 -4.3074 0.0 0
M  V30 12 C -0.8899 -2.0647 0.0 0
M  V30 13 C -0.8781 -6.5383 0.0 0
M  V30 14 C 1.7206 -6.5383 0.0 0
M  V30 15 C -2.1952 -5.7789 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 1 5 7 CFG=1
M  V30 6 1 5 8
M  V30 7 2 6 9
M  V30 8 1 6 10
M  V30 9 1 9 11
M  V30 10 1 9 12
M  V30 11 2 10 13
M  V30 12 1 10 14
M  V30 13 2 11 15
M  V30 14 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",71395-14-7,Tocainide hydrochloride,"2-amino-N-(2,6-dimethylphenyl)propanamide hydrochloride","MI, 13, 9568",Am Heart J. 1985 Oct 110(4):856-63,2/22/1973,1981,Yes,C01BB03,,"New therapeutic use, Reference, Therapeutic classification (according ATC code)","Anti-tinnitus, Clin Otolaryngol Allied Sci. 1985 Apr 10(2):97-101, Antiarrhythmic, class Ib",Yes,Oral,GI tract,Plasmatic proteins,Liver,Inactive,1200,"Anorexia, Arthralgia, Bradycardia, Confusion, Diarrhoea, Hallucinations, Headache, Hypersensitivity reactions, Hypotension, Nausea, Paresthesia, Seizure, Tremor, Vertigo",LGIC,Voltage-gated sodium channel,"Cardiovascular, Central Nervous System","Anesthetic, Antiarrhythmic",,,10,,10 - 20,,
"Benzathine benzylpenicillin
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 66 71 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C 0.8213 -1.1646 0.0 0
M  V30 3 C -1.4833 -0.429 0.0 0 CFG=1
M  V30 4 C -0.098 -2.3292 0.0 0 CFG=1
M  V30 5 C 1.5936 -2.366 0.0 0
M  V30 6 C 1.6549 0.0858 0.0 0
M  V30 7 N -1.5323 -1.8879 0.0 0
M  V30 8 C -3.0402 -0.38 0.0 0 CFG=1
M  V30 9 C 0.3187 -3.7022 0.0 0
M  V30 10 C -3.0893 -1.8388 0.0 0
M  V30 11 N -4.5971 -0.2942 0.0 0
M  V30 12 O 1.753 -3.9842 0.0 0
M  V30 13 O -0.7232 -4.7565 0.0 0
M  V30 14 O -4.2048 -2.8441 0.0 0
M  V30 15 C -5.9456 0.5026 0.0 0
M  V30 16 O -6.0069 2.0595 0.0 0
M  V30 17 C -7.2942 -0.2206 0.0 0
M  V30 18 O -8.6427 0.5761 0.0 0
M  V30 19 C -9.9912 -0.1593 0.0 0
M  V30 20 C -11.3519 0.6252 0.0 0
M  V30 21 C -10.028 -1.6182 0.0 0
M  V30 22 C -12.7005 -0.098 0.0 0
M  V30 23 C -11.3765 -2.3415 0.0 0
M  V30 24 C -12.7495 -1.5569 0.0 0
M  V30 25 S 11.7688 4.9036 0.0 0
M  V30 26 C 12.5779 3.739 0.0 0
M  V30 27 C 10.2854 4.4745 0.0 0 CFG=1
M  V30 28 C 11.6707 2.5744 0.0 0 CFG=1
M  V30 29 C 13.4237 4.9894 0.0 0
M  V30 30 C 13.3502 2.5376 0.0 0
M  V30 31 N 10.2364 3.0157 0.0 0
M  V30 32 C 8.7285 4.5236 0.0 0 CFG=1
M  V30 33 C 12.0998 1.2013 0.0 0
M  V30 34 C 8.6794 3.0647 0.0 0
M  V30 35 N 7.1838 4.6094 0.0 0
M  V30 36 O 13.5218 0.9194 0.0 0
M  V30 37 O 11.0577 0.1471 0.0 0
M  V30 38 O 7.5761 2.0595 0.0 0
M  V30 39 C 5.8353 5.394 0.0 0
M  V30 40 O 5.774 6.9509 0.0 0
M  V30 41 C 4.4868 4.6707 0.0 0
M  V30 42 O 3.126 5.4553 0.0 0
M  V30 43 C 1.7775 4.7197 0.0 0
M  V30 44 C 0.429 5.5166 0.0 0
M  V30 45 C 1.7408 3.2609 0.0 0
M  V30 46 C -0.9194 4.7933 0.0 0
M  V30 47 C 0.38 2.5376 0.0 0
M  V30 48 C -0.9684 3.3344 0.0 0
M  V30 49 N -6.4728 10.9842 0.0 0
M  V30 50 C -5.2224 10.2486 0.0 0
M  V30 51 C -7.8213 10.2486 0.0 0
M  V30 52 C -3.9719 11.0455 0.0 0
M  V30 53 C -7.8703 8.7898 0.0 0
M  V30 54 C -2.7215 10.3222 0.0 0
M  V30 55 C -4.021 12.6146 0.0 0
M  V30 56 N -6.6199 8.0787 0.0 0
M  V30 57 C -1.4711 11.119 0.0 0
M  V30 58 C -2.7705 13.3992 0.0 0
M  V30 59 C -5.394 8.8756 0.0 0
M  V30 60 C -1.5201 12.6882 0.0 0
M  V30 61 C -4.1436 8.1523 0.0 0
M  V30 62 C -2.8931 8.9491 0.0 0
M  V30 63 C -4.1926 6.6935 0.0 0
M  V30 64 C -1.6304 8.2259 0.0 0
M  V30 65 C -2.9299 5.9702 0.0 0
M  V30 66 C -1.6795 6.767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 1 CFG=1
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 8 3 CFG=1
M  V30 8 1 4 9 CFG=3
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 25 26
M  V30 25 1 27 25 CFG=1
M  V30 26 1 26 28
M  V30 27 1 26 29
M  V30 28 1 26 30
M  V30 29 1 27 31
M  V30 30 1 32 27 CFG=1
M  V30 31 1 28 33 CFG=3
M  V30 32 1 31 34
M  V30 33 1 32 35
M  V30 34 2 33 36
M  V30 35 1 33 37
M  V30 36 2 34 38
M  V30 37 1 35 39
M  V30 38 2 39 40
M  V30 39 1 39 41
M  V30 40 1 41 42
M  V30 41 1 42 43
M  V30 42 2 43 44
M  V30 43 1 43 45
M  V30 44 1 44 46
M  V30 45 2 45 47
M  V30 46 2 46 48
M  V30 47 1 49 50
M  V30 48 1 49 51
M  V30 49 1 50 52
M  V30 50 1 51 53
M  V30 51 2 52 54
M  V30 52 1 52 55
M  V30 53 1 53 56
M  V30 54 1 54 57
M  V30 55 2 55 58
M  V30 56 1 56 59
M  V30 57 2 57 60
M  V30 58 1 59 61
M  V30 59 2 61 62
M  V30 60 1 61 63
M  V30 61 1 62 64
M  V30 62 2 63 65
M  V30 63 2 64 66
M  V30 64 1 4 7
M  V30 65 1 8 10
M  V30 66 1 23 24
M  V30 67 1 28 31
M  V30 68 1 32 34
M  V30 69 1 47 48
M  V30 70 1 58 60
M  V30 71 1 65 66
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 3 4 8 27 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",5928-84-7,Benzathine benzylpenicillin,"3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid N,N'-dibenzylethane-1,2-diamine","MI, 13, 7171",Lancet. 2012 Jan 28 379(9813):342-7,2/3/1953,1952,Yes,J01CE08Â ,H2O,Chemical classification (according ATC code),Beta-lactamase sensitive penicillin,,Oral,,Plasmatic proteins,Low,,3600,"Diarrhoea, Hypersensitivity reactions, Nausea, Rash",,,"Infectiology, Metabolism",Antibacterial,,12 - 24,40 - 60,,336,,
"Risperidone
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0 0.0 0.0 0
M  V30 2 C -1.4688 -0.282 0.0 0
M  V30 3 C -1.9505 -1.692 0.0 0
M  V30 4 C -2.4793 0.8577 0.0 0
M  V30 5 C -3.4193 -1.974 0.0 0
M  V30 6 C -3.9481 0.5522 0.0 0
M  V30 7 O -4.1949 -3.2548 0.0 0
M  V30 8 C -4.4181 -0.8342 0.0 0
M  V30 9 N -5.6637 -2.9141 0.0 0
M  V30 10 C -5.8047 -1.4218 0.0 0
M  V30 11 C -7.109 -0.6462 0.0 0
M  V30 12 C -8.4133 -1.3748 0.0 0
M  V30 13 C -7.0972 0.8577 0.0 0
M  V30 14 C -9.7176 -0.5992 0.0 0
M  V30 15 C -8.4015 1.6333 0.0 0
M  V30 16 N -9.7058 0.9047 0.0 0
M  V30 17 C -11.0101 1.6568 0.0 0
M  V30 18 C -12.3145 0.9282 0.0 0
M  V30 19 C -13.607 1.7038 0.0 0
M  V30 20 C -14.9113 0.9752 0.0 0
M  V30 21 C -13.6188 3.2078 0.0 0
M  V30 22 O -14.9348 -0.5052 0.0 0
M  V30 23 N -16.2156 1.7273 0.0 0
M  V30 24 N -14.9231 3.9599 0.0 0
M  V30 25 C -12.338 3.9481 0.0 0
M  V30 26 C -16.2156 3.2313 0.0 0
M  V30 27 C -17.5082 1.0105 0.0 0
M  V30 28 C -17.5199 3.9951 0.0 0
M  V30 29 C -18.8125 1.7508 0.0 0
M  V30 30 C -18.8242 3.2548 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 1 21 25
M  V30 25 1 23 26
M  V30 26 1 23 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 6 8
M  V30 31 2 9 10
M  V30 32 1 15 16
M  V30 33 2 24 26
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
",106266-06-2,Risperidone,"3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl}-6,7,8,9-tetrahydro-2-methylpyrido[1,2-a]pyrimidin-4-one","MI, 13, 8316",Adv Ther. 2009 Jun 26(6):588-99.,10/1/1986,1993,Yes,N05AX08,,,,,Oral,,"Albumin, alpha-1-acid glycoprotein",Liver,Active (9-hydroxy-risperidone),5,"Arthralgia, Blurred vision, Constipation, Dyspnea, Headache, Hypertension, Insomnia, Mouth dryness, Nausea, Nose bleed, Oedema, Rash, Sedation, Somnolence, Tachycardia, Upper respiratory tract infection, Urinary troubles, Weight gain",,,Central Nervous System,Antipsychotic,,1 - 2,90,70,3 - 24,,1 - 2
"Cyproheptadine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 N 1.3291 -5.4113 0.0 0
M  V30 3 C 2.0648 -6.6811 0.0 0
M  V30 4 C 2.0648 -4.1059 0.0 0
M  V30 5 C -0.1898 -5.3994 0.0 0
M  V30 6 C 3.56 -6.6692 0.0 0
M  V30 7 C 3.56 -4.0941 0.0 0
M  V30 8 C 4.2958 -5.3757 0.0 0
M  V30 9 C 5.791 -5.3638 0.0 0
M  V30 10 C 6.4319 -6.7048 0.0 0
M  V30 11 C 6.4319 -4.011 0.0 0
M  V30 12 C 7.9034 -7.0252 0.0 0
M  V30 13 C 5.3994 -7.7966 0.0 0
M  V30 14 C 7.9034 -3.655 0.0 0
M  V30 15 C 5.3994 -2.8836 0.0 0
M  V30 16 C 9.0545 -6.0759 0.0 0
M  V30 17 C 8.3306 -8.4611 0.0 0
M  V30 18 C 5.8385 -9.2325 0.0 0
M  V30 19 C 9.0545 -4.5806 0.0 0
M  V30 20 C 8.3306 -2.1953 0.0 0
M  V30 21 C 5.8385 -1.4359 0.0 0
M  V30 22 C 7.2982 -9.5529 0.0 0
M  V30 23 C 7.2982 -1.068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 1 2 5
M  V30 4 1 3 6
M  V30 5 1 4 7
M  V30 6 1 6 8
M  V30 7 2 8 9
M  V30 8 1 9 10
M  V30 9 1 9 11
M  V30 10 2 10 12
M  V30 11 1 10 13
M  V30 12 2 11 14
M  V30 13 1 11 15
M  V30 14 1 12 16
M  V30 15 1 12 17
M  V30 16 2 13 18
M  V30 17 1 14 19
M  V30 18 1 14 20
M  V30 19 2 15 21
M  V30 20 2 17 22
M  V30 21 2 20 23
M  V30 22 1 7 8
M  V30 23 2 16 19
M  V30 24 1 18 22
M  V30 25 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
",969-33-5,Cyproheptadine hydrochloride,"4-(5H-dibenzo [a,d]cyclohepten-5-ylidene)-1-methylpiperidine hydrochloride","MI, 12, 2842",Arch Gen Psychiatry. 1986 Feb 43(2):177-81,12/26/1961,1961,Yes,R06AX02,,,,,Oral,GI tract,,Liver,,12,"Blurred vision, Confusion, Constipation, Dizziness, Memory loss, Motor incoordination, Mouth dryness, Mydriasis, Orthostatic hypotension, Palpitations, Sedation, Somnolence, Urinary troubles, Weight gain",GPCR,Histamine H1 receptor,"Allergology, Central Nervous System","Antihistaminic, Antipruritic, Sedative",,6 - 9,,,10 - 15,,
"Torsemide
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 0.621 1.3614 0.0 0
M  V30 3 O 1.4689 0.1074 0.0 0
M  V30 4 N -1.3256 0.7523 0.0 0
M  V30 5 C -0.0238 -1.5047 0.0 0
M  V30 6 C -2.6393 0.0119 0.0 0
M  V30 7 C 1.2778 -2.2452 0.0 0
M  V30 8 C -1.3375 -2.2332 0.0 0
M  V30 9 O -2.6512 -1.4808 0.0 0
M  V30 10 N -3.953 0.7762 0.0 0
M  V30 11 N 2.5676 -1.4808 0.0 0
M  V30 12 C 1.2659 -3.738 0.0 0
M  V30 13 N -1.3495 -3.738 0.0 0
M  V30 14 C -5.2667 0.0358 0.0 0
M  V30 15 C 3.8574 -2.2094 0.0 0
M  V30 16 C -0.0597 -4.4904 0.0 0
M  V30 17 C -6.5804 0.8001 0.0 0
M  V30 18 C -5.2786 -1.457 0.0 0
M  V30 19 C 5.1353 -1.445 0.0 0
M  V30 20 C 3.8336 -3.7022 0.0 0
M  V30 21 C 6.4251 -2.1855 0.0 0
M  V30 22 C 5.1234 -4.4426 0.0 0
M  V30 23 C 6.4251 -3.6783 0.0 0
M  V30 24 C 7.7149 -1.4092 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 15 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 21 24
M  V30 24 1 13 16
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
",56211-40-6,Torsemide,1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea,"MI, 13, 9629",Future Cardiol. 2012 Sep 8(5):707-28.,4/19/1977,1993,Yes,C03CA04,,"Chemical classification (according ATC code), Therapeutic classification (according ATC code)","Sulfonamide, High-ceiling diuretic",,Oral,,,,,15,"Dizziness, Drowsiness, Headache, Hypersensitivity reactions, Hypokalemia, Mouth dryness, Nausea",Carrier,Solute carrier family 12 member 1,Cardiovascular,"Antihypertensive, Diuretic",,,,,,,
"Halofantrine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C -1.3107 0.779 0.0 0
M  V30 3 C -1.3354 2.2875 0.0 0
M  V30 4 C -2.6214 0.0494 0.0 0
M  V30 5 C -2.6338 3.0666 0.0 0
M  V30 6 C -0.0494 3.0666 0.0 0
M  V30 7 C -3.9321 0.8284 0.0 0
M  V30 8 C -2.6709 4.5628 0.0 0
M  V30 9 C -3.9569 2.337 0.0 0
M  V30 10 C -0.0865 4.5628 0.0 0
M  V30 11 Cl -5.2552 0.0989 0.0 0
M  V30 12 C -1.3972 5.3418 0.0 0
M  V30 13 C -3.9816 5.3418 0.0 0
M  V30 14 C 1.187 5.3665 0.0 0 CFG=1
M  V30 15 C -1.422 6.8751 0.0 0
M  V30 16 C -4.0063 6.8503 0.0 0
M  V30 17 O 1.1499 6.8751 0.0 0
M  V30 18 C 2.4483 4.637 0.0 0
M  V30 19 C -2.7451 7.6541 0.0 0
M  V30 20 C -5.317 7.6294 0.0 0
M  V30 21 C 3.7096 5.416 0.0 0
M  V30 22 F -6.5165 8.3589 0.0 0
M  V30 23 F -5.5891 9.2121 0.0 0
M  V30 24 F -6.7885 7.11 0.0 0
M  V30 25 N 4.9708 4.6864 0.0 0
M  V30 26 C 6.2444 5.4654 0.0 0
M  V30 27 C 4.9461 3.2273 0.0 0
M  V30 28 C 7.5057 4.7359 0.0 0
M  V30 29 C 6.2197 2.4977 0.0 0
M  V30 30 C 8.767 5.5149 0.0 0
M  V30 31 C 7.481 3.2768 0.0 0
M  V30 32 C 10.0406 4.7853 0.0 0
M  V30 33 C 8.7546 2.5472 0.0 0
M  V30 34 Cl -0.7913 12.2664 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 10 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 14 17 CFG=1
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 18 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 2 7 9
M  V30 34 2 10 12
M  V30 35 1 16 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",36167-63-2,Halofantrine hydrochloride,"3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride","MI, 13, 4609",Ann Trop Med Parasitol. 1997 Oct 91(7):867-73,3/26/1985,1988,Yes,P01BX01,,,,,Oral,GI tract,,,,1500,"Diarrhoea, Electrocardiogram disturbances, Hypersensitivity reactions, Nausea, Pruritus",,,Metabolism,Antimalarial,,3 - 6,,,24 - 48,,
"Articaine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 S -0.5851 -4.0963 0.0 0
M  V30 3 C 0.6461 -4.9619 0.0 0
M  V30 4 C -1.8652 -4.9619 0.0 0
M  V30 5 C 0.2925 -6.4248 0.0 0
M  V30 6 C 1.9018 -4.1085 0.0 0
M  V30 7 C -1.402 -6.4127 0.0 0
M  V30 8 N 1.5483 -7.2173 0.0 0
M  V30 9 O 1.8043 -2.548 0.0 0
M  V30 10 O 3.2551 -4.7912 0.0 0
M  V30 11 C -2.3529 -7.6196 0.0 0
M  V30 12 C 2.9015 -6.4858 0.0 0
M  V30 13 C 4.5108 -3.9378 0.0 0
M  V30 14 O 2.8284 -5.5227 0.0 0
M  V30 15 C 4.1572 -7.2904 0.0 0 CFG=1
M  V30 16 N 5.5105 -6.559 0.0 0
M  V30 17 C 4.0597 -8.8022 0.0 0
M  V30 18 C 6.7906 -7.3636 0.0 0
M  V30 19 C 8.1195 -6.6321 0.0 0
M  V30 20 C 9.3996 -7.4367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 2 3 5
M  V30 4 1 3 6
M  V30 5 2 4 7
M  V30 6 1 5 8
M  V30 7 2 6 9
M  V30 8 1 6 10
M  V30 9 1 7 11
M  V30 10 1 8 12
M  V30 11 1 10 13
M  V30 12 2 12 14
M  V30 13 1 12 15
M  V30 14 1 15 16 CFG=1
M  V30 15 1 15 17
M  V30 16 1 16 18
M  V30 17 1 18 19
M  V30 18 1 19 20
M  V30 19 1 5 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",23964-57-0,Articaine hydrochloride,methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate hydrochloride,"MI, 13, 1884",Br Dent J. 2011 Apr 9 210(7):323-9,12/17/1974,1976,Yes,N01BB08,,Chemical classification (according ATC code),Amides,,Parenteral,,,Liver,,,Lipothymia,Ion channel,Voltage-gated sodium channel,Central Nervous System,Anesthetic,,0.5,,,1.83,,
"Nomegestrol acetate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2735 0.7837 0.0 0
M  V30 3 C 2.5274 0.0783 0.0 0
M  V30 4 C 1.2539 2.2335 0.0 0
M  V30 5 C 3.7617 0.8228 0.0 0
M  V30 6 C 2.4882 2.978 0.0 0
M  V30 7 C 4.9764 0.1175 0.0 0
M  V30 8 C 3.7225 2.3119 0.0 0 CFG=2
M  V30 9 C 6.2304 0.8816 0.0 0
M  V30 10 C 4.9569 -1.3714 0.0 0
M  V30 11 C 4.9569 3.0564 0.0 0 CFG=2
M  V30 12 C 6.1912 2.3511 0.0 0 CFG=2
M  V30 13 C 4.9177 4.5062 0.0 0
M  V30 14 C 7.4255 3.1152 0.0 0 CFG=1
M  V30 15 C 6.1716 5.2703 0.0 0
M  V30 16 C 7.3863 4.5846 0.0 0 CFG=2
M  V30 17 C 9.8942 3.1152 0.0 0
M  V30 18 C 8.6402 5.3291 0.0 0 CFG=1
M  V30 19 C 7.4059 6.1128 0.0 0
M  V30 20 C 9.8942 4.6238 0.0 0
M  V30 21 O 9.9921 5.9757 0.0 0
M  V30 22 C 8.6207 6.8573 0.0 0
M  V30 23 C 11.1873 5.1136 0.0 0
M  V30 24 O 7.308 7.641 0.0 0
M  V30 25 C 9.9138 7.6214 0.0 0
M  V30 26 O 11.0305 3.6442 0.0 0
M  V30 27 C 12.5392 5.7601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 12 9 CFG=3
M  V30 12 1 11 13 CFG=1
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 14 17 CFG=1
M  V30 17 1 16 18
M  V30 18 1 16 19 CFG=1
M  V30 19 1 17 20
M  V30 20 1 18 21 CFG=3
M  V30 21 1 18 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 1 22 25
M  V30 25 2 23 26
M  V30 26 1 23 27
M  V30 27 1 8 6 CFG=3
M  V30 28 1 11 12
M  V30 29 1 15 16
M  V30 30 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 8 11 12 14 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",58652-20-3,Nomegestrol acetate,"[(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate",,Drugs. 2010 Mar 26 70(5):541-59,6/21/1978,1985,,G03DB04,,,,,Oral,,Plasmatic proteins,,,,"Amenorrhoea, Hypersensitivity reactions, Insomnia, Menstrual disturbances, Weight gain",Nuclear receptor,Progesterone receptor,Endocrinology,Contraceptive,,2,96 - 97,,40,,
"Pancuronium bromide
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0 0.0 0.0 0 CHG=-1
M  V30 2 Br 2.0313 0.0 0.0 0 CHG=-1
M  V30 3 O -5.4689 -13.5942 0.0 0
M  V30 4 C -4.1798 -12.8324 0.0 0
M  V30 5 O -4.1993 -11.309 0.0 0
M  V30 6 C -2.9102 -13.5747 0.0 0
M  V30 7 C -2.9297 -10.5667 0.0 0 CFG=2
M  V30 8 C -2.9493 -9.0823 0.0 0 CFG=1
M  V30 9 C -1.6797 -11.2699 0.0 0
M  V30 10 N -4.2774 -8.3206 0.0 0 CHG=1
M  V30 11 C -1.7188 -8.3401 0.0 0
M  V30 12 C -0.4492 -10.5081 0.0 0 CFG=1
M  V30 13 C -4.297 -6.8166 0.0 0
M  V30 14 C -5.5861 -9.0823 0.0 0
M  V30 15 C -2.9297 -7.6565 0.0 0
M  V30 16 C -0.4882 -9.0432 0.0 0 CFG=1
M  V30 17 C 0.7812 -11.2113 0.0 0
M  V30 18 C -5.6056 -6.0549 0.0 0
M  V30 19 C -6.8947 -8.301 0.0 0
M  V30 20 C 0.7422 -8.301 0.0 0 CFG=2
M  V30 21 C -0.5273 -7.5198 0.0 0
M  V30 22 C 2.0117 -10.4496 0.0 0
M  V30 23 C -6.9143 -6.7775 0.0 0
M  V30 24 C 1.9727 -9.0042 0.0 0 CFG=1
M  V30 25 C 0.7031 -6.8361 0.0 0
M  V30 26 C 3.2032 -8.2424 0.0 0 CFG=1
M  V30 27 C 1.9531 -6.0939 0.0 0
M  V30 28 C 3.1641 -6.7775 0.0 0 CFG=2
M  V30 29 C 5.6642 -8.2229 0.0 0
M  V30 30 C 4.4142 -6.0353 0.0 0 CFG=2
M  V30 31 C 3.1446 -5.254 0.0 0
M  V30 32 C 5.6642 -6.7385 0.0 0 CFG=1
M  V30 33 O 4.3946 -4.5118 0.0 0
M  V30 34 N 6.9338 -5.9767 0.0 0 CHG=1
M  V30 35 C 3.0665 -3.7501 0.0 0
M  V30 36 C 8.2034 -6.6994 0.0 0
M  V30 37 C 6.9143 -4.4532 0.0 0
M  V30 38 C 6.6408 -7.4221 0.0 0
M  V30 39 O 3.0469 -2.2266 0.0 0
M  V30 40 C 1.7578 -4.4728 0.0 0
M  V30 41 C 9.473 -5.9572 0.0 0
M  V30 42 C 8.2034 -3.6915 0.0 0
M  V30 43 C 9.473 -4.4337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 3 4
M  V30 2 1 4 5
M  V30 3 1 4 6
M  V30 4 1 7 5 CFG=3
M  V30 5 1 7 8
M  V30 6 1 7 9
M  V30 7 1 8 10 CFG=1
M  V30 8 1 8 11
M  V30 9 1 12 9 CFG=1
M  V30 10 1 10 13
M  V30 11 1 10 14
M  V30 12 1 10 15
M  V30 13 1 11 16
M  V30 14 1 12 17
M  V30 15 1 13 18
M  V30 16 1 14 19
M  V30 17 1 16 20
M  V30 18 1 16 21 CFG=1
M  V30 19 1 17 22
M  V30 20 1 18 23
M  V30 21 1 20 24
M  V30 22 1 20 25 CFG=1
M  V30 23 1 24 26
M  V30 24 1 25 27
M  V30 25 1 26 28
M  V30 26 1 26 29 CFG=1
M  V30 27 1 28 30
M  V30 28 1 28 31 CFG=1
M  V30 29 1 29 32
M  V30 30 1 30 33 CFG=1
M  V30 31 1 32 34 CFG=1
M  V30 32 1 33 35
M  V30 33 1 34 36
M  V30 34 1 34 37
M  V30 35 1 34 38
M  V30 36 2 35 39
M  V30 37 1 35 40
M  V30 38 1 36 41
M  V30 39 1 37 42
M  V30 40 1 41 43
M  V30 41 1 12 16
M  V30 42 1 19 23
M  V30 43 1 24 22 CFG=3
M  V30 44 1 27 28
M  V30 45 1 30 32
M  V30 46 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 7 8 12 16 20 24 26 28 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",15500-66-0,Pancuronium bromide,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide","MI, 13, 7077",Ann Intern Med. 1978 Jan 88(1):64-8,2/3/1967,1968,Yes,M03AC01,"H2O, CHCl3",Chemical classification (according ATC code),Quaternary ammonium,,Parenteral,,Plasmatic proteins,Liver,Active (3-hydroxy pancuronium bromide),,"Burning, Hypersensitivity reactions, Hypertension, Miosis, Rash, Tachycardia",,,Neuromuscular,Muscle relaxant,,,80,,,,
"Molindone hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 3.7978 -8.2602 0.0 0
M  V30 3 C 3.774 -6.7411 0.0 0
M  V30 4 C 5.0439 -5.9697 0.0 0
M  V30 5 C 2.4567 -5.9697 0.0 0 CFG=2
M  V30 6 C 5.0202 -4.4505 0.0 0
M  V30 7 C 6.4444 -6.3969 0.0 0
M  V30 8 C 2.4329 -4.4505 0.0 0
M  V30 9 C 1.1393 -6.7055 0.0 0
M  V30 10 N 6.3969 -3.9758 0.0 0
M  V30 11 C 3.7028 -3.691 0.0 0
M  V30 12 C 7.2752 -5.1508 0.0 0
M  V30 13 C 6.4207 -7.8686 0.0 0
M  V30 14 N -0.178 -5.9341 0.0 0
M  V30 15 C 8.7468 -5.127 0.0 0
M  V30 16 C 7.6906 -8.5807 0.0 0
M  V30 17 C -1.5072 -6.6818 0.0 0
M  V30 18 C -0.2136 -4.4149 0.0 0
M  V30 19 C -2.8246 -5.8985 0.0 0
M  V30 20 C -1.531 -3.6672 0.0 0
M  V30 21 O -2.8483 -4.3793 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 2 4 6
M  V30 5 1 4 7
M  V30 6 1 5 8
M  V30 7 1 5 9 CFG=1
M  V30 8 1 6 10
M  V30 9 1 6 11
M  V30 10 2 7 12
M  V30 11 1 7 13
M  V30 12 1 9 14
M  V30 13 1 12 15
M  V30 14 1 13 16
M  V30 15 1 14 17
M  V30 16 1 14 18
M  V30 17 1 17 19
M  V30 18 1 18 20
M  V30 19 1 19 21
M  V30 20 1 8 11
M  V30 21 1 10 12
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",15622-65-8,Molindone hydrochloride,"3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one hydrochloride","MI, 13, 6255",J Clin Psychopharmacol. 1989 Aug 9(4):268-76,1/30/1973,1974,Yes,N05AE02,,Chemical classification (according ATC code),Indole derivative,,Oral,,,Liver,,50,"Anxiety, Arrhythmia, Constipation, Depression, Drowsiness, Extrapyramidal syndrome, Galactorrhoea, Gynecomastia, Orthostatic hypotension, Sedation, Tachycardia, Urinary troubles",,,Central Nervous System,Antipsychotic,,,,,1.5,,
"Alcuronium chloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 52 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0 CHG=-1
M  V30 2 Cl -4.7861 1.113 0.0 0 CHG=-1
M  V30 3 O 3.0052 -5.5653 0.0 0
M  V30 4 C 4.174 -6.3027 0.0 0
M  V30 5 C 5.3983 -5.5514 0.0 0
M  V30 6 C 6.567 -6.2888 0.0 0
M  V30 7 C 7.3601 -5.3009 0.0 0 CFG=1
M  V30 8 C 7.0262 -7.5966 0.0 0
M  V30 9 C 8.3201 -3.9653 0.0 0
M  V30 10 C 7.9166 -6.567 0.0 0
M  V30 11 N 8.4036 -7.7914 0.0 0 CHG=1 CFG=1
M  V30 12 C 7.2905 -2.9496 0.0 0
M  V30 13 C 9.6975 -4.16 0.0 0 CFG=2
M  V30 14 C 9.3219 -6.6227 0.0 0 CFG=2
M  V30 15 C 10.0871 -8.7236 0.0 0
M  V30 16 C 7.9723 -9.1271 0.0 0
M  V30 17 N 7.3323 -1.433 0.0 0
M  V30 18 N 10.7689 -3.2278 0.0 0
M  V30 19 C 10.1428 -5.4401 0.0 0 CFG=2
M  V30 20 C 11.2419 -7.1931 0.0 0
M  V30 21 C 6.4836 -8.8488 0.0 0
M  V30 22 C 6.0383 -0.5008 0.0 0
M  V30 23 C 8.3758 -0.4452 0.0 0 CFG=1
M  V30 24 C 11.8959 -4.007 0.0 0
M  V30 25 C 10.7828 -1.6278 0.0 0
M  V30 26 C 11.5202 -5.3427 0.0 0
M  V30 27 C 5.5235 -9.9062 0.0 0
M  V30 28 C 6.4001 0.96 0.0 0
M  V30 29 C 4.5774 -0.8069 0.0 0
M  V30 30 C 9.781 -0.473 0.0 0
M  V30 31 C 7.7358 0.9461 0.0 0 CFG=2
M  V30 32 C 13.2315 -3.6174 0.0 0
M  V30 33 C 12.4385 -6.3166 0.0 0
M  V30 34 C 5.3427 2.0452 0.0 0
M  V30 35 C 3.52 0.2782 0.0 0
M  V30 36 C 10.6019 0.6539 0.0 0 CFG=2
M  V30 37 C 8.5706 2.1426 0.0 0 CFG=2
M  V30 38 C 6.5114 2.727 0.0 0
M  V30 39 C 14.1498 -4.5914 0.0 0
M  V30 40 C 13.7742 -5.927 0.0 0
M  V30 41 C 3.8679 1.7391 0.0 0
M  V30 42 C 11.4506 1.8783 0.0 0
M  V30 43 C 9.9619 2.0452 0.0 0
M  V30 44 N 9.3358 3.4922 0.0 0 CHG=1 CFG=1
M  V30 45 C 7.5827 4.2992 0.0 0
M  V30 46 C 12.6472 1.2104 0.0 0
M  V30 47 C 10.7828 3.2696 0.0 0
M  V30 48 C 10.5323 4.647 0.0 0
M  V30 49 C 13.8437 2.0313 0.0 0
M  V30 50 C 11.9098 4.5218 0.0 0
M  V30 51 O 15.0542 1.3635 0.0 0
M  V30 52 C 12.7446 5.7462 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 3 4
M  V30 2 1 4 5
M  V30 3 2 5 6
M  V30 4 1 7 6 CFG=1
M  V30 5 1 6 8
M  V30 6 1 7 9
M  V30 7 1 7 10
M  V30 8 1 8 11
M  V30 9 2 9 12
M  V30 10 1 9 13
M  V30 11 1 10 14
M  V30 12 1 11 15
M  V30 13 1 11 16 CFG=3
M  V30 14 1 12 17
M  V30 15 1 13 18 CFG=3
M  V30 16 1 13 19
M  V30 17 1 15 20
M  V30 18 1 16 21
M  V30 19 1 17 22
M  V30 20 1 23 17 CFG=3
M  V30 21 1 18 24
M  V30 22 1 18 25
M  V30 23 1 19 26
M  V30 24 2 21 27
M  V30 25 2 22 28
M  V30 26 1 22 29
M  V30 27 1 23 30
M  V30 28 1 23 31
M  V30 29 1 24 32
M  V30 30 1 26 33
M  V30 31 1 28 34
M  V30 32 2 29 35
M  V30 33 1 30 36
M  V30 34 1 31 37
M  V30 35 1 31 38 CFG=1
M  V30 36 2 32 39
M  V30 37 2 33 40
M  V30 38 2 34 41
M  V30 39 1 36 42 CFG=1
M  V30 40 1 36 43
M  V30 41 1 37 44
M  V30 42 1 38 45
M  V30 43 2 42 46
M  V30 44 1 42 47
M  V30 45 1 44 48 CFG=3
M  V30 46 1 46 49
M  V30 47 1 48 50
M  V30 48 1 49 51
M  V30 49 2 50 52
M  V30 50 1 14 11 CFG=1
M  V30 51 1 14 19
M  V30 52 1 19 20 CFG=1
M  V30 53 2 24 26
M  V30 54 2 25 30
M  V30 55 1 28 31
M  V30 56 1 35 41
M  V30 57 1 37 43 CFG=1
M  V30 58 1 39 40
M  V30 59 1 44 45
M  V30 60 1 44 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 7 11 13 14 19 23 31 36 37 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",15180-03-7,Alcuronium chloride,"4,4'-Didemethyl-4,4'-di-propenyltoxiferin-1-dichloride","MI, 13, 220",Anesth Analg. 1995 Feb 80(2):373-7.,3/5/1963,1963,,M03AA01,,Chemical classification (according ATC code),Curare alkaloid,,Parenteral,,,,,,"Anaphylactic shock, Hypotension, Tachycardia",,,Neuromuscular,Muscle relaxant,,0.03,,,0.3 - 0.5,,
"Zalcitabine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0118 -1.4961 0.0 0
M  V30 3 N -1.3298 -2.2322 0.0 0
M  V30 4 N 1.2823 -2.2322 0.0 0
M  V30 5 C -1.3417 -3.7283 0.0 0
M  V30 6 C 1.2704 -3.7283 0.0 0
M  V30 7 C 2.5766 -1.4723 0.0 0 CFG=2
M  V30 8 N -2.6597 -4.4645 0.0 0
M  V30 9 C -0.0474 -4.4645 0.0 0
M  V30 10 O 3.9302 -2.0779 0.0 0
M  V30 11 C 2.7191 0.0356 0.0 0
M  V30 12 C 4.9395 -0.9617 0.0 0 CFG=1
M  V30 13 C 4.1795 0.3562 0.0 0
M  V30 14 C 6.4237 -1.1042 0.0 0
M  V30 15 O 7.0292 -2.4697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 7 4 CFG=1
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14 CFG=1
M  V30 14 1 14 15
M  V30 15 2 6 9
M  V30 16 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",7481-89-2,Zalcitabine,"4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one","MI, 13, 10163",Drugs. 1997 Jun 53(6):1054-80,3/12/1987,1992 Withdrawn (2006),Yes,J05AF03,,,,Yes,Oral,,Plasmatic proteins,Intracellular,Active (zalcitabine triphosphate),"2,25","Dizziness, Gastrointestinal ulceration, Headache, Leucopenia, Nausea, Neutropenia, Peripheral neuropathy, Seizure",,,Metabolism,Antiviral,,,0 - 5,80,2,,
"Methyldopate hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O -2.4673 -0.9489 0.0 0
M  V30 3 C -2.8706 -2.3961 0.0 0
M  V30 4 O -4.3415 -2.7638 0.0 0
M  V30 5 C -1.8149 -3.44 0.0 0 CFG=1
M  V30 6 C -5.421 -1.6962 0.0 0
M  V30 7 N -0.9608 -4.6618 0.0 0
M  V30 8 C -0.5219 -2.6808 0.0 0
M  V30 9 C -2.9774 -4.4008 0.0 0
M  V30 10 C -6.8919 -2.0758 0.0 0
M  V30 11 C 0.771 -3.4281 0.0 0
M  V30 12 C 2.064 -2.6689 0.0 0
M  V30 13 C 0.7591 -4.9228 0.0 0
M  V30 14 C 3.357 -3.4163 0.0 0
M  V30 15 C 2.0521 -5.6701 0.0 0
M  V30 16 O 4.6499 -2.6571 0.0 0
M  V30 17 C 3.3451 -4.9109 0.0 0
M  V30 18 O 4.6381 -5.6582 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 1 5 7 CFG=3
M  V30 6 1 5 8
M  V30 7 1 5 9
M  V30 8 1 6 10
M  V30 9 1 8 11
M  V30 10 2 11 12
M  V30 11 1 11 13
M  V30 12 1 12 14
M  V30 13 2 13 15
M  V30 14 1 14 16
M  V30 15 2 14 17
M  V30 16 1 17 18
M  V30 17 1 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",2508-79-4,Methyldopate hydrochloride,"ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate hydrochloride","MI, 13, 6080",J Pharmacol Exp Ther. 1975 Oct 195(1):151-8,1/13/1959,1962,Yes,Not yet attributed,H2O,,,,,,,,,,,,,Cardiovascular,Antihypertensive,,,,,,,
"Levocabastine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 F -5.0978 -1.9606 0.0 0
M  V30 3 C -4.2767 -3.1983 0.0 0
M  V30 4 C -2.7694 -3.0758 0.0 0
M  V30 5 C -4.9385 -4.5341 0.0 0
M  V30 6 C -1.9484 -4.3135 0.0 0
M  V30 7 C -4.1052 -5.7718 0.0 0
M  V30 8 C -2.6224 -5.6492 0.0 0
M  V30 9 C -1.7891 -6.8746 0.0 0 CFG=2
M  V30 10 C -3.2719 -7.1565 0.0 0
M  V30 11 C -1.0783 -5.5512 0.0 0
M  V30 12 C -1.0416 -8.1491 0.0 0
M  V30 13 N -4.8404 -7.5241 0.0 0
M  V30 14 C 0.4166 -5.5144 0.0 0
M  V30 15 C 0.4534 -8.1123 0.0 0
M  V30 16 C 1.1641 -6.8011 0.0 0 CFG=2
M  V30 17 N 2.6714 -6.7644 0.0 0
M  V30 18 C 3.4189 -8.0388 0.0 0
M  V30 19 C 3.3699 -5.4409 0.0 0
M  V30 20 C 4.9139 -8.002 0.0 0 CFG=2
M  V30 21 C 4.8649 -5.4041 0.0 0
M  V30 22 C 5.6247 -6.6908 0.0 0 CFG=2
M  V30 23 C 5.6737 -9.2888 0.0 0
M  V30 24 C 6.1761 -5.2816 0.0 0
M  V30 25 C 7.0952 -6.9482 0.0 0
M  V30 26 C 5.2326 -4.0929 0.0 0
M  V30 27 C 7.6467 -5.0487 0.0 0
M  V30 28 O 7.5854 -8.3574 0.0 0
M  V30 29 O 8.0633 -5.7963 0.0 0
M  V30 30 C 5.7718 -2.6837 0.0 0
M  V30 31 C 8.1859 -3.6395 0.0 0
M  V30 32 C 7.2423 -2.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 2 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 2 5 7
M  V30 6 2 6 8
M  V30 7 1 9 8 CFG=3
M  V30 8 1 9 10
M  V30 9 1 9 11
M  V30 10 1 9 12
M  V30 11 3 10 13
M  V30 12 1 11 14
M  V30 13 1 12 15
M  V30 14 1 14 16
M  V30 15 1 16 17 CFG=1
M  V30 16 1 17 18
M  V30 17 1 17 19
M  V30 18 1 18 20
M  V30 19 1 19 21
M  V30 20 1 20 22
M  V30 21 1 20 23 CFG=3
M  V30 22 1 22 24 CFG=3
M  V30 23 1 22 25
M  V30 24 2 24 26
M  V30 25 1 24 27
M  V30 26 2 25 28
M  V30 27 1 25 29
M  V30 28 1 26 30
M  V30 29 2 27 31
M  V30 30 2 30 32
M  V30 31 1 7 8
M  V30 32 1 15 16
M  V30 33 1 21 22
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 16 20 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",79547-78-7,Levocabastine hydrochloride,"(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride","MI, 13, 5484",Drugs. 1995 Dec 50(6):1032-49,8/26/1981,1991,Yes,R01AC02,,,,,Ocular,,,,,"0,6",Occular irritation,,,Allergology,Antihistaminic,,,,,,,
"Famotidine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 0.8625 1.1697 0.0 0
M  V30 3 O -0.827 -1.1933 0.0 0
M  V30 4 N -1.3115 0.7798 0.0 0
M  V30 5 N 1.2997 -0.8625 0.0 0
M  V30 6 C -1.3233 2.2922 0.0 0
M  V30 7 N -0.0354 3.0602 0.0 0
M  V30 8 C -2.6703 3.0602 0.0 0
M  V30 9 C -4.0055 2.3158 0.0 0
M  V30 10 S -5.3524 3.0366 0.0 0
M  V30 11 C -5.3643 4.4899 0.0 0
M  V30 12 C -6.6758 5.2107 0.0 0
M  V30 13 N -8.0819 4.6199 0.0 0
M  V30 14 C -6.8648 6.7112 0.0 0
M  V30 15 C -9.0507 5.6951 0.0 0
M  V30 16 S -8.3654 6.9948 0.0 0
M  V30 17 N -10.5513 5.506 0.0 0
M  V30 18 C -11.1303 4.1472 0.0 0
M  V30 19 N -10.2323 2.9893 0.0 0
M  V30 20 N -12.6191 3.9346 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 4 6
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 17 18
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
",76824-35-6,Famotidine,"3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide","MI, 12, 3972",Clin Drug Investig. 2013 Sep 33(9):689-97,9/11/1980,1985,Yes,A02BA03,"DMSO, AcOH",,,Yes,Oral,GI tract,Plasmatic proteins,Liver,Sulfoxyde metabolite,40,"Constipation, Diarrhoea, Dizziness, Headache",GPCR,Histamine H2 receptor,Gastroenterology,Antiulcer,,1 - 3.5,15 - 20,40,2.6 - 4,,
"Pyrvinium pamoate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 87 96 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.3067 -0.7365 0.0 0
M  V30 3 O -1.3067 -2.2213 0.0 0 CHG=-1
M  V30 4 C -2.6252 0.0118 0.0 0
M  V30 5 C -2.649 1.5324 0.0 0
M  V30 6 C -3.9319 -0.7365 0.0 0
M  V30 7 O -1.366 2.3045 0.0 0
M  V30 8 C -3.9676 2.2807 0.0 0
M  V30 9 C -5.2505 0.0237 0.0 0
M  V30 10 C -5.2624 1.5324 0.0 0
M  V30 11 C -3.3023 3.6231 0.0 0
M  V30 12 C -6.5691 -0.7246 0.0 0
M  V30 13 C -6.581 2.2926 0.0 0
M  V30 14 C -4.1339 4.8823 0.0 0
M  V30 15 C -7.8758 0.0356 0.0 0
M  V30 16 C -7.8877 1.5442 0.0 0
M  V30 17 C -2.8509 5.6544 0.0 0
M  V30 18 C -5.4525 5.6425 0.0 0
M  V30 19 O -1.5561 4.9179 0.0 0
M  V30 20 C -2.8747 7.1749 0.0 0
M  V30 21 C -5.4643 7.1512 0.0 0
M  V30 22 C -6.771 4.8941 0.0 0
M  V30 23 C -1.5918 7.9471 0.0 0
M  V30 24 C -4.1933 7.9233 0.0 0
M  V30 25 C -6.7829 7.9114 0.0 0
M  V30 26 C -8.0777 5.6544 0.0 0
M  V30 27 O -1.6155 9.4557 0.0 0
M  V30 28 O -0.2969 7.2224 0.0 0 CHG=-1
M  V30 29 C -8.0896 7.1631 0.0 0
M  V30 30 N 9.2181 2.8509 0.0 0 CHG=1
M  V30 31 C 7.9114 2.1144 0.0 0
M  V30 32 C 10.513 2.1263 0.0 0
M  V30 33 C 9.1944 4.3596 0.0 0
M  V30 34 C 7.8996 0.6177 0.0 0
M  V30 35 C 6.6047 2.8747 0.0 0
M  V30 36 C 10.513 0.6295 0.0 0
M  V30 37 C 11.7959 2.8985 0.0 0
M  V30 38 C 6.5929 -0.1306 0.0 0
M  V30 39 C 9.1825 -0.1187 0.0 0
M  V30 40 C 5.298 2.1382 0.0 0
M  V30 41 C 13.2808 2.946 0.0 0
M  V30 42 C 5.2862 0.6295 0.0 0
M  V30 43 C 14.7657 2.946 0.0 0
M  V30 44 N 3.9795 -0.1069 0.0 0
M  V30 45 C 15.4547 1.6274 0.0 0
M  V30 46 C 15.811 4.0388 0.0 0
M  V30 47 C 2.6727 0.6533 0.0 0
M  V30 48 C 3.9676 -1.5918 0.0 0
M  V30 49 N 16.9277 1.8887 0.0 0
M  V30 50 C 14.7776 0.2969 0.0 0
M  V30 51 C 17.1534 3.3855 0.0 0
M  V30 52 C 17.9849 0.8552 0.0 0
M  V30 53 C 18.472 4.0982 0.0 0
M  V30 54 C 17.5929 -0.582 0.0 0
M  V30 55 C 19.4104 1.271 0.0 0
M  V30 56 C 18.6502 -1.6155 0.0 0
M  V30 57 C 20.4677 0.2375 0.0 0
M  V30 58 C 20.0875 -1.1997 0.0 0
M  V30 59 N 7.7926 11.1188 0.0 0 CHG=1
M  V30 60 C 6.4859 10.3823 0.0 0
M  V30 61 C 9.0875 10.3942 0.0 0
M  V30 62 C 7.7689 12.6274 0.0 0
M  V30 63 C 6.4741 8.8855 0.0 0
M  V30 64 C 5.1792 11.1426 0.0 0
M  V30 65 C 9.0875 8.8974 0.0 0
M  V30 66 C 10.3704 11.1663 0.0 0
M  V30 67 C 5.1674 8.1371 0.0 0
M  V30 68 C 7.757 8.149 0.0 0
M  V30 69 C 3.8725 10.4061 0.0 0
M  V30 70 C 11.8553 11.2138 0.0 0
M  V30 71 C 3.8607 8.8974 0.0 0
M  V30 72 C 13.3402 11.2138 0.0 0
M  V30 73 N 2.554 8.1609 0.0 0
M  V30 74 C 14.0292 9.8952 0.0 0
M  V30 75 C 14.3856 12.3067 0.0 0
M  V30 76 C 1.2473 8.9212 0.0 0
M  V30 77 C 2.5421 6.676 0.0 0
M  V30 78 N 15.5022 10.1566 0.0 0
M  V30 79 C 13.3521 8.5648 0.0 0
M  V30 80 C 15.7279 11.6534 0.0 0
M  V30 81 C 16.5594 9.1231 0.0 0
M  V30 82 C 17.0465 12.3661 0.0 0
M  V30 83 C 16.1674 7.6857 0.0 0
M  V30 84 C 17.9849 9.5389 0.0 0
M  V30 85 C 17.2247 6.6523 0.0 0
M  V30 86 C 19.0422 8.5054 0.0 0
M  V30 87 C 18.662 7.068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 2 23 27
M  V30 27 1 23 28
M  V30 28 1 25 29
M  V30 29 1 30 31
M  V30 30 2 30 32
M  V30 31 1 30 33
M  V30 32 1 31 34
M  V30 33 2 31 35
M  V30 34 1 32 36
M  V30 35 1 32 37
M  V30 36 2 34 38
M  V30 37 1 34 39
M  V30 38 1 35 40
M  V30 39 2 37 41 CFG=2
M  V30 40 1 38 42
M  V30 41 1 41 43
M  V30 42 1 42 44
M  V30 43 2 43 45
M  V30 44 1 43 46
M  V30 45 1 44 47
M  V30 46 1 44 48
M  V30 47 1 45 49
M  V30 48 1 45 50
M  V30 49 2 46 51
M  V30 50 1 49 52
M  V30 51 1 51 53
M  V30 52 2 52 54
M  V30 53 1 52 55
M  V30 54 1 54 56
M  V30 55 2 55 57
M  V30 56 2 56 58
M  V30 57 1 59 60
M  V30 58 2 59 61
M  V30 59 1 59 62
M  V30 60 1 60 63
M  V30 61 2 60 64
M  V30 62 1 61 65
M  V30 63 1 61 66
M  V30 64 2 63 67
M  V30 65 1 63 68
M  V30 66 1 64 69
M  V30 67 2 66 70 CFG=2
M  V30 68 1 67 71
M  V30 69 1 70 72
M  V30 70 1 71 73
M  V30 71 2 72 74
M  V30 72 1 72 75
M  V30 73 1 73 76
M  V30 74 1 73 77
M  V30 75 1 74 78
M  V30 76 1 74 79
M  V30 77 2 75 80
M  V30 78 1 78 81
M  V30 79 1 80 82
M  V30 80 2 81 83
M  V30 81 1 81 84
M  V30 82 1 83 85
M  V30 83 2 84 86
M  V30 84 2 85 87
M  V30 85 1 9 10
M  V30 86 2 15 16
M  V30 87 1 21 24
M  V30 88 2 26 29
M  V30 89 2 36 39
M  V30 90 2 40 42
M  V30 91 1 49 51
M  V30 92 1 57 58
M  V30 93 2 65 68
M  V30 94 2 69 71
M  V30 95 1 78 80
M  V30 96 1 86 87
M  V30 END BOND
M  V30 END CTAB
M  END
",3546-41-6,Pyrvinium pamoate,"2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine  3-carboxy-1-[(3-carboxy-2-oxidonaphthalen-1-yl)methyl]naphthalen-2-olate","MI, 13, 8111",Antimicrob Agents Chemother. 2008 Sep 52(9):3106-12,2/16/1960,Preclinical,Yes,P02CX01Â ,EtOH,"New therapeutic use, Reference","Anti-cancer, Front Oncol. 2012 Oct 2 2:137",,Oral,GI tract,,,,350,"Headache, Nausea, Red colored stool",,,Metabolism,,,,,,,0 - 15,
"Etomidate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.556 1.4078 0.0 0
M  V30 3 O -2.0466 1.668 0.0 0
M  V30 4 C 0.3904 2.579 0.0 0
M  V30 5 C -2.5908 3.0759 0.0 0
M  V30 6 N 1.8692 2.5198 0.0 0
M  V30 7 C -0.0118 4.0459 0.0 0
M  V30 8 C -4.0933 3.3361 0.0 0
M  V30 9 C 2.3897 3.9276 0.0 0
M  V30 10 C 2.6736 1.2776 0.0 0 CFG=2
M  V30 11 N 1.2303 4.8741 0.0 0
M  V30 12 C 4.1642 1.3604 0.0 0
M  V30 13 C 1.9756 -0.0591 0.0 0
M  V30 14 C 4.8149 2.7209 0.0 0
M  V30 15 C 4.9569 0.1183 0.0 0
M  V30 16 C 6.3055 2.8038 0.0 0
M  V30 17 C 6.4475 0.2011 0.0 0
M  V30 18 C 7.11 1.5616 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 10 6 CFG=3
M  V30 10 1 7 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 2 9 11
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",33125-97-2,Etomidate,ethyl 3-(1-phenylethyl)imidazole-4-carboxylate,"MI, 13, 3913",Anesthesiology. 2011 Mar 114(3):695-707,11/21/1967,1977,Yes,N01AX07,,"New therapeutic use, Reference, Therapeutic classification (according ATC code)","Anticortisolic, Eur J Endocrinol. 2012 Aug 167(2):137-43, General anesthetic",Yes,Parenteral,,Plasmatic proteins,Liver,,,"Bronchospasm, Nausea",,,Central Nervous System,"Anesthetic, Hypnotic",,,75,,4,,4.5
"Tridihexethyl chloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0 CHG=-1
M  V30 2 O -1.6379 -6.2626 0.0 0
M  V30 3 C -0.3613 -5.4677 0.0 0 CFG=2
M  V30 4 C -1.6981 -4.697 0.0 0
M  V30 5 C -0.3853 -6.9491 0.0 0
M  V30 6 C 0.9153 -4.697 0.0 0
M  V30 7 C -1.6981 -3.1554 0.0 0
M  V30 8 C -2.9988 -5.4196 0.0 0
M  V30 9 C -1.7101 -7.6717 0.0 0
M  V30 10 C 0.8912 -7.6717 0.0 0
M  V30 11 C 2.1678 -5.4316 0.0 0
M  V30 12 C -3.0229 -2.3846 0.0 0
M  V30 13 C -4.3236 -4.6488 0.0 0
M  V30 14 C -1.7583 -9.1531 0.0 0
M  V30 15 C 0.8671 -9.1531 0.0 0
M  V30 16 N 3.4565 -4.6608 0.0 0 CHG=1
M  V30 17 C -4.3597 -3.1192 0.0 0
M  V30 18 C -0.4817 -9.8877 0.0 0
M  V30 19 C 4.7331 -5.3955 0.0 0
M  V30 20 C 3.4565 -6.1422 0.0 0
M  V30 21 C 3.4324 -3.1313 0.0 0
M  V30 22 C 6.0097 -4.6247 0.0 0
M  V30 23 C 4.7331 -6.8528 0.0 0
M  V30 24 C 4.709 -2.3605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 3 2 CFG=1
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 3 6
M  V30 5 2 4 7
M  V30 6 1 4 8
M  V30 7 1 5 9
M  V30 8 1 5 10
M  V30 9 1 6 11
M  V30 10 1 7 12
M  V30 11 2 8 13
M  V30 12 1 9 14
M  V30 13 1 10 15
M  V30 14 1 11 16
M  V30 15 2 12 17
M  V30 16 1 14 18
M  V30 17 1 16 19
M  V30 18 1 16 20
M  V30 19 1 16 21
M  V30 20 1 19 22
M  V30 21 1 20 23
M  V30 22 1 21 24
M  V30 23 1 13 17
M  V30 24 1 15 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",4310-35-4,Tridihexethyl chloride,(3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium chloride,"MI, 13, 9735",Neurology. 1991 Nov 41(11):1737-41.,12/28/1954,1954 Withdrawn (2003),Yes,A03AB08,,Chemical classification (according ATC code),"Synthetic anticholinergic, quaternary ammonium compound",,Oral,,,,,125,"Blurred vision, Constipation, Dizziness, Drowsiness, Mouth dryness",,,Neuromuscular,Antispastic,,,,,,,
"Penbutolol sulfate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 47 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 0.767 -1.2054 0.0 0
M  V30 3 O -0.8644 1.3028 0.0 0
M  V30 4 O 1.2541 0.7914 0.0 0
M  V30 5 O -1.2662 -0.8279 0.0 0
M  V30 6 O 10.5199 -1.6559 0.0 0
M  V30 7 C 9.1684 -2.3742 0.0 0
M  V30 8 C 11.774 -2.3742 0.0 0
M  V30 9 C 7.8047 -1.5706 0.0 0
M  V30 10 C 9.1197 -3.811 0.0 0
M  V30 11 C 13.0281 -1.5706 0.0 0 CFG=1
M  V30 12 C 6.4532 -2.289 0.0 0
M  V30 13 C 7.7682 -0.0121 0.0 0
M  V30 14 C 7.7682 -4.5294 0.0 0
M  V30 15 O 14.0266 -0.4505 0.0 0
M  V30 16 C 14.2823 -2.3012 0.0 0
M  V30 17 C 6.4045 -3.7501 0.0 0
M  V30 18 C 8.937 0.901 0.0 0
M  V30 19 C 6.5019 0.901 0.0 0
M  V30 20 N 15.5364 -1.5098 0.0 0
M  V30 21 C 8.4257 2.3742 0.0 0
M  V30 22 C 6.9402 2.3742 0.0 0
M  V30 23 C 16.7783 -2.216 0.0 0
M  V30 24 C 17.9837 -2.9952 0.0 0
M  V30 25 C 18.0446 -1.4245 0.0 0
M  V30 26 C 16.7418 -3.6892 0.0 0
M  V30 27 O 6.234 -8.377 0.0 0
M  V30 28 C 4.8825 -9.0953 0.0 0
M  V30 29 C 7.4881 -9.0953 0.0 0
M  V30 30 C 3.531 -8.3039 0.0 0
M  V30 31 C 4.8338 -10.5443 0.0 0
M  V30 32 C 8.7544 -8.3039 0.0 0 CFG=1
M  V30 33 C 2.1794 -9.0223 0.0 0
M  V30 34 C 3.4823 -6.7454 0.0 0
M  V30 35 C 3.4823 -11.2748 0.0 0
M  V30 36 O 9.7528 -7.1837 0.0 0
M  V30 37 C 9.9963 -9.0223 0.0 0
M  V30 38 C 2.1307 -10.4834 0.0 0
M  V30 39 C 4.6511 -5.82 0.0 0
M  V30 40 C 2.2281 -5.82 0.0 0
M  V30 41 N 11.2505 -8.2308 0.0 0
M  V30 42 C 4.1397 -4.3467 0.0 0
M  V30 43 C 2.6543 -4.3467 0.0 0
M  V30 44 C 12.4802 -8.937 0.0 0
M  V30 45 C 13.6856 -9.7041 0.0 0
M  V30 46 C 13.7465 -8.1578 0.0 0
M  V30 47 C 12.4559 -10.3981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 6 7
M  V30 6 1 6 8
M  V30 7 2 7 9
M  V30 8 1 7 10
M  V30 9 1 8 11
M  V30 10 1 9 12
M  V30 11 1 9 13
M  V30 12 2 10 14
M  V30 13 1 11 15 CFG=1
M  V30 14 1 11 16
M  V30 15 2 12 17
M  V30 16 1 13 18
M  V30 17 1 13 19
M  V30 18 1 16 20
M  V30 19 1 18 21
M  V30 20 1 19 22
M  V30 21 1 20 23
M  V30 22 1 23 24
M  V30 23 1 23 25
M  V30 24 1 23 26
M  V30 25 1 27 28
M  V30 26 1 27 29
M  V30 27 2 28 30
M  V30 28 1 28 31
M  V30 29 1 29 32
M  V30 30 1 30 33
M  V30 31 1 30 34
M  V30 32 2 31 35
M  V30 33 1 32 36 CFG=1
M  V30 34 1 32 37
M  V30 35 2 33 38
M  V30 36 1 34 39
M  V30 37 1 34 40
M  V30 38 1 37 41
M  V30 39 1 39 42
M  V30 40 1 40 43
M  V30 41 1 41 44
M  V30 42 1 44 45
M  V30 43 1 44 46
M  V30 44 1 44 47
M  V30 45 1 14 17
M  V30 46 1 21 22
M  V30 47 1 35 38
M  V30 48 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",38363-32-5,Penbutolol sulfate,(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol sulfuric acid,"MI, 13, 7153",DICP. 1990 Apr 24(4):403-8,12/1/1981,1981,Yes,C07AA23,,Therapeutic classification (according ATC code),Non-selective beta-blocking agent,,Oral,GI tract,Plasmatic proteins,Liver,,40,"Blurred vision, Bradycardia, Bronchospasm, Dizziness, Dyspnea, Fatigue, Headache, Hypersensitivity reactions, Hypotension, Nausea, Raynaud's syndrome",GPCR,Adrenergic receptor beta,Cardiovascular,"Antianginal, Antiarrhythmic, Antihypertensive",,,80 - 98,,5,,
"Prednicarbate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2907 0.7823 0.0 0
M  V30 3 C 2.5229 0.0782 0.0 0
M  V30 4 C 1.2516 2.2491 0.0 0
M  V30 5 C 3.755 0.8409 0.0 0
M  V30 6 C 2.4838 2.9923 0.0 0
M  V30 7 C 3.7159 2.3077 0.0 0 CFG=2
M  V30 8 C 4.9871 0.1369 0.0 0
M  V30 9 C 4.948 3.0509 0.0 0 CFG=1
M  V30 10 C 3.7354 3.8332 0.0 0
M  V30 11 C 6.2193 0.8996 0.0 0
M  V30 12 C 4.9285 4.5177 0.0 0 CFG=1
M  V30 13 C 6.1801 2.3469 0.0 0 CFG=1
M  V30 14 O 3.5985 5.2805 0.0 0
M  V30 15 C 6.1606 5.2609 0.0 0
M  V30 16 C 7.4123 3.1096 0.0 0 CFG=1
M  V30 17 C 7.3927 4.5764 0.0 0 CFG=1
M  V30 18 C 9.8765 3.1292 0.0 0
M  V30 19 C 8.6053 5.3196 0.0 0 CFG=1
M  V30 20 C 7.4123 6.1019 0.0 0
M  V30 21 C 9.8765 4.6155 0.0 0
M  V30 22 O 9.8765 6.1215 0.0 0
M  V30 23 C 8.6053 6.8451 0.0 0
M  V30 24 C 11.1478 5.3978 0.0 0
M  V30 25 O 9.8765 7.6078 0.0 0
M  V30 26 C 7.2754 7.6078 0.0 0
M  V30 27 O 11.1282 3.9115 0.0 0
M  V30 28 O 12.4386 6.1606 0.0 0
M  V30 29 O 5.965 6.8842 0.0 0
M  V30 30 C 13.7098 5.4369 0.0 0
M  V30 31 C 4.6546 7.647 0.0 0
M  V30 32 C 15.0006 6.1997 0.0 0
M  V30 33 O 4.6351 9.1724 0.0 0
M  V30 34 C 3.3443 6.9233 0.0 0
M  V30 35 C 2.0144 7.6861 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10 CFG=1
M  V30 10 1 8 11
M  V30 11 1 9 12 CFG=1
M  V30 12 1 9 13
M  V30 13 1 12 14 CFG=1
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 1 16 18 CFG=1
M  V30 18 1 17 19
M  V30 19 1 17 20 CFG=1
M  V30 20 1 18 21
M  V30 21 1 19 22 CFG=3
M  V30 22 1 19 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 1 23 26
M  V30 26 2 24 27
M  V30 27 1 24 28
M  V30 28 1 26 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 2 31 33
M  V30 33 1 31 34
M  V30 34 1 34 35
M  V30 35 1 6 7
M  V30 36 1 13 11 CFG=3
M  V30 37 1 16 17
M  V30 38 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 7 9 12 13 16 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",73771-04-7,Prednicarbate,"[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate","MI, 13, 7805","Skin Therapy Lett. 2004 Dec-2005 Jan 9(10):5-6, 9",12/30/1980,1986,Yes,D07AC18,EtOH,Chemical classification (according ATC code),"Corticosteroid, potent",,Topical,Skin,,,,,Burning,,,Metabolism,Anti-Inflammatory,,,,,,,
"Sertaconazole nitrate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C 0.4297 -1.4323 0.0 0
M  V30 3 C 1.862 -1.7307 0.0 0
M  V30 4 C -0.5968 -2.5186 0.0 0
M  V30 5 C 2.2918 -3.1393 0.0 0
M  V30 6 C 2.8408 -0.5968 0.0 0 CFG=1
M  V30 7 C -0.1551 -3.9271 0.0 0
M  V30 8 C 1.2652 -4.2255 0.0 0
M  V30 9 O 2.3634 0.8594 0.0 0
M  V30 10 C 4.2732 -0.8952 0.0 0
M  V30 11 Cl -1.1817 -5.0252 0.0 0
M  V30 12 C 0.8713 1.2055 0.0 0
M  V30 13 N 4.7268 -2.3037 0.0 0
M  V30 14 C 0.37 2.6618 0.0 0
M  V30 15 C 6.0518 -2.9005 0.0 0
M  V30 16 C 3.6883 -3.3899 0.0 0
M  V30 17 C -1.0742 3.1393 0.0 0
M  V30 18 C 1.2294 3.8913 0.0 0
M  V30 19 N 5.8727 -4.3806 0.0 0
M  V30 20 C 4.4165 -4.6671 0.0 0
M  V30 21 C -1.0981 4.6671 0.0 0
M  V30 22 C -2.3992 2.4111 0.0 0
M  V30 23 S 0.3222 5.1327 0.0 0
M  V30 24 C -2.4231 5.4311 0.0 0
M  V30 25 C -3.7361 3.187 0.0 0
M  V30 26 Cl -2.4469 6.9589 0.0 0
M  V30 27 C -3.76 4.7029 0.0 0
M  V30 28 O -7.1619 0.5729 0.0 0
M  V30 29 N -7.1977 -0.9071 0.0 0 CHG=1
M  V30 30 O -8.5346 -1.6233 0.0 0
M  V30 31 O -5.9205 -1.6353 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 6 9 CFG=1
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 21 24
M  V30 24 2 22 25
M  V30 25 1 24 26
M  V30 26 2 24 27
M  V30 27 2 28 29
M  V30 28 1 29 30
M  V30 29 1 29 31
M  V30 30 1 7 8
M  V30 31 1 19 20
M  V30 32 1 21 23
M  V30 33 1 25 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",99592-39-9,Sertaconazole nitrate,"1-[2-[(7-chlorobenzo[b]thien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole-(RS) nitrate","MI, 13, 8639",Expert Rev Anti Infect Ther. 2013 Apr 11(4):347-58,11/18/1991,1992,Yes,D01AC14,"EtOH, CHCl3, CH3COCH3",Chemical classification (according ATC code),Imidazole derivative,,Topical,"Skin, Vagina",,,,,"Burning, Hypersensitivity reactions, Pruritus",,,"Infectiology, Metabolism","Antibacterial, Antifungal",,,,,,,
"Repaglinide
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.3068 0.7603 0.0 0
M  V30 3 O -1.3187 2.2692 0.0 0
M  V30 4 C -2.6137 0.0237 0.0 0
M  V30 5 C -2.6375 -1.4732 0.0 0
M  V30 6 C -3.9325 0.7841 0.0 0
M  V30 7 O -1.3425 -2.2098 0.0 0
M  V30 8 C -3.9444 -2.2098 0.0 0
M  V30 9 C -5.2394 0.0475 0.0 0
M  V30 10 C -0.0594 -1.4494 0.0 0
M  V30 11 C -5.2513 -1.4375 0.0 0
M  V30 12 C 1.2356 -2.186 0.0 0
M  V30 13 C -6.5582 -2.1623 0.0 0
M  V30 14 C -7.8651 -1.4138 0.0 0
M  V30 15 O -7.877 0.095 0.0 0
M  V30 16 N -9.1838 -2.1385 0.0 0
M  V30 17 C -10.4907 -1.39 0.0 0 CFG=2
M  V30 18 C -11.8095 -2.1147 0.0 0
M  V30 19 C -10.5026 0.1188 0.0 0
M  V30 20 C -11.8095 -3.5998 0.0 0
M  V30 21 C -13.1164 -1.3544 0.0 0
M  V30 22 C -11.8214 0.8791 0.0 0
M  V30 23 N -10.5145 -4.3365 0.0 0
M  V30 24 C -13.1164 -4.3365 0.0 0
M  V30 25 C -14.4233 -2.091 0.0 0
M  V30 26 C -11.8333 2.388 0.0 0
M  V30 27 C -13.1283 0.1425 0.0 0
M  V30 28 C -9.2432 -3.5642 0.0 0
M  V30 29 C -10.5264 -5.8216 0.0 0
M  V30 30 C -14.4352 -3.5761 0.0 0
M  V30 31 C -7.9482 -4.3008 0.0 0
M  V30 32 C -9.2551 -6.5582 0.0 0
M  V30 33 C -7.9601 -5.7859 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 17 16 CFG=3
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 22 27
M  V30 27 1 23 28
M  V30 28 1 23 29
M  V30 29 2 24 30
M  V30 30 1 28 31
M  V30 31 1 29 32
M  V30 32 1 31 33
M  V30 33 1 9 11
M  V30 34 1 25 30
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",135062-02-1,Repaglinide,2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid,"MI, 13, 8220",Drugs. 2012 Jan 22 72(2):249-72,6/14/1989,1998,Yes,A10BX02,,,,,Oral,GI tract,Plasmatic proteins,,,4,"Diarrhoea, Hypoglycemia",Transmembrane receptor,Sulfonylurea receptors K-ATP channels,Endocrinology,Antidiabetic,,1,98,63,1,,0.46
"Piretanide
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 1.3842 -0.5205 0.0 0
M  V30 3 O -1.2422 -0.8399 0.0 0
M  V30 4 N 1.2777 0.769 0.0 0
M  V30 5 C -1.3132 0.7571 0.0 0
M  V30 6 C -2.6264 0.0236 0.0 0
M  V30 7 C -1.325 2.2715 0.0 0
M  V30 8 O -2.6382 -1.4551 0.0 0
M  V30 9 C -3.9278 0.7808 0.0 0
M  V30 10 C -2.6382 3.0287 0.0 0
M  V30 11 C -3.9396 -2.1887 0.0 0
M  V30 12 N -5.3948 0.4495 0.0 0
M  V30 13 C -3.9396 2.2951 0.0 0
M  V30 14 C -2.6501 4.5312 0.0 0
M  V30 15 C -3.9396 -3.6675 0.0 0
M  V30 16 C -5.4067 -1.4315 0.0 0
M  V30 17 C -5.9982 -0.9228 0.0 0
M  V30 18 C -6.5424 1.4315 0.0 0
M  V30 19 O -1.3723 5.2884 0.0 0
M  V30 20 O -3.9515 5.2884 0.0 0
M  V30 21 C -5.241 -4.401 0.0 0
M  V30 22 C -6.5543 -2.165 0.0 0
M  V30 23 C -7.4889 -0.7926 0.0 0
M  V30 24 C -7.8438 0.6625 0.0 0
M  V30 25 C -6.5543 -3.6439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 2 14 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 2 16 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 2 21 25
M  V30 25 1 10 13
M  V30 26 1 22 25
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
",55837-27-9,Piretanide,4-phenoxy-3-pyrrolidin-1-yl-5-sulfamoylbenzoic acid,"MI, 13, 7575",Drugs. 1985 Jun 29(6):489-530,3/1/1977,1981,,C03CA03,,"Chemical classification (according ATC code), Therapeutic classification (according ATC code)","Sulfonamide, High-ceiling diuretic",,Oral,GI tract,Albumin,,,,"Anorexia, Asthenia, Diarrhoea, Headache, Hypokalemia, Hypotension, Nausea, Urinary troubles, Vertigo",,,Cardiovascular,"Antihypertensive, Diuretic",,,96,,1,,
"Piperacetazine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C 1.2922 0.7636 0.0 0
M  V30 3 C -1.304 0.7636 0.0 0
M  V30 4 C 1.2805 2.2673 0.0 0
M  V30 5 C 2.5728 0.0234 0.0 0
M  V30 6 C -1.3157 2.2673 0.0 0
M  V30 7 C -2.608 0.0234 0.0 0
M  V30 8 N -0.0352 3.0427 0.0 0
M  V30 9 C 2.561 3.0192 0.0 0
M  V30 10 C 3.8533 0.7871 0.0 0
M  V30 11 C -2.6198 3.0192 0.0 0
M  V30 12 C -3.912 0.7871 0.0 0
M  V30 13 C -0.0469 4.5464 0.0 0
M  V30 14 C 3.8416 2.3026 0.0 0
M  V30 15 C -3.9238 2.2908 0.0 0
M  V30 16 C -1.351 5.2983 0.0 0
M  V30 17 C 5.1221 3.0544 0.0 0
M  V30 18 C -2.655 4.5699 0.0 0
M  V30 19 O 5.0986 4.5582 0.0 0
M  V30 20 C 6.4026 2.3261 0.0 0
M  V30 21 N -3.959 5.3218 0.0 0
M  V30 22 C -5.2631 4.5699 0.0 0
M  V30 23 C -3.9708 6.8256 0.0 0
M  V30 24 C -6.5671 5.3453 0.0 0
M  V30 25 C -5.2748 7.5774 0.0 0
M  V30 26 C -6.5671 6.8491 0.0 0
M  V30 27 C -7.8711 7.6009 0.0 0
M  V30 28 C -9.1752 6.8726 0.0 0
M  V30 29 O -10.4792 7.6479 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 2 11 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 26 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 29 1 6 8
M  V30 30 1 10 14
M  V30 31 1 12 15
M  V30 32 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
",3819-00-9,Piperacetazine,1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone,"MI, 13, 7543",Dis Nerv Syst. 1974 May 35(5):231-6,3/1/1961,1969,Yes,Not yet attributed,,,,,,,,,,,"Amenorrhoea, Dizziness, Drowsiness, Extrapyramidal syndrome, Mouth dryness, Orthostatic hypotension, Rash, Weight gain",,,Central Nervous System,Antipsychotic,,,,,,,
"Oxyphenbutazone
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.9 1.2317 0.0 0
M  V30 3 N -0.45 2.6766 0.0 0
M  V30 4 C -2.416 1.2553 0.0 0 CFG=2
M  V30 5 N -1.6817 3.5648 0.0 0
M  V30 6 C 0.9474 3.174 0.0 0
M  V30 7 C -2.8897 2.7002 0.0 0
M  V30 8 C -3.7306 0.5329 0.0 0
M  V30 9 C -1.7054 5.0808 0.0 0
M  V30 10 C 2.0133 2.191 0.0 0
M  V30 11 C 1.2317 4.6426 0.0 0
M  V30 12 O -4.3346 3.1977 0.0 0
M  V30 13 C -5.0452 1.2909 0.0 0
M  V30 14 C -0.4382 5.8506 0.0 0
M  V30 15 C -3.02 5.8506 0.0 0
M  V30 16 C 3.4108 2.6884 0.0 0
M  V30 17 C 2.6055 5.1281 0.0 0
M  V30 18 C -6.3598 0.5684 0.0 0
M  V30 19 C -0.4618 7.3665 0.0 0
M  V30 20 C -3.0437 7.3665 0.0 0
M  V30 21 C 3.6951 4.1807 0.0 0
M  V30 22 C -7.6745 1.3264 0.0 0
M  V30 23 C -1.7765 8.1245 0.0 0
M  V30 24 O 5.0926 4.6544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=1
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 11 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 2 15 20
M  V30 20 2 16 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 1 21 24
M  V30 24 1 5 7
M  V30 25 1 17 21
M  V30 26 1 20 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",129-20-4,Oxyphenbutazone,"4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione","MI, 13, 7041",Jpn J Pharmacol. 1965 Jun 15(2):187-98,5/15/1956,1960 Withdrawn (1985),Yes,M01AA03,,"Chemical classification (according ATC code), Therapeutic classification (according ATC code)","Butylpyrazolidine, NSAID",,Oral,,,,,300,"Anorexia, Blurred vision, Diarrhoea, Drowsiness, Epigastric misery, Headache, Hypersensitivity reactions, Irritability, Weight loss",Enzyme,Cyclooxygenase,Metabolism,Anti-inflammatory,,,,,,,
"Danazol
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 N -0.9014 1.2217 0.0 0
M  V30 3 C 1.4114 0.4744 0.0 0
M  V30 4 C -0.0237 2.4552 0.0 0
M  V30 5 C 1.3996 1.9808 0.0 0
M  V30 6 C 2.6925 -0.2728 0.0 0
M  V30 7 C 2.6806 2.7399 0.0 0
M  V30 8 C 3.9972 0.4981 0.0 0
M  V30 9 C 3.9853 2.0045 0.0 0 CFG=1
M  V30 10 C 5.2782 -0.249 0.0 0
M  V30 11 C 5.2664 2.7636 0.0 0 CFG=2
M  V30 12 C 3.9735 3.5109 0.0 0
M  V30 13 C 6.5592 0.5218 0.0 0
M  V30 14 C 6.5474 2.0282 0.0 0 CFG=1
M  V30 15 C 5.2545 4.2819 0.0 0
M  V30 16 C 7.8403 2.7874 0.0 0 CFG=1
M  V30 17 C 6.5355 5.041 0.0 0
M  V30 18 C 7.8284 4.3056 0.0 0 CFG=2
M  V30 19 C 9.2518 2.3366 0.0 0
M  V30 20 C 9.2399 4.7801 0.0 0 CFG=2
M  V30 21 C 7.5912 5.8001 0.0 0
M  V30 22 C 10.1295 3.5583 0.0 0
M  V30 23 O 8.9196 6.2509 0.0 0
M  V30 24 C 10.3549 5.7883 0.0 0
M  V30 25 C 11.458 6.8083 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=1
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15 CFG=1
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 16 19 CFG=1
M  V30 19 1 18 20
M  V30 20 1 18 21 CFG=1
M  V30 21 1 19 22
M  V30 22 1 20 23 CFG=1
M  V30 23 1 20 24
M  V30 24 3 24 25
M  V30 25 1 4 5
M  V30 26 1 8 9
M  V30 27 1 14 13 CFG=3
M  V30 28 1 17 18
M  V30 29 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 9 11 14 16 18 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",17230-88-5,Danazol,"(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol","MI, 12, 2875",Am J Med. 1989 Sep 87(3N):49N-55N,6/2/1964,1974,Yes,G03XA01,"CHCl3, EtOH",,,,Oral,,,Liver,2-hydroxymethyl ethisterone,600,"Acne, Anxiety, Headache, Hepatic enzyme levels elevated, Menstrual disturbances, Pruritus, Weight gain",,,Endocrinology,"Anabolic, Antigonadotropin",,2,,,4.7,,
"Quinethazone
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C 1.2853 -0.7259 0.0 0
M  V30 3 C 1.2615 -2.2255 0.0 0
M  V30 4 C 2.5706 0.0595 0.0 0
M  V30 5 S -0.0952 -2.9515 0.0 0
M  V30 6 C 2.5468 -2.9515 0.0 0
M  V30 7 C 3.856 -0.6664 0.0 0
M  V30 8 O -1.1306 -4.0583 0.0 0
M  V30 9 O 0.9521 -4.0107 0.0 0
M  V30 10 N -1.4162 -2.166 0.0 0
M  V30 11 C 3.8322 -2.1541 0.0 0
M  V30 12 N 5.1413 0.1309 0.0 0
M  V30 13 C 5.1175 -2.892 0.0 0
M  V30 14 C 6.4386 -0.6069 0.0 0 CFG=1
M  V30 15 O 5.0937 -4.3796 0.0 0
M  V30 16 N 6.4148 -2.1065 0.0 0
M  V30 17 C 7.7358 0.1785 0.0 0
M  V30 18 C 9.0212 -0.5474 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17 CFG=3
M  V30 17 1 17 18
M  V30 18 1 7 11
M  V30 19 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",73-49-4,Quinethazone,"7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide","MI, 13, 8146",Can Med Assoc J. 1966 Jul 9 95(2):62-7,3/21/1961,1963,Yes,C03BA02,"CH3COCH3, EtOH","Chemical classification (according ATC code), Therapeutic classification (according ATC code)","Sulfonamide, Low-ceiling diuretic",,Oral,,,,,50,"Dizziness, Hypokalemia, Mouth dryness, Nausea",,,Cardiovascular,"Antihypertensive, Diuretic",,,,,,,
"Moricizine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 S 0.4718 -9.5311 0.0 0
M  V30 3 C 1.7576 -8.7526 0.0 0
M  V30 4 C -0.8493 -8.7526 0.0 0
M  V30 5 C 1.7458 -7.2427 0.0 0
M  V30 6 C 3.0433 -9.4957 0.0 0
M  V30 7 C -0.8493 -7.2427 0.0 0
M  V30 8 C -2.1586 -9.5075 0.0 0
M  V30 9 N 0.4364 -6.476 0.0 0
M  V30 10 C 3.0315 -6.4878 0.0 0
M  V30 11 C 4.3291 -8.729 0.0 0
M  V30 12 C -2.1704 -6.4878 0.0 0
M  V30 13 C -3.468 -8.7408 0.0 0
M  V30 14 C 0.4246 -4.9661 0.0 0
M  V30 15 C 4.3173 -7.2191 0.0 0
M  V30 16 C -3.4798 -7.2191 0.0 0
M  V30 17 O -0.8847 -4.2111 0.0 0
M  V30 18 C 1.7104 -4.2111 0.0 0
M  V30 19 N 5.6031 -6.4524 0.0 0
M  V30 20 C 2.9961 -4.9425 0.0 0
M  V30 21 C 6.8888 -7.1955 0.0 0
M  V30 22 N 4.2819 -4.1875 0.0 0
M  V30 23 O 6.877 -8.6818 0.0 0
M  V30 24 O 8.1746 -6.4288 0.0 0
M  V30 25 C 4.2701 -2.6894 0.0 0
M  V30 26 C 5.5795 -4.9307 0.0 0
M  V30 27 C 9.4721 -7.1483 0.0 0
M  V30 28 C 5.5677 -1.9227 0.0 0
M  V30 29 C 6.8416 -4.1875 0.0 0
M  V30 30 C 10.7579 -6.3816 0.0 0
M  V30 31 O 6.8534 -2.6776 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 2 3 5
M  V30 4 1 3 6
M  V30 5 2 4 7
M  V30 6 1 4 8
M  V30 7 1 5 9
M  V30 8 1 5 10
M  V30 9 2 6 11
M  V30 10 1 7 12
M  V30 11 2 8 13
M  V30 12 1 9 14
M  V30 13 2 10 15
M  V30 14 2 12 16
M  V30 15 2 14 17
M  V30 16 1 14 18
M  V30 17 1 15 19
M  V30 18 1 18 20
M  V30 19 1 19 21
M  V30 20 1 20 22
M  V30 21 2 21 23
M  V30 22 1 21 24
M  V30 23 1 22 25
M  V30 24 1 22 26
M  V30 25 1 24 27
M  V30 26 1 25 28
M  V30 27 1 26 29
M  V30 28 1 27 30
M  V30 29 1 28 31
M  V30 30 1 7 9
M  V30 31 1 11 15
M  V30 32 1 13 16
M  V30 33 1 29 31
M  V30 END BOND
M  V30 END CTAB
M  END
",31883-05-3,Moricizine hydrochloride,ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate hydrochloride,"MI, 13, 6291",Cleve Clin J Med. 1992 Jan-Feb 59(1):79-86,4/12/1972,1990 Withdrawn (2007),Yes,C01BG01,"H2O, EtOH",,,,Oral,,Plasmatic proteins,Liver,,750,"Anxiety, Arrhythmia, Dizziness, Headache, Nausea, Tremor, Urinary troubles",,,Cardiovascular,Antiarrhythmic,,0.5 - 2,95,38,1.5 - 3.5,,4
"Iopanoic acid
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 0.0 0.0 0.0 0
M  V30 2 C -0.0238 -1.4776 0.0 0
M  V30 3 C 1.2512 -2.2164 0.0 0
M  V30 4 C -1.3465 -2.2164 0.0 0
M  V30 5 N 2.5263 -1.4419 0.0 0
M  V30 6 C 1.2274 -3.6941 0.0 0
M  V30 7 C -1.3704 -3.6941 0.0 0
M  V30 8 C -2.6693 -1.4419 0.0 0
M  V30 9 I 2.5024 -4.4329 0.0 0
M  V30 10 C -0.0953 -4.4329 0.0 0
M  V30 11 I -2.6931 -4.4329 0.0 0
M  V30 12 C -3.992 -2.1807 0.0 0 CFG=1
M  V30 13 C -5.3147 -1.418 0.0 0
M  V30 14 C -4.0158 -3.6583 0.0 0
M  V30 15 O -5.3386 0.1072 0.0 0
M  V30 16 O -6.6375 -2.1568 0.0 0
M  V30 17 C -5.3386 -4.3972 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 12 8 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 7 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",96-83-3,Iopanoic acid,"2-[(3-amino-2,4,6-triiodophenyl)methyl]butanoic acid","MI, 13, 5074",J Clin Endocrinol Metab. 2005 Dec 90(12):6536-40,4/5/1955,1951,Yes,V08AC06,,Chemical classification (according ATC code),"Watersoluble, hepatotropic X-ray contrast media",,Oral,,Albumin,Liver,Glucuronic acid conjugates and inorganic iodide,,"Haemorrhage, Hypersensitivity reactions, Nausea",,,Diagnostic,Contrastant,,,85 - 100,,,0 - 15,
"Pivmecillinam hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 S 0.0 -3.1229 0.0 0
M  V30 3 C 0.8635 -4.3177 0.0 0
M  V30 4 C -1.4432 -3.5725 0.0 0 CFG=1
M  V30 5 C -0.0236 -5.5362 0.0 0 CFG=1
M  V30 6 C 2.0228 -5.2641 0.0 0
M  V30 7 C 2.0819 -3.4187 0.0 0
M  V30 8 N -1.455 -5.063 0.0 0
M  V30 9 C -2.9573 -3.5606 0.0 0 CFG=1
M  V30 10 C 0.4258 -6.9557 0.0 0
M  V30 11 C -2.9692 -5.0512 0.0 0
M  V30 12 N -4.4242 -3.1584 0.0 0
M  V30 13 O -0.5914 -8.044 0.0 0
M  V30 14 O 1.869 -7.2633 0.0 0
M  V30 15 O -4.0338 -6.104 0.0 0
M  V30 16 C -5.4889 -4.2113 0.0 0
M  V30 17 C 2.8627 -6.1395 0.0 0
M  V30 18 N -6.9321 -3.8327 0.0 0
M  V30 19 O 4.3177 -6.447 0.0 0
M  V30 20 C -8.0085 -4.8855 0.0 0
M  V30 21 C -7.1213 -2.354 0.0 0
M  V30 22 C 5.3114 -5.3232 0.0 0
M  V30 23 C -9.4991 -4.7199 0.0 0
M  V30 24 C -8.3871 -1.5496 0.0 0
M  V30 25 O 4.8382 -3.88 0.0 0
M  V30 26 C 6.7546 -5.6308 0.0 0
M  V30 27 C -10.3153 -3.4305 0.0 0
M  V30 28 C -9.8303 -2.0346 0.0 0
M  V30 29 C 6.4234 -7.0858 0.0 0
M  V30 30 C 7.0622 -4.1403 0.0 0
M  V30 31 C 8.2215 -5.9384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 4 2 CFG=1
M  V30 3 1 3 5
M  V30 4 1 3 6
M  V30 5 1 3 7
M  V30 6 1 4 8
M  V30 7 1 4 9
M  V30 8 1 5 10 CFG=3
M  V30 9 1 8 11
M  V30 10 1 9 12 CFG=1
M  V30 11 2 10 13
M  V30 12 1 10 14
M  V30 13 2 11 15
M  V30 14 2 12 16
M  V30 15 1 14 17
M  V30 16 1 16 18
M  V30 17 1 17 19
M  V30 18 1 18 20
M  V30 19 1 18 21
M  V30 20 1 19 22
M  V30 21 1 20 23
M  V30 22 1 21 24
M  V30 23 2 22 25
M  V30 24 1 22 26
M  V30 25 1 23 27
M  V30 26 1 24 28
M  V30 27 1 26 29
M  V30 28 1 26 30
M  V30 29 1 26 31
M  V30 30 1 5 8
M  V30 31 1 9 11
M  V30 32 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 5 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",32887-03-9,Pivmecillinam hydrochloride,"(2,2-Dimethyl-1-oxo-propoxy)methylester 6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid hydrochloride","MI, 13, 389",Int J Antimicrob Agents. 2003 Oct 22 Suppl 2:73-8,5/18/1976,1977,,J01CA08Â ,,Chemical classification (according ATC code),Penicillin with extended spectrum,,Oral,GI tract,Plasmatic proteins,,"Mecillinam, pivalic acid, formaldehyde",600,"Diarrhoea, Nausea, Rash",,,"Infectiology, Metabolism",Antibacterial,,,10 - 15,,6,75,
"Levopropoxyphene napsylate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 39 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 0.7275 -1.2854 0.0 0
M  V30 3 O -0.7761 1.3218 0.0 0
M  V30 4 O 1.2854 0.7761 0.0 0
M  V30 5 C -1.3339 -0.7275 0.0 0
M  V30 6 C -2.6436 0.0485 0.0 0
M  V30 7 C -1.3581 -2.1949 0.0 0
M  V30 8 C -3.9532 -0.679 0.0 0
M  V30 9 C -2.6678 -2.9225 0.0 0
M  V30 10 C -3.9775 -2.1464 0.0 0
M  V30 11 C -5.2629 0.097 0.0 0
M  V30 12 C -5.2872 -2.874 0.0 0
M  V30 13 C -6.5726 -0.6305 0.0 0
M  V30 14 C -6.5968 -2.0979 0.0 0
M  V30 15 O -6.5968 -4.9476 0.0 0
M  V30 16 C -6.6211 -6.4149 0.0 0
M  V30 17 O -5.3599 -7.1304 0.0 0
M  V30 18 C -7.955 -7.1425 0.0 0
M  V30 19 C -4.0745 -7.8337 0.0 0
M  V30 20 C -9.2647 -6.3664 0.0 0
M  V30 21 C -4.8627 -9.0707 0.0 0
M  V30 22 C -2.8618 -8.6098 0.0 0
M  V30 23 C -3.3469 -6.5241 0.0 0
M  V30 24 C -6.3785 -9.0221 0.0 0
M  V30 25 C -4.1594 -10.3439 0.0 0
M  V30 26 C -1.5522 -7.9065 0.0 0
M  V30 27 C -2.9588 -10.0772 0.0 0
M  V30 28 C -1.8553 -6.0633 0.0 0
M  V30 29 C -7.1668 -10.2712 0.0 0
M  V30 30 C -4.9476 -11.593 0.0 0
M  V30 31 N -0.3395 -8.6705 0.0 0
M  V30 32 C -1.5158 -4.511 0.0 0
M  V30 33 C -0.7518 -7.1183 0.0 0
M  V30 34 C -6.4634 -11.5566 0.0 0
M  V30 35 C 0.9701 -7.9671 0.0 0
M  V30 36 C -0.4365 -10.1378 0.0 0
M  V30 37 C -0.0485 -4.0502 0.0 0
M  V30 38 C 0.7397 -6.6453 0.0 0
M  V30 39 C 1.0792 -5.1053 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 15 16
M  V30 15 1 16 17
M  V30 16 1 16 18
M  V30 17 1 17 19
M  V30 18 1 18 20
M  V30 19 1 19 21
M  V30 20 1 19 22
M  V30 21 1 19 23
M  V30 22 2 21 24
M  V30 23 1 21 25
M  V30 24 1 22 26
M  V30 25 1 22 27
M  V30 26 1 23 28
M  V30 27 1 24 29
M  V30 28 2 25 30
M  V30 29 1 26 31
M  V30 30 2 28 32
M  V30 31 1 28 33
M  V30 32 2 29 34
M  V30 33 1 31 35
M  V30 34 1 31 36
M  V30 35 1 32 37
M  V30 36 2 33 38
M  V30 37 2 37 39
M  V30 38 1 9 10
M  V30 39 2 13 14
M  V30 40 1 30 34
M  V30 41 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
",5714-90-9,Levopropoxyphene napsylate,"[4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate naphthalene-2-sulfonic acid","MI, 13, 5489",Xenobiotica. 1977 Jun 7(6):377-82,6/7/1977,1962,Yes,Not yet attributed,"H2O, MeOH, EtOH, CHCl3",,,,,,,,,,,,,"Central Nervous System, Respiratory","Analgesic, Antitussive",,,,,,,
"Piperidolate hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 0.8637 -4.7987 0.0 0
M  V30 3 C 0.8397 -6.2744 0.0 0
M  V30 4 O 2.1114 -7.0062 0.0 0
M  V30 5 C -0.4798 -7.0062 0.0 0
M  V30 6 C 3.3831 -6.2264 0.0 0 CFG=2
M  V30 7 C -1.7995 -6.2264 0.0 0
M  V30 8 C -0.5038 -8.4818 0.0 0
M  V30 9 C 3.3591 -4.7028 0.0 0
M  V30 10 C 4.6548 -6.9582 0.0 0
M  V30 11 C -1.8235 -4.6908 0.0 0
M  V30 12 C -3.1192 -6.9462 0.0 0
M  V30 13 C 0.7678 -9.2016 0.0 0
M  V30 14 C -1.8355 -9.2016 0.0 0
M  V30 15 N 4.6308 -3.923 0.0 0
M  V30 16 C 5.9265 -6.1904 0.0 0
M  V30 17 C -3.1432 -3.911 0.0 0
M  V30 18 C -4.4388 -6.1784 0.0 0
M  V30 19 C 0.7438 -10.6773 0.0 0
M  V30 20 C -1.8595 -10.6773 0.0 0
M  V30 21 C 5.9025 -4.6548 0.0 0
M  V30 22 C 4.6068 -2.3993 0.0 0
M  V30 23 C -4.4628 -4.6428 0.0 0
M  V30 24 C -0.5758 -11.4091 0.0 0
M  V30 25 C 5.8905 -1.6315 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 6 4 CFG=3
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 7 1 6 9
M  V30 8 1 6 10
M  V30 9 2 7 11
M  V30 10 1 7 12
M  V30 11 2 8 13
M  V30 12 1 8 14
M  V30 13 1 9 15
M  V30 14 1 10 16
M  V30 15 1 11 17
M  V30 16 2 12 18
M  V30 17 1 13 19
M  V30 18 2 14 20
M  V30 19 1 15 21
M  V30 20 1 15 22
M  V30 21 2 17 23
M  V30 22 2 19 24
M  V30 23 1 22 25
M  V30 24 1 16 21
M  V30 25 1 18 23
M  V30 26 1 20 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",129-77-1,Piperidolate hydrochloride,N-Ethyl-3-piperidyl diphenylacetate hydrochloride,"MI, 13, 7551",AMA Arch Surg. 1957 Nov 75(5):780-4,7/3/1979,,,A03AA30,H2O,Chemical classification (according ATC code),"Synthetic anticholinergic, esters with tertiary amino group",,,,,,,,"Dizziness, Hepatic enzyme levels elevated, Mouth dryness, Mydriasis, Nausea, Palpitations",,,Neuromuscular,Antispastic,,,,,,,
"Trifluridine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0 0.0 0.0 0
M  V30 2 C 1.2941 -0.7361 0.0 0
M  V30 3 F 1.2822 -2.2321 0.0 0
M  V30 4 F 0.8904 0.7242 0.0 0
M  V30 5 C 2.6001 0.0237 0.0 0
M  V30 6 C 2.5883 1.5434 0.0 0
M  V30 7 C 3.8705 -0.7123 0.0 0
M  V30 8 O 1.2585 2.3033 0.0 0
M  V30 9 N 3.8587 2.3033 0.0 0
M  V30 10 N 5.1647 0.0474 0.0 0
M  V30 11 C 5.1528 1.5672 0.0 0
M  V30 12 C 6.4707 -0.6886 0.0 0 CFG=2
M  V30 13 O 6.4589 2.3271 0.0 0
M  V30 14 O 7.8243 -0.0593 0.0 0
M  V30 15 C 6.6013 -2.1846 0.0 0
M  V30 16 C 8.8216 -1.1872 0.0 0 CFG=1
M  V30 17 C 8.0617 -2.4814 0.0 0 CFG=1
M  V30 18 C 10.3057 -1.021 0.0 0
M  V30 19 O 8.6554 -3.8468 0.0 0
M  V30 20 O 11.1843 -2.2321 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 12 10 CFG=3
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18 CFG=3
M  V30 18 1 17 19 CFG=1
M  V30 19 1 18 20
M  V30 20 1 10 11
M  V30 21 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",70-00-8,Trifluridine,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione","MI, 13, 9758",Drugs. 1982 May 23(5):329-53,8/17/1965,1975,Yes,S01AD02,,,,,Ocular,Eye,,,,,"Blurred vision, Burning, Hypersensitivity reactions, Occular irritation",,,Metabolism,Antiviral,,,,,,,
"Oxprenolol hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 4.8557 -7.1408 0.0 0
M  V30 3 C 3.5347 -6.3672 0.0 0
M  V30 4 C 6.1292 -6.3672 0.0 0
M  V30 5 C 3.5109 -4.8438 0.0 0
M  V30 6 C 2.2017 -7.1051 0.0 0
M  V30 7 C 7.4026 -7.1051 0.0 0
M  V30 8 O 4.7843 -4.0702 0.0 0
M  V30 9 C 2.1779 -4.0702 0.0 0
M  V30 10 C 0.8807 -6.3315 0.0 0
M  V30 11 C 8.6761 -6.3315 0.0 0
M  V30 12 C 6.0578 -4.7962 0.0 0
M  V30 13 C 0.8569 -4.7962 0.0 0
M  V30 14 C 7.3312 -4.0345 0.0 0 CFG=1
M  V30 15 O 7.3074 -2.5112 0.0 0
M  V30 16 C 8.6047 -4.7605 0.0 0
M  V30 17 N 9.8781 -3.9988 0.0 0
M  V30 18 C 11.1635 -4.7248 0.0 0
M  V30 19 C 12.4369 -3.9512 0.0 0
M  V30 20 C 11.1397 -6.2006 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 2 3 5
M  V30 4 1 3 6
M  V30 5 1 4 7
M  V30 6 1 5 8
M  V30 7 1 5 9
M  V30 8 2 6 10
M  V30 9 2 7 11
M  V30 10 1 8 12
M  V30 11 2 9 13
M  V30 12 1 12 14
M  V30 13 1 14 15 CFG=1
M  V30 14 1 14 16
M  V30 15 1 16 17
M  V30 16 1 17 18
M  V30 17 1 18 19
M  V30 18 1 18 20
M  V30 19 1 10 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",6452-73-9,Oxprenolol hydrochloride,1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol hydrochloride,"MI, 13, 7021",Pharmacotherapy. 1983 Mar-Apr 3(2 Pt 1):68-81,6/3/1966,1968,Yes,C07AA02,,Therapeutic classification (according ATC code),Non-selective beta-blocking agent,Yes,Oral,GI tract,Plasmatic proteins,Liver,Inactive,160,"Asthenia, Bradycardia, Bronchospasm, Erectile dysfunction, Hypersensitivity reactions, Hypotension, Insomnia, Nightmare, Raynaud's syndrome",GPCR,Adrenergic receptor beta,Cardiovascular,"Antianginal, Antiarrhythmic, Antihypertensive",,1 - 2,80 - 90,20 - 75,1 - 3,,
"Ondansetron Hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 2.3033 -3.1671 0.0 0
M  V30 3 C 2.7232 -4.5947 0.0 0
M  V30 4 C 1.6675 -5.6624 0.0 0
M  V30 5 C 4.1628 -4.9426 0.0 0 CFG=2
M  V30 6 C 0.1319 -5.6024 0.0 0
M  V30 7 C 2.0634 -7.078 0.0 0
M  V30 8 C 4.5587 -6.3582 0.0 0
M  V30 9 C 5.1706 -3.8389 0.0 0
M  V30 10 C -0.4198 -6.9941 0.0 0
M  V30 11 C -0.8757 -4.4268 0.0 0
M  V30 12 N 0.8037 -7.9058 0.0 0
M  V30 13 C 3.479 -7.4259 0.0 0
M  V30 14 N 6.6582 -3.7309 0.0 0
M  V30 15 C -1.9074 -7.246 0.0 0
M  V30 16 C -2.3633 -4.6787 0.0 0
M  V30 17 C 0.7318 -9.3934 0.0 0
M  V30 18 C 7.5939 -4.8826 0.0 0
M  V30 19 C 7.4499 -2.4473 0.0 0
M  V30 20 C -2.8912 -6.0823 0.0 0
M  V30 21 N 8.9855 -4.3308 0.0 0
M  V30 22 C 7.174 -6.3222 0.0 0
M  V30 23 C 8.8896 -2.8312 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 2 4 7
M  V30 6 1 5 8
M  V30 7 1 5 9 CFG=1
M  V30 8 2 6 10
M  V30 9 1 6 11
M  V30 10 1 7 12
M  V30 11 1 7 13
M  V30 12 1 9 14
M  V30 13 1 10 15
M  V30 14 2 11 16
M  V30 15 1 12 17
M  V30 16 1 14 18
M  V30 17 1 14 19
M  V30 18 2 15 20
M  V30 19 2 18 21
M  V30 20 1 18 22
M  V30 21 2 19 23
M  V30 22 1 8 13
M  V30 23 1 10 12
M  V30 24 1 16 20
M  V30 25 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",103639-04-9,Ondansetron Hydrochloride,"1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1 H-imidazol-1-yl)methyl]-4 H carbazol-4-one hydrochloride","MI, 13, 6916",Am J Hosp Pharm. 1994 Mar 15 51(6):762-71,9/22/1987,1990,Yes,A04AA01,,,,,Oral,GI tract,Plasmatic proteins,,,16,"Constipation, Headache, Hot flushes",LGIC,Serotonin 3 (5-HT3) receptor,Central Nervous System,Antianemic,,1.5,70 - 76,60,3,,1.86
"Propoxycaine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 3.4198 3.9898 0.0 0
M  V30 3 C 4.7141 3.2535 0.0 0
M  V30 4 O 6.0084 4.0135 0.0 0
M  V30 5 C 4.7141 1.7574 0.0 0
M  V30 6 C 7.3027 3.2773 0.0 0
M  V30 7 C 6.0084 1.0212 0.0 0
M  V30 8 C 3.396 1.0212 0.0 0
M  V30 9 C 8.597 4.0373 0.0 0
M  V30 10 O 7.3027 1.7811 0.0 0
M  V30 11 C 5.9965 -0.4749 0.0 0
M  V30 12 C 3.3842 -0.4749 0.0 0
M  V30 13 N 9.9388 3.3129 0.0 0
M  V30 14 C 8.6089 1.0568 0.0 0
M  V30 15 C 4.6785 -1.223 0.0 0
M  V30 16 C 11.1857 4.0729 0.0 0
M  V30 17 C 9.9863 4.8328 0.0 0
M  V30 18 C 9.927 1.8286 0.0 0
M  V30 19 N 4.6666 -2.7192 0.0 0
M  V30 20 C 12.4918 3.3367 0.0 0
M  V30 21 C 11.3044 5.5572 0.0 0
M  V30 22 C 11.2213 1.0805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 2 5 7
M  V30 6 1 5 8
M  V30 7 1 6 9
M  V30 8 1 7 10
M  V30 9 1 7 11
M  V30 10 2 8 12
M  V30 11 1 9 13
M  V30 12 1 10 14
M  V30 13 2 11 15
M  V30 14 1 13 16
M  V30 15 1 13 17
M  V30 16 1 14 18
M  V30 17 1 15 19
M  V30 18 1 16 20
M  V30 19 1 17 21
M  V30 20 1 18 22
M  V30 21 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
",550-83-4,Propoxycaine hydrochloride,2-(diethylamino)ethyl 4-amino-2-propoxybenzoate hydrochloride,"MI, 13, 7930",Obstet Gynecol. 1961 Jan 17:90-1,2/27/1980,,Yes,Not yet attributed,"H2O, EtOH, CHCl3",,,,,,,,,,,Ion channel,Voltage-gated sodium channel,Central Nervous System,Anesthetic,,,,,,,
"Nicorandil
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 N -0.0118 1.4895 0.0 0 CHG=1
M  V30 3 O -1.3358 2.2579 0.0 0
M  V30 4 O 1.2412 2.2461 0.0 0 CHG=-1
M  V30 5 C -2.6716 1.5131 0.0 0
M  V30 6 C -3.9602 2.2697 0.0 0
M  V30 7 N -5.2369 1.584 0.0 0
M  V30 8 C -6.5255 2.3643 0.0 0
M  V30 9 O -6.5373 3.8774 0.0 0
M  V30 10 C -7.8377 1.6313 0.0 0
M  V30 11 C -7.8495 0.1536 0.0 0
M  V30 12 C -9.1262 2.4352 0.0 0
M  V30 13 N -9.1972 -0.5437 0.0 0
M  V30 14 C -10.4739 1.7023 0.0 0
M  V30 15 C -10.4857 0.2364 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 5 6
M  V30 6 1 6 7
M  V30 7 1 7 8
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
",65141-46-0,Nicorandil,2-[(pyridin-3-ylcarbonyl)amino]ethyl nitrate,"MI, 13, 6548",Expert Opin Pharmacother. 2001 May 2(5):845-56,4/29/1980,1983,,C01DX16Â ,DMSO,,,,Oral,GI tract,Plasmatic proteins,Liver,Inactive (2-nicotamidoethanol),40,"Facial flushing, Headache, Nausea, Tachycardia, Vertigo",,,Cardiovascular,"Antianginal, Vasodilator",,0.5 - 1,25,75,,,
"Oxaprozin
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0117 -1.4842 0.0 0
M  V30 3 O 1.2722 -2.2146 0.0 0
M  V30 4 C -1.3193 -2.2146 0.0 0
M  V30 5 C -2.6269 -1.4607 0.0 0
M  V30 6 C -3.9462 -2.191 0.0 0
M  V30 7 O -5.1713 -1.2957 0.0 0
M  V30 8 N -4.4174 -3.6046 0.0 0
M  V30 9 C -6.3964 -2.1674 0.0 0
M  V30 10 C -5.9252 -3.5928 0.0 0
M  V30 11 C -7.8336 -1.6963 0.0 0
M  V30 12 C -6.8205 -4.7944 0.0 0
M  V30 13 C -8.9409 -2.6858 0.0 0
M  V30 14 C -8.1516 -0.2238 0.0 0
M  V30 15 C -8.3165 -4.6294 0.0 0
M  V30 16 C -6.2197 -6.1373 0.0 0
M  V30 17 C -10.378 -2.2263 0.0 0
M  V30 18 C -9.5888 0.2591 0.0 0
M  V30 19 C -9.2118 -5.831 0.0 0
M  V30 20 C -7.1032 -7.3388 0.0 0
M  V30 21 C -10.7078 -0.7421 0.0 0
M  V30 22 C -8.611 -7.1739 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 19 22
M  V30 22 2 9 10
M  V30 23 1 18 21
M  V30 24 1 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
",21256-18-8,Oxaprozin,"3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid","MI, 13, 6993",Expert Opin Pharmacother. 2005 May 6(5):777-85,9/23/1970,1983,Yes,M01AE12,,"Chemical classification (according ATC code), Therapeutic classification (according ATC code)","Propionic acid derivative, NSAID",,Oral,GI tract,,Liver,,900,"Confusion, Depression, Dyspepsia, Gastrointestinal ulceration, Nausea, Photosensitization, Rash, Somnolence",Enzyme,Cyclooxygenase,"Central Nervous System, Metabolism","Analgesic, Anti-inflammatory",,2 - 4,99,,40 - 50,80 - 100,
"Phensuximide
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.4586 -0.4304 0.0 0
M  V30 3 N -2.702 0.4662 0.0 0
M  V30 4 C -1.9607 -1.8412 0.0 0 CFG=1
M  V30 5 C -3.9335 -0.3825 0.0 0
M  V30 6 C -2.7259 1.9966 0.0 0
M  V30 7 C -1.0999 -3.0368 0.0 0
M  V30 8 C -3.4911 -1.8173 0.0 0
M  V30 9 O -5.3921 0.0956 0.0 0
M  V30 10 C 0.3586 -2.8575 0.0 0
M  V30 11 C -1.7575 -4.3759 0.0 0
M  V30 12 C 1.2195 -4.0411 0.0 0
M  V30 13 C -0.9086 -5.5715 0.0 0
M  V30 14 C 0.5738 -5.3921 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7 CFG=1
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 5 8
M  V30 15 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",86-34-0,Phensuximide,"1-methyl-3-phenylpyrrolidine-2,5-dione","MI, 13, 7345",Epilepsia. 1963 Mar 4:66-76,6/23/1953,Withdrawn (1996),Yes,N03AD02,"H2O, MeOH, EtOH",Chemical classification (according ATC code),Succinimide derivatives,,Oral,,,,,2000,"Drowsiness, Haematuria, Nausea, Nephrotoxicity, Urinary troubles, Urine coloration",,,Central Nervous System,Anticonvulsant,,,,,,,
"Ioxaglic acid 
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 0.0 0.0 0.0 0
M  V30 2 C -0.0117 1.5071 0.0 0
M  V30 3 C 1.2716 2.2606 0.0 0
M  V30 4 C -1.3187 2.2606 0.0 0
M  V30 5 N 2.5667 1.5306 0.0 0
M  V30 6 C 1.2598 3.7677 0.0 0
M  V30 7 C -1.3304 3.756 0.0 0
M  V30 8 C -2.6256 1.5188 0.0 0
M  V30 9 C 3.8501 2.2842 0.0 0
M  V30 10 C 2.555 0.047 0.0 0
M  V30 11 I 2.5432 4.5448 0.0 0
M  V30 12 C -0.047 4.5213 0.0 0
M  V30 13 I -2.6374 4.5095 0.0 0
M  V30 14 O -2.6374 0.0353 0.0 0
M  V30 15 N -3.9326 2.2724 0.0 0
M  V30 16 O 3.8384 3.7913 0.0 0
M  V30 17 C 5.1335 1.5659 0.0 0
M  V30 18 C -0.0706 6.0284 0.0 0
M  V30 19 C -5.2395 1.5424 0.0 0
M  V30 20 O -1.3775 6.7819 0.0 0
M  V30 21 N 1.2127 6.8055 0.0 0
M  V30 22 C -6.5465 2.2959 0.0 0
M  V30 23 C 2.5079 6.0755 0.0 0
M  V30 24 O -6.5582 3.803 0.0 0
M  V30 25 N -7.8534 1.5659 0.0 0
M  V30 26 C -9.1721 2.3195 0.0 0
M  V30 27 C -9.1839 3.8266 0.0 0
M  V30 28 C -10.4791 1.5895 0.0 0
M  V30 29 I -7.9005 4.5919 0.0 0
M  V30 30 C -10.4908 4.5802 0.0 0
M  V30 31 I -10.4908 0.1059 0.0 0
M  V30 32 C -11.786 2.343 0.0 0
M  V30 33 C -11.7978 3.8501 0.0 0
M  V30 34 C -10.5144 6.0873 0.0 0
M  V30 35 C -13.093 1.613 0.0 0
M  V30 36 I -13.1047 4.6037 0.0 0
M  V30 37 O -11.8213 6.8408 0.0 0
M  V30 38 O -9.231 6.8408 0.0 0
M  V30 39 O -13.1047 0.1295 0.0 0
M  V30 40 N -14.3999 2.3666 0.0 0
M  V30 41 C -15.7186 1.6366 0.0 0
M  V30 42 C -17.0256 2.3901 0.0 0
M  V30 43 O -18.3325 1.6601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 8 14
M  V30 14 1 8 15
M  V30 15 2 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 15 19
M  V30 19 2 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 1 22 25
M  V30 25 1 25 26
M  V30 26 2 26 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 28 31
M  V30 31 2 28 32
M  V30 32 2 30 33
M  V30 33 1 30 34
M  V30 34 1 32 35
M  V30 35 1 33 36
M  V30 36 2 34 37
M  V30 37 1 34 38
M  V30 38 2 35 39
M  V30 39 1 35 40
M  V30 40 1 40 41
M  V30 41 1 41 42
M  V30 42 1 42 43
M  V30 43 1 7 12
M  V30 44 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
",59017-64-0,Ioxaglic acid ,"3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoate sodium","MI, 13, 5086",Invest Radiol. 1984 Nov-Dec 19(6 Suppl):S289-392,6/26/1980,1985,Yes,V08AB03,,Chemical classification (according ATC code),"Watersoluble, nephrotropic, low osmolar X-ray contrast media",,,,,,,,"Arrhythmia, Confusion, Headache, Hot flushes, Hypersensitivity reactions, Hyperthyroidism, Hypothyroidism, Kidney deficiency, Nausea",,,Diagnostic,Contrastant,,,,,,,
"Naftifine hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 N 3.502 -4.1646 0.0 0
M  V30 3 C 2.1887 -4.8981 0.0 0
M  V30 4 C 4.7916 -4.8981 0.0 0
M  V30 5 C 3.4902 -2.6502 0.0 0
M  V30 6 C 2.1887 -6.3888 0.0 0
M  V30 7 C 6.0812 -4.1409 0.0 0
M  V30 8 C 0.8991 -7.146 0.0 0
M  V30 9 C 3.4902 -7.1224 0.0 0
M  V30 10 C 7.3827 -4.8626 0.0 0
M  V30 11 C 0.8873 -8.6368 0.0 0
M  V30 12 C -0.4259 -6.3888 0.0 0
M  V30 13 C 3.4783 -8.6131 0.0 0
M  V30 14 C 8.6723 -4.1054 0.0 0
M  V30 15 C 2.1769 -9.3703 0.0 0
M  V30 16 C -0.4377 -9.3822 0.0 0
M  V30 17 C -1.7391 -7.1224 0.0 0
M  V30 18 C 9.9619 -4.8389 0.0 0
M  V30 19 C 8.6368 -2.591 0.0 0
M  V30 20 C -1.751 -8.625 0.0 0
M  V30 21 C 11.2515 -4.0699 0.0 0
M  V30 22 C 9.9264 -1.8338 0.0 0
M  V30 23 C 11.2278 -2.5555 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 1 2 5
M  V30 4 1 3 6
M  V30 5 1 4 7
M  V30 6 1 6 8
M  V30 7 2 6 9
M  V30 8 2 7 10
M  V30 9 1 8 11
M  V30 10 2 8 12
M  V30 11 1 9 13
M  V30 12 1 10 14
M  V30 13 1 11 15
M  V30 14 2 11 16
M  V30 15 1 12 17
M  V30 16 2 14 18
M  V30 17 1 14 19
M  V30 18 1 16 20
M  V30 19 1 18 21
M  V30 20 2 19 22
M  V30 21 2 21 23
M  V30 22 2 13 15
M  V30 23 2 17 20
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
",65473-14-5,Naftifine hydrochloride,(E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine hydrochloride,"MI, 13, 6381",J Cutan Med Surg. 2008 Mar-Apr 12(2):51-8,12/31/1980,1985,Yes,D01AE22,,,,,Topical,Skin,,,,,"Burning, Erythema, Irritation, Skin dryness",,,"Infectiology, Metabolism",Antifungal,,,,,,,
"Meprylcaine hydrochloride 
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O -0.286 -6.579 0.0 0
M  V30 3 C 1.2037 -6.5194 0.0 0
M  V30 4 O 1.9069 -5.1845 0.0 0
M  V30 5 C 1.9904 -7.7828 0.0 0
M  V30 6 C 3.3967 -5.1249 0.0 0
M  V30 7 C 1.2276 -9.07 0.0 0
M  V30 8 C 3.4802 -7.7709 0.0 0
M  V30 9 C 4.2072 -3.8377 0.0 0
M  V30 10 C 1.9665 -10.3572 0.0 0
M  V30 11 C 4.2191 -9.0581 0.0 0
M  V30 12 N 2.8962 -3.0749 0.0 0
M  V30 13 C 5.5063 -3.0749 0.0 0
M  V30 14 C 5.3037 -4.8508 0.0 0
M  V30 15 C 3.4683 -10.3453 0.0 0
M  V30 16 C 1.5732 -3.8139 0.0 0
M  V30 17 C 0.2622 -3.0511 0.0 0
M  V30 18 C -1.0488 -3.7901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 2 5 7
M  V30 6 1 5 8
M  V30 7 1 6 9
M  V30 8 1 7 10
M  V30 9 2 8 11
M  V30 10 1 9 12
M  V30 11 1 9 13
M  V30 12 1 9 14
M  V30 13 2 10 15
M  V30 14 1 12 16
M  V30 15 1 16 17
M  V30 16 1 17 18
M  V30 17 1 11 15
M  V30 END BOND
M  V30 END CTAB
M  END
",956-03-6,Meprylcaine hydrochloride ,[2-methyl-2-(propylamino)propyl] benzoate hydrochloride,,Arch Int Pharmacodyn Ther. 1958 Jul 1 115(4):483-97,5/17/1977,,,Not yet attributed,,,,,,,,,,,,Ion channel,Voltage-gated sodium channel,Neuromuscular,Local anesthetic,,,,,,,
"Milrinone
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.491 0.0119 0.0 0
M  V30 3 N 2.2306 1.3359 0.0 0
M  V30 4 C 2.2306 -1.2763 0.0 0
M  V30 5 C 3.7217 1.3479 0.0 0
M  V30 6 C 1.4433 -2.5646 0.0 0
M  V30 7 C 3.7217 -1.2644 0.0 0
M  V30 8 C 4.4612 0.0477 0.0 0
M  V30 9 C 4.4732 2.66 0.0 0
M  V30 10 N 0.656 -3.8648 0.0 0
M  V30 11 C 5.9523 0.0596 0.0 0
M  V30 12 C 6.6919 -1.2286 0.0 0
M  V30 13 C 6.6919 1.3717 0.0 0
M  V30 14 C 8.1949 -1.2167 0.0 0
M  V30 15 C 8.1949 1.3837 0.0 0
M  V30 16 N 8.9344 0.0954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 3 6 10
M  V30 10 1 8 11
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 7 8
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
",78415-72-2,Milrinone,6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,"MI, 13, 6219",Basic Res Cardiol. 1989 84 Suppl 1:85-103,7/1/1981,1988,Yes,C01CE02,,,,,Parenteral,,Plasmatic proteins,Liver,,50,"Arrhythmia, Headache, Hypotension",Enzyme,Phosphodiesterases,Cardiovascular,Vasodilator,,,70,,2.3 - 2.4,,0.38 - 0.45
"Methantheline bromide
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0 0.0 0.0 0 CHG=-1
M  V30 2 O -3.5989 -4.4513 0.0 0
M  V30 3 C -2.3085 -5.1971 0.0 0
M  V30 4 O -1.0181 -4.4276 0.0 0
M  V30 5 C -2.3203 -6.6888 0.0 0
M  V30 6 C 0.2722 -5.1735 0.0 0
M  V30 7 C -1.0299 -7.4465 0.0 0
M  V30 8 C -3.6344 -7.4465 0.0 0
M  V30 9 C 1.5627 -4.4039 0.0 0
M  V30 10 C -1.0418 -8.9382 0.0 0
M  V30 11 C 0.2604 -6.6888 0.0 0
M  V30 12 C -3.6699 -8.9382 0.0 0
M  V30 13 C -4.9722 -6.6888 0.0 0
M  V30 14 N 2.8531 -5.1498 0.0 0 CHG=1
M  V30 15 O -2.3559 -9.6722 0.0 0
M  V30 16 C 0.2486 -9.6722 0.0 0
M  V30 17 C 1.5508 -7.411 0.0 0
M  V30 18 C -4.984 -9.6722 0.0 0
M  V30 19 C -6.2863 -7.4228 0.0 0
M  V30 20 C 3.5042 -6.4876 0.0 0
M  V30 21 C 4.1435 -4.3803 0.0 0
M  V30 22 C 1.9533 -6.3692 0.0 0
M  V30 23 C 1.539 -8.9145 0.0 0
M  V30 24 C -6.2981 -8.9145 0.0 0
M  V30 25 C 4.9959 -6.4994 0.0 0
M  V30 26 C 5.4576 -5.1261 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 7 1 6 9
M  V30 8 2 7 10
M  V30 9 1 7 11
M  V30 10 2 8 12
M  V30 11 1 8 13
M  V30 12 1 9 14
M  V30 13 1 10 15
M  V30 14 1 10 16
M  V30 15 2 11 17
M  V30 16 1 12 18
M  V30 17 2 13 19
M  V30 18 1 14 20
M  V30 19 1 14 21
M  V30 20 1 14 22
M  V30 21 2 16 23
M  V30 22 2 18 24
M  V30 23 1 20 25
M  V30 24 1 21 26
M  V30 25 1 12 15
M  V30 26 1 17 23
M  V30 27 1 19 24
M  V30 END BOND
M  V30 END CTAB
M  END
",53-46-3,Methantheline bromide,diethyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium bromide,"MI, 13, 5985",J Eur Acad Dermatol Venereol. 2013 Oct 27(10):1278-84,6/4/1963,1951,Yes,A03AB07,"H2O, EtOH",Chemical classification (according ATC code),"Synthetic anticholinergic, quaternary ammonium compound",,Oral,,,,,150,"Anxiety, Mouth dryness, Sweat",,,Neuromuscular,Antispastic,,,,,,,
"Ticarcillin sodium
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C 1.4503 -0.2925 0.0 0
M  V30 3 C -0.8044 -1.2919 0.0 0
M  V30 4 C 1.5966 -1.7672 0.0 0
M  V30 5 C 0.1706 -2.3888 0.0 0
M  V30 6 C 2.8763 -2.4985 0.0 0
M  V30 7 C 2.8398 -3.9854 0.0 0
M  V30 8 C 4.1561 -1.6941 0.0 0
M  V30 9 O 4.1195 -4.7167 0.0 0
M  V30 10 O 1.4869 -4.7167 0.0 0
M  V30 11 O 4.1195 -0.134 0.0 0
M  V30 12 N 5.4358 -2.4254 0.0 0
M  V30 13 C 6.9227 -2.3766 0.0 0 CFG=2
M  V30 14 C 6.9105 -3.8514 0.0 0
M  V30 15 C 8.434 -2.3279 0.0 0 CFG=2
M  V30 16 O 5.7892 -4.8995 0.0 0
M  V30 17 N 8.3975 -3.8148 0.0 0
M  V30 18 S 9.8357 -1.816 0.0 0
M  V30 19 C 9.8113 -4.2536 0.0 0 CFG=2
M  V30 20 C 10.701 -2.9982 0.0 0
M  V30 21 C 10.2622 -5.6674 0.0 0
M  V30 22 C 11.7004 -1.8403 0.0 0
M  V30 23 C 12.0539 -3.6442 0.0 0
M  V30 24 O 11.7126 -5.9355 0.0 0
M  V30 25 O 9.2141 -6.7765 0.0 0 CHG=-1
M  V30 26 Na 4.0951 2.9251 0.0 0 CHG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 13 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18 CFG=1
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21 CFG=3
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 2 21 24
M  V30 24 1 21 25
M  V30 25 1 4 5
M  V30 26 1 15 17
M  V30 27 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",74682-62-5,Ticarcillin sodium,"(2S,5R,6R)-6-[2-carboxylato-2-(3-thienyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0] heptane-2-carboxylate sodium","MI, 13, 9505",Ann Pharmacother. 1998 Jan 32(1):S17-21,4/20/1976,1985,Yes,J01CA13,H2O,Chemical classification (according ATC code),Penicillin with extended spectrum,,Parenteral,,Plasmatic proteins,None,,15000,"Diarrhoea, Fever, Hypersensitivity reactions, Hypokalemia, Nausea, Rash",,,"Infectiology, Metabolism",Antibacterial,,0.5 - 1,45 - 50,,1.2,,0.2
"Thiethylperazine dimalate 
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 45 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C 1.2838 0.7777 0.0 0
M  V30 3 C -1.3209 0.7777 0.0 0
M  V30 4 C 1.2715 2.2961 0.0 0
M  V30 5 C 2.5677 0.037 0.0 0
M  V30 6 C -1.3209 2.2961 0.0 0
M  V30 7 C -2.6294 0.0246 0.0 0
M  V30 8 N -0.037 3.0615 0.0 0
M  V30 9 C 2.5553 3.0615 0.0 0
M  V30 10 C 3.8515 0.8024 0.0 0
M  V30 11 C -2.6418 3.0615 0.0 0
M  V30 12 C -3.938 0.79 0.0 0
M  V30 13 C -0.0493 4.5799 0.0 0
M  V30 14 C 3.8392 2.3208 0.0 0
M  V30 15 C -3.9503 2.3084 0.0 0
M  V30 16 C 1.2344 5.3453 0.0 0
M  V30 17 S 5.1231 3.0862 0.0 0
M  V30 18 C 2.5183 4.6046 0.0 0
M  V30 19 C 6.4193 2.3578 0.0 0
M  V30 20 N 3.8145 5.37 0.0 0
M  V30 21 C 7.7031 3.1232 0.0 0
M  V30 22 C 5.0984 4.6293 0.0 0
M  V30 23 C 3.7898 6.8884 0.0 0
M  V30 24 C 6.3822 5.3947 0.0 0
M  V30 25 C 5.086 7.6538 0.0 0
M  V30 26 N 6.3822 6.9131 0.0 0
M  V30 27 C 7.6661 7.6661 0.0 0
M  V30 28 O 2.864 12.2461 0.0 0
M  V30 29 C 2.8516 10.7523 0.0 0
M  V30 30 O 1.5431 10.0116 0.0 0
M  V30 31 C 4.1355 10.0116 0.0 0
M  V30 32 O 4.1231 8.5179 0.0 0
M  V30 33 C 5.4193 10.777 0.0 0
M  V30 34 C 6.7032 10.0363 0.0 0
M  V30 35 O 7.9871 10.8017 0.0 0
M  V30 36 O 6.6909 8.5426 0.0 0
M  V30 37 O -4.7404 12.6411 0.0 0
M  V30 38 C -4.7527 11.1474 0.0 0
M  V30 39 O -6.0613 10.4067 0.0 0
M  V30 40 C -3.4689 10.4067 0.0 0
M  V30 41 O -3.4812 8.9129 0.0 0
M  V30 42 C -2.1726 11.1721 0.0 0
M  V30 43 C -0.8888 10.4314 0.0 0
M  V30 44 O 0.395 11.1967 0.0 0
M  V30 45 O -0.9011 8.9376 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 2 11 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 26 27
M  V30 27 2 28 29
M  V30 28 1 29 30
M  V30 29 1 29 31
M  V30 30 1 31 32
M  V30 31 1 31 33
M  V30 32 1 33 34
M  V30 33 2 34 35
M  V30 34 1 34 36
M  V30 35 2 37 38
M  V30 36 1 38 39
M  V30 37 1 38 40
M  V30 38 1 40 41
M  V30 39 1 40 42
M  V30 40 1 42 43
M  V30 41 2 43 44
M  V30 42 1 43 45
M  V30 43 1 6 8
M  V30 44 1 10 14
M  V30 45 1 12 15
M  V30 46 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
",52239-63-1,Thiethylperazine dimalate ,2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine 2-hydroxybutanedioic acid,"MI, 13, 9386",Can Med Assoc J. 1965 Feb 20 92:422-3,8/15/1967,,Yes,R06AD03,,Chemical classification (according ATC code),Phenothiazine derivative,,,,,,,13,"Blurred vision, Dizziness, Extrapyramidal syndrome, Headache, Hypotension, Mouth dryness, Sedation, Seizure, Taste alteration",GPCR,Dopamine D2 receptor,Central Nervous System,"Antiemetic, Antivertigo",,,,,,,
"Mesalamine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.3212 -0.7379 0.0 0
M  V30 3 O -2.6305 0.0238 0.0 0
M  V30 4 C -1.3212 -2.2258 0.0 0
M  V30 5 C -0.0357 -2.9638 0.0 0
M  V30 6 C -2.6305 -2.9638 0.0 0
M  V30 7 O 1.2498 -2.1901 0.0 0
M  V30 8 C -0.0476 -4.4636 0.0 0
M  V30 9 C -2.6424 -4.4636 0.0 0
M  V30 10 C -1.3569 -5.2016 0.0 0
M  V30 11 N -3.9636 -5.2016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
",89-57-6,Mesalamine,5-amino-2-hydroxybenzoic acid,"MI, 13, 5931",Arzneimittelforschung. 2012 Feb 62(2):53-8,1/29/1985,1984,Yes,A07EC02,"EtOH, H2O",Chemical classification (according ATC code),Aminosalicylic acid derivative,,Oral,"Small intestine, Colon",,Liver,Acetyl-5-aminosalicylic acid,1500,"Cardiac toxicity, Fulminans hepatitis, Hepatic enzyme levels elevated, Hypersensitivity reactions, Interstitial pulmonary fibrosis, Nephrotoxicity",,,Metabolism,Anti-inflammatory,,,,,1,,
"Imidurea
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.4066 -0.4448 0.0 0
M  V30 3 N 2.6089 0.4688 0.0 0
M  V30 4 N 1.8635 -1.8635 0.0 0
M  V30 5 C 3.8111 -0.3967 0.0 0
M  V30 6 C 2.5728 2.0077 0.0 0
M  V30 7 C 3.3422 -1.8394 0.0 0
M  V30 8 N 5.0976 0.3847 0.0 0
M  V30 9 O 1.2383 2.7892 0.0 0
M  V30 10 O 4.2079 -3.0297 0.0 0
M  V30 11 C 6.384 -0.3606 0.0 0
M  V30 12 O 6.3599 -1.8514 0.0 0
M  V30 13 N 7.6824 0.4207 0.0 0
M  V30 14 C 8.9688 -0.3246 0.0 0
M  V30 15 N 10.2553 0.4568 0.0 0
M  V30 16 C 11.5417 -0.2885 0.0 0
M  V30 17 O 11.5176 -1.7793 0.0 0
M  V30 18 N 12.8281 0.4929 0.0 0
M  V30 19 C 14.1145 -0.2524 0.0 0
M  V30 20 N 15.3168 0.6612 0.0 0
M  V30 21 C 14.5714 -1.6711 0.0 0
M  V30 22 C 16.5191 -0.2043 0.0 0
M  V30 23 C 15.2928 2.2001 0.0 0
M  V30 24 O 13.6577 -2.8613 0.0 0
M  V30 25 N 16.0622 -1.6471 0.0 0
M  V30 26 O 17.9377 0.2765 0.0 0
M  V30 27 O 16.5792 2.9816 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 2 21 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 23 27
M  V30 27 1 5 7
M  V30 28 1 22 25
M  V30 END BOND
M  V30 END CTAB
M  END
",39236-46-9,Imidurea,"1-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea","MI, 13, 4939",Contact Dermatitis. 1986 May 14(5):322-4,7/19/1970,,,Not yet attributed,"H2O, MeOH",,,,,,,,,,,,,Infectiology,Antifungal,,,,,,,
"Lansoprazole
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0 CFG=2
M  V30 2 O 0.3807 1.4755 0.0 0
M  V30 3 C -1.5231 0.0356 0.0 0
M  V30 4 C 1.2613 -0.7496 0.0 0
M  V30 5 N -2.4275 -1.1661 0.0 0
M  V30 6 N -2.4394 1.2613 0.0 0
M  V30 7 C 2.5346 0.0118 0.0 0
M  V30 8 C -3.8793 -0.6901 0.0 0
M  V30 9 C -3.8912 0.8091 0.0 0
M  V30 10 N 2.5346 1.5231 0.0 0
M  V30 11 C 3.796 -0.7377 0.0 0
M  V30 12 C -5.2239 -1.416 0.0 0
M  V30 13 C -5.2358 1.5945 0.0 0
M  V30 14 C 3.8198 2.2847 0.0 0
M  V30 15 C 5.0692 0.0237 0.0 0
M  V30 16 C 3.7365 -2.2133 0.0 0
M  V30 17 C -6.5448 -0.6544 0.0 0
M  V30 18 C -6.5567 0.8448 0.0 0
M  V30 19 C 5.093 1.5469 0.0 0
M  V30 20 O 6.3306 -0.7258 0.0 0
M  V30 21 C 7.6277 0.0356 0.0 0
M  V30 22 C 8.8533 -0.7139 0.0 0
M  V30 23 F 9.8172 0.5235 0.0 0
M  V30 24 F 10.2099 -0.6901 0.0 0
M  V30 25 F 9.8291 -1.892 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 11 16
M  V30 16 2 12 17
M  V30 17 2 13 18
M  V30 18 2 14 19
M  V30 19 1 15 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 2 8 9
M  V30 26 1 15 19
M  V30 27 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",103577-45-3,Lansoprazole,"2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole","MI, 13, 5378",Curr Pharm Des. 2013 19(1):67-75,2/20/1986,1992,Yes,A02BC03,,,,,Oral,Small intestine,Plasmatic proteins,,Sulfoxide,30,"Constipation, Diarrhoea, Dizziness, Fatigue, Headache, Hepatic enzyme levels elevated, Mouth dryness, Nausea, Pruritus, Rash",Enzyme,H+/K+ ATPase,Metabolism,Antiulcer,,1.5 - 2,97,80 - 90,1 - 2,,
"Bethanechol chloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 12 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0 CHG=-1
M  V30 2 O -2.2952 -6.4075 0.0 0
M  V30 3 C -2.3191 -4.8773 0.0 0
M  V30 4 O -1.04 -4.1123 0.0 0
M  V30 5 N -3.646 -4.1123 0.0 0
M  V30 6 C 0.239 -4.8415 0.0 0 CFG=2
M  V30 7 C 1.5182 -4.0644 0.0 0
M  V30 8 C 0.2151 -6.3238 0.0 0
M  V30 9 N 2.7973 -4.7937 0.0 0 CHG=1
M  V30 10 C 4.0884 -4.0286 0.0 0
M  V30 11 C 2.7734 -6.276 0.0 0
M  V30 12 C 2.3789 -3.3113 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 6 4 CFG=3
M  V30 5 1 6 7
M  V30 6 1 6 8
M  V30 7 1 7 9
M  V30 8 1 9 10
M  V30 9 1 9 11
M  V30 10 1 9 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",590-63-6,Bethanechol chloride,2-carbamoyloxypropyl(trimethyl)azanium chloride,"MI, 13, 1189",Urology. 1976 Nov 8(5):455-8,6/22/1943,1949,Yes,N07AB02,H2O,Therapeutic classification (according ATC code),Parasympathomimetic,No,"Oral, Parenteral",,,,,45,"Bronchospasm, Diarrhoea, Facial flushing, Headache, Hypotension, Miosis, Nausea, Sweat, Tachycardia, Urinary troubles",,,Metabolism,,,,,,,,
"Cyproterone acetate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C 0.0 1.4748 0.0 0
M  V30 3 C -1.2389 2.1828 0.0 0
M  V30 4 C 1.2979 2.2418 0.0 0
M  V30 5 C -2.4778 1.4748 0.0 0
M  V30 6 C -1.2389 3.6577 0.0 0 CFG=1
M  V30 7 C 1.2979 3.7167 0.0 0 CFG=2
M  V30 8 C -3.7167 2.1828 0.0 0
M  V30 9 C 0.0 4.4246 0.0 0 CFG=2
M  V30 10 C -2.4778 4.4246 0.0 0 CFG=2
M  V30 11 C -1.2389 5.1326 0.0 0
M  V30 12 C 2.5958 4.4246 0.0 0 CFG=1
M  V30 13 O -4.9556 1.4748 0.0 0
M  V30 14 C -3.7167 3.6577 0.0 0 CFG=1
M  V30 15 C 0.0 5.8995 0.0 0
M  V30 16 C -3.7167 5.1326 0.0 0
M  V30 17 C 2.5958 5.8995 0.0 0 CFG=2
M  V30 18 C 5.1326 4.4246 0.0 0
M  V30 19 C 1.2979 6.6075 0.0 0
M  V30 20 C 3.8937 6.6075 0.0 0 CFG=1
M  V30 21 C 2.9497 7.3155 0.0 0
M  V30 22 C 5.1326 5.8406 0.0 0
M  V30 23 O 5.3096 7.0205 0.0 0
M  V30 24 C 3.8937 8.0824 0.0 0
M  V30 25 C 6.6075 6.2535 0.0 0
M  V30 26 O 5.1916 8.7904 0.0 0
M  V30 27 C 2.5958 8.8493 0.0 0
M  V30 28 O 7.9054 7.0205 0.0 0
M  V30 29 C 6.6075 4.7786 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 7 4 CFG=3
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 6 11 CFG=1
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15 CFG=1
M  V30 15 1 10 16 CFG=3
M  V30 16 1 12 17
M  V30 17 1 12 18 CFG=1
M  V30 18 1 15 19
M  V30 19 1 17 20
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 22
M  V30 22 1 20 23 CFG=3
M  V30 23 1 20 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 1 24 27
M  V30 27 2 25 28
M  V30 28 1 25 29
M  V30 29 1 7 9
M  V30 30 1 10 14
M  V30 31 1 14 16 CFG=3
M  V30 32 1 17 19
M  V30 33 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 6 7 9 10 12 14 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",427-51-0,Cyproterone acetate,"(1R,3aS,3bR,7aR,8aS,8bS,8cS,10aS)-1-Acetyl-5-chloro-8b,10a-dimethyl-7-oxo-1,2,3,3a,3b,7,7a,8,8a,8b,8c,9,10,10a-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-1-yl acetate","MI, 13, 2804",Urol Clin North Am. 1991 Feb 18(1):111-22,12/12/1963,1973,,G03HA01Â ,,,,,Oral,,,Liver,15beta-hydroxycyproterone,100,"Asthenia, Breast pain, Depression, Hypersensitivity reactions, Migraine, Nausea, Occular irritation, Oedema, Rash, Weight gain",,,Endocrinology,"Antineoplastic, Contraceptive",,3 - 4,,,48,,
"(R)-Propranolol hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O -5.369 4.2387 0.0 0
M  V30 3 C -5.369 2.7198 0.0 0
M  V30 4 C -4.0974 5.0158 0.0 0
M  V30 5 C -6.6759 1.978 0.0 0
M  V30 6 C -4.0621 1.978 0.0 0
M  V30 7 C -2.7551 4.274 0.0 0 CFG=2
M  V30 8 C -6.6759 0.4591 0.0 0
M  V30 9 C -7.9829 2.7198 0.0 0
M  V30 10 C -4.0621 0.4591 0.0 0
M  V30 11 O -2.2253 3.073 0.0 0
M  V30 12 C -1.4482 5.0511 0.0 0
M  V30 13 C -5.369 -0.2825 0.0 0
M  V30 14 C -7.9829 -0.2825 0.0 0
M  V30 15 C -9.2898 1.978 0.0 0
M  V30 16 N -0.1412 4.3093 0.0 0
M  V30 17 C -9.2898 0.4591 0.0 0
M  V30 18 C 1.1656 5.0864 0.0 0
M  V30 19 C 2.4725 4.3446 0.0 0
M  V30 20 C 1.1303 6.6053 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 1 3 5
M  V30 4 2 3 6
M  V30 5 1 4 7
M  V30 6 1 5 8
M  V30 7 2 5 9
M  V30 8 1 6 10
M  V30 9 1 7 11 CFG=1
M  V30 10 1 7 12
M  V30 11 1 8 13
M  V30 12 2 8 14
M  V30 13 1 9 15
M  V30 14 1 12 16
M  V30 15 1 14 17
M  V30 16 1 16 18
M  V30 17 1 18 19
M  V30 18 1 18 20
M  V30 19 2 10 13
M  V30 20 2 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",13071-11-9,(R)-Propranolol hydrochloride,(2R)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol hydrochloride,"MI, 13, 7932",Am J Med. 1976 May 31 60(6):837-52,10/28/1963,1964,Yes,C07AA05,"H2O, EtOH","New therapeutic use, Reference, Therapeutic classification (according ATC code)","Infantile hemangioma, Exp Ther Med. 2013 Aug 6(2):574-578, Non-selective beta-blocking agent",Yes,Oral,GI tract,Albumin,Liver,Active (4-hydroxypropranolol),160,"Asthenia, Bradycardia, Bronchospasm, Insomnia, Nightmare, Raynaud's syndrome",GPCR,Adrenergic receptor beta,Cardiovascular,"Antianginal, Antiarrhythmic, Antihypertensive, Antimigraine",,,90,,3 - 6,,4
"Ciprofibrate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 C -0.6477 1.0755 0.0 0
M  V30 3 Cl -1.3444 0.1099 0.0 0
M  V30 4 C 0.0244 2.4566 0.0 0 CFG=2
M  V30 5 C -1.5155 2.4566 0.0 0
M  V30 6 C 1.3322 3.2632 0.0 0
M  V30 7 C 2.6399 2.5177 0.0 0
M  V30 8 C 1.3077 4.8277 0.0 0
M  V30 9 C 3.9477 3.3121 0.0 0
M  V30 10 C 2.6155 5.6221 0.0 0
M  V30 11 C 3.9232 4.8643 0.0 0
M  V30 12 O 5.231 5.6588 0.0 0
M  V30 13 C 6.5388 4.9132 0.0 0
M  V30 14 C 7.8587 5.7077 0.0 0
M  V30 15 C 5.3288 4.0699 0.0 0
M  V30 16 C 7.7976 4.1066 0.0 0
M  V30 17 O 7.8343 7.2721 0.0 0
M  V30 18 O 9.1665 4.9621 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 4 6 CFG=3
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 4 5
M  V30 19 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",52214-84-3,Ciprofibrate,"2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid","MI, 13, 2336",Atherosclerosis. 1996 Jul 124 Suppl:S83-7,3/7/1974,1985,,C10AB08,,Therapeutic classification (according ATC code),Fibrate,,Oral,GI tract,Plasmatic proteins,Liver,,100,"Dizziness, Drowsiness, Dyspepsia, Erectile dysfunction, Hair loss, Headache, Hepatic enzyme levels elevated, Kidney stone, Nausea, Photosensitization, Pruritus",Nuclear receptor,Peroxisome proliferator-activated receptor (PPAR) alpha,Metabolism,Hypocholesterolemic,,2,85 - 100,,17,,
"Benzylpenicillin sodium
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C 0.8774 -1.19 0.0 0
M  V30 3 C -1.4304 -0.4687 0.0 0 CFG=1
M  V30 4 C 0.0 -2.404 0.0 0 CFG=1
M  V30 5 C 1.7309 -2.404 0.0 0
M  V30 6 C 1.7549 0.024 0.0 0
M  V30 7 N -1.4424 -1.9593 0.0 0
M  V30 8 C -2.945 -0.4567 0.0 0 CFG=1
M  V30 9 C 0.4447 -3.8225 0.0 0
M  V30 10 C -2.981 -1.9473 0.0 0
M  V30 11 N -4.4595 -0.3726 0.0 0
M  V30 12 O 1.9112 -4.1109 0.0 0
M  V30 13 O -0.1803 -5.0125 0.0 0 CHG=-1
M  V30 14 O -4.0388 -2.981 0.0 0
M  V30 15 C -5.7698 0.3966 0.0 0
M  V30 16 O -5.7818 1.9112 0.0 0
M  V30 17 C -7.104 -0.3485 0.0 0
M  V30 18 C -8.4143 0.4327 0.0 0
M  V30 19 C -9.7245 -0.3125 0.0 0
M  V30 20 C -8.4263 1.9473 0.0 0
M  V30 21 C -11.0347 0.4567 0.0 0
M  V30 22 C -9.7365 2.7166 0.0 0
M  V30 23 C -11.0467 1.9713 0.0 0
M  V30 24 Na -3.7503 4.6158 0.0 0 CHG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 1 CFG=1
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 8 3 CFG=1
M  V30 8 1 4 9 CFG=3
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 4 7
M  V30 24 1 8 10
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 3 4 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",69-57-8,Benzylpenicillin sodium,"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate sodium","MI, 13, 7165",J Antimicrob Chemother. 2004 Apr 53(4):675-7,6/13/1950,1942,Yes,J01CE01Â ,"H2O, MeOH",Chemical classification (according ATC code),Beta-lactamase sensitive penicillin,,Parenteral,,,,,3600,"Diarrhoea, Nausea",,,"Infectiology, Metabolism",Antibacterial,,,60,,0.5,30,
"Nomifensine maleate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0249 -1.4239 0.0 0
M  V30 3 O 1.1866 -2.1608 0.0 0
M  V30 4 C -1.3115 -2.1608 0.0 0
M  V30 5 C -2.598 -1.3989 0.0 0
M  V30 6 C -2.623 0.0999 0.0 0
M  V30 7 O -3.9095 0.8368 0.0 0
M  V30 8 O -1.3864 0.8368 0.0 0
M  V30 9 N 8.9932 -2.4981 0.0 0
M  V30 10 C 7.6567 -3.2225 0.0 0
M  V30 11 C 8.9682 -0.9742 0.0 0
M  V30 12 C 10.2423 -3.1976 0.0 0
M  V30 13 C 6.3077 -2.4481 0.0 0
M  V30 14 C 7.6317 -0.2123 0.0 0 CFG=2
M  V30 15 C 4.9837 -3.1726 0.0 0
M  V30 16 C 6.2827 -0.9243 0.0 0
M  V30 17 C 7.6067 1.299 0.0 0
M  V30 18 N 4.9587 -4.6215 0.0 0
M  V30 19 C 3.6472 -2.3982 0.0 0
M  V30 20 C 4.9587 -0.1623 0.0 0
M  V30 21 C 6.2578 2.0359 0.0 0
M  V30 22 C 8.8183 2.0359 0.0 0
M  V30 23 C 3.6222 -0.8743 0.0 0
M  V30 24 C 6.2328 3.5598 0.0 0
M  V30 25 C 8.7934 3.6347 0.0 0
M  V30 26 C 7.5068 4.3592 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 4 5
M  V30 5 1 5 6
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 9 10
M  V30 9 1 9 11
M  V30 10 1 9 12
M  V30 11 1 10 13
M  V30 12 1 11 14
M  V30 13 2 13 15
M  V30 14 1 13 16
M  V30 15 1 14 17 CFG=3
M  V30 16 1 15 18
M  V30 17 1 15 19
M  V30 18 2 16 20
M  V30 19 2 17 21
M  V30 20 1 17 22
M  V30 21 2 19 23
M  V30 22 1 21 24
M  V30 23 2 22 25
M  V30 24 2 24 26
M  V30 25 1 14 16
M  V30 26 1 20 23
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",32795-47-4,Nomifensine maleate,"2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine (Z)-but-2-enedioic acid","MI, 12, 6768",Br J Clin Pharmacol. 1977 4Suppl 2:237S-241S,5/10/1968,Launched,,N06AX04,"DMSO, HCl, H2O",,,,,,,,,150,"Anticholinergic effects, Drowsiness",,,Central Nervous System,Antidepressant,,,,,,,
"Methiazole
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 C 1.2927 -0.759 0.0 0
M  V30 3 C -0.0118 1.5181 0.0 0
M  V30 4 C 2.5855 0.0237 0.0 0
M  V30 5 C 1.2809 -2.2534 0.0 0
M  V30 6 C -1.3283 2.2772 0.0 0
M  V30 7 C 1.2809 2.2772 0.0 0
M  V30 8 C 3.8902 -0.7116 0.0 0
M  V30 9 C 2.5737 -2.9888 0.0 0
M  V30 10 N 5.3016 -0.2253 0.0 0
M  V30 11 C 3.8902 -2.206 0.0 0
M  V30 12 C 6.1911 -1.4351 0.0 0
M  V30 13 N 5.3134 -2.6448 0.0 0
M  V30 14 N 7.6855 -1.4113 0.0 0
M  V30 15 C 8.4327 -2.7041 0.0 0
M  V30 16 O 7.6737 -4.0088 0.0 0
M  V30 17 O 9.9272 -2.6923 0.0 0
M  V30 18 C 10.6625 -3.9732 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 14 15
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 9 11
M  V30 19 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
",108579-67-5,Methiazole,methyl N-(6-propan-2-ylsulfanyl-1H-benzimidazol-2-yl)carbamate,,Antimicrob Agents Chemother. 2006 Sep 50(9):2966-70,8/19/1980,,,Not yet attributed,,,,,,,,,,,,,,"Infectiology, Metabolism",Antihelmintic,,,,,,,
"(S)-propranolol hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O -5.3406 4.2163 0.0 0
M  V30 3 C -5.3406 2.7054 0.0 0
M  V30 4 C -4.0757 4.9893 0.0 0
M  V30 5 C -6.6407 1.9676 0.0 0
M  V30 6 C -4.0406 1.9676 0.0 0
M  V30 7 C -2.7757 4.2514 0.0 0 CFG=1
M  V30 8 C -6.6407 0.4567 0.0 0
M  V30 9 C -7.9407 2.7054 0.0 0
M  V30 10 C -4.0406 0.4567 0.0 0
M  V30 11 O -2.0378 2.9514 0.0 0
M  V30 12 C -1.4757 5.0244 0.0 0
M  V30 13 C -5.3406 -0.281 0.0 0
M  V30 14 C -7.9407 -0.281 0.0 0
M  V30 15 C -9.2407 1.9676 0.0 0
M  V30 16 N -0.1756 4.2865 0.0 0
M  V30 17 C -9.2407 0.4567 0.0 0
M  V30 18 C 1.1243 5.0595 0.0 0
M  V30 19 C 1.0892 6.5704 0.0 0
M  V30 20 C 2.4243 4.3217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 1 2 4
M  V30 3 1 3 5
M  V30 4 2 3 6
M  V30 5 1 4 7
M  V30 6 1 5 8
M  V30 7 2 5 9
M  V30 8 1 6 10
M  V30 9 1 7 11 CFG=3
M  V30 10 1 7 12
M  V30 11 1 8 13
M  V30 12 2 8 14
M  V30 13 1 9 15
M  V30 14 1 12 16
M  V30 15 1 14 17
M  V30 16 1 16 18
M  V30 17 1 18 19
M  V30 18 1 18 20
M  V30 19 2 10 13
M  V30 20 2 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",04.10.4199,(S)-propranolol hydrochloride,(2S)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol hydrochloride,"MI, 13, 7932",Am J Med. 1976 May 31 60(6):837-52,6/10/1965,1964,Yes,C07AA05,"H2O, EtOH",Therapeutic classification (according ATC code),Non-selective beta-blocking agent,Yes,Oral,GI tract,Alpha-1-acid glycoprotein,Liver,Active (4-hydroxypropranolol),160,"Asthenia, Bradycardia, Bronchospasm, Insomnia, Nightmare, Raynaud's syndrome",GPCR,Adrenergic receptor beta,Cardiovascular,"Antianginal, Antiarrhythmic, Antihypertensive",,,90,,3 - 6,,4
"(-)-Eseroline fumarate salt
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 0.7219 -1.29 0.0 0
M  V30 3 O 2.2132 -1.2782 0.0 0
M  V30 4 C -0.0473 -2.5801 0.0 0
M  V30 5 C -1.5623 -2.5446 0.0 0
M  V30 6 C -2.8879 -3.2784 0.0 0
M  V30 7 O -2.8879 -4.7697 0.0 0
M  V30 8 O -4.2016 -2.5328 0.0 0
M  V30 9 O -4.5449 -7.5748 0.0 0
M  V30 10 C -3.2548 -8.3086 0.0 0
M  V30 11 C -1.9647 -7.5511 0.0 0
M  V30 12 C -3.2666 -9.7999 0.0 0
M  V30 13 C -0.6746 -8.2849 0.0 0
M  V30 14 C -1.9765 -10.5337 0.0 0
M  V30 15 C -0.6746 -9.7762 0.0 0
M  V30 16 C 0.7456 -7.7997 0.0 0 CFG=1
M  V30 17 N 0.7574 -10.2378 0.0 0
M  V30 18 C 1.6333 -9.0187 0.0 0 CFG=2
M  V30 19 C 1.6214 -6.5569 0.0 0
M  V30 20 C -0.1538 -6.5806 0.0 0
M  V30 21 C 1.219 -11.6344 0.0 0
M  V30 22 N 3.0654 -8.5335 0.0 0
M  V30 23 C 3.0654 -6.9948 0.0 0
M  V30 24 C 4.2726 -9.3856 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 4 5
M  V30 5 1 5 6
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 9 10
M  V30 9 2 10 11
M  V30 10 1 10 12
M  V30 11 1 11 13
M  V30 12 2 12 14
M  V30 13 2 13 15
M  V30 14 1 13 16
M  V30 15 1 15 17
M  V30 16 1 16 18
M  V30 17 1 16 19
M  V30 18 1 16 20 CFG=1
M  V30 19 1 17 21
M  V30 20 1 18 22 CFG=1
M  V30 21 1 19 23
M  V30 22 1 22 24
M  V30 23 1 14 15
M  V30 24 1 17 18
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",104015-29-4,(-)-Eseroline fumarate salt,"(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol (E)-but-2-enedioic acid",,J Enzyme Inhib Med Chem. 2002 Oct 17(5):279-85,6/15/1982,Preclinical,,Not yet attributed,"H2O, MeOH",,,,,,,,,,,,,Central Nervous System,Analgesic,,,,,,,
"D-cycloserine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.2264 0.8877 0.0 0
M  V30 3 N -2.6514 0.4438 0.0 0
M  V30 4 C -1.2381 2.3828 0.0 0 CFG=2
M  V30 5 O -3.5391 1.6469 0.0 0
M  V30 6 N -0.035 3.2822 0.0 0
M  V30 7 C -2.6631 2.8617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 7
M  V30 7 1 5 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",68-41-7,D-cycloserine,"(4R)-4-Amino-1,2-oxazolidin-3-one","MI, 13, 2780",Curr Pharm Des. 2012 18(35):5659-62,12/11/1956,1952,Yes,J04AB01,"H2O, MeOH",,,Yes,Oral,GI tract,,,,750,"Anxiety, Confusion, Dizziness, Drowsiness, Fever, Headache, Nausea, Nightmare, Pruritus, Seizure",,,"Infectiology, Metabolism",Antibacterial,,3 - 4,,,10,,
"(+,-)-Synephrine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2871 0.7698 0.0 0
M  V30 3 C 2.5622 0.036 0.0 0
M  V30 4 C 1.263 2.3096 0.0 0
M  V30 5 C 3.8493 0.8059 0.0 0
M  V30 6 C 2.5381 3.0914 0.0 0
M  V30 7 C 3.8252 2.3456 0.0 0
M  V30 8 C 5.1003 3.1275 0.0 0 CFG=1
M  V30 9 O 5.0642 4.6552 0.0 0
M  V30 10 C 6.3754 2.3938 0.0 0
M  V30 11 N 7.6505 3.1636 0.0 0
M  V30 12 C 8.9376 2.4298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9 CFG=1
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 6 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",94-07-5,"(+,-)-Synephrine",4-[1-hydroxy-2-(methylamino)ethyl]phenol,"MI, 13, 9104",Phytother Res. 2011 Oct 25(10):1421-8,8/18/1976,,,C01CA08Â ,,,,,Oral,,,,,200,"Arrhythmia, Dizziness, Glaucoma, Headache, Hypertension, Sweat",,,Cardiovascular,Vasoconstrictor,,1 - 2,,,2,,
"(S)-(-)-Cycloserine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.2264 0.8877 0.0 0
M  V30 3 N -2.6514 0.4438 0.0 0
M  V30 4 C -1.2381 2.3828 0.0 0 CFG=1
M  V30 5 O -3.5391 1.6469 0.0 0
M  V30 6 N -0.035 3.2822 0.0 0
M  V30 7 C -2.6631 2.8617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 7
M  V30 7 1 5 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",339-72-0,(S)-(-)-Cycloserine,"(4S)-4-Amino-1,2-oxazolidin-3-one","MI, 13, 2780",Can J Physiol Pharmacol. 1978 Feb 56(1):62-8,12/11/1956,1952,Yes,J04AB01,"H2O, MeOH",,,Yes,Oral,GI tract,,,,750,"Anxiety, Confusion, Dizziness, Drowsiness, Fever, Headache, Nausea, Nightmare, Pruritus, Seizure",,,"Infectiology, Metabolism",Antibacterial,,3 - 4,,,10,,
"Dizocilpine maleate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.5177 0.0 0.0 0
M  V30 3 O 2.2535 -1.2877 0.0 0
M  V30 4 C 2.2535 1.2877 0.0 0
M  V30 5 C 3.7712 1.2877 0.0 0
M  V30 6 C 4.5071 0.0 0.0 0
M  V30 7 O 6.0248 0.0 0.0 0
M  V30 8 O 3.7712 -1.2877 0.0 0
M  V30 9 N -3.3113 -3.6793 0.0 0
M  V30 10 C -3.2193 -5.6569 0.0 0 CFG=1
M  V30 11 C -2.5755 -2.3915 0.0 0 CFG=1
M  V30 12 C -4.5531 -5.059 0.0 0
M  V30 13 C -1.9316 -4.967 0.0 0
M  V30 14 C -3.2193 -7.1286 0.0 0
M  V30 15 C -1.6096 -3.4953 0.0 0
M  V30 16 C -4.0472 -2.4375 0.0 0
M  V30 17 C -4.921 -3.6333 0.0 0
M  V30 18 C -5.6109 -6.1168 0.0 0
M  V30 19 C -0.8278 -5.9328 0.0 0
M  V30 20 C -0.2299 -3.0354 0.0 0
M  V30 21 C -6.3467 -3.2653 0.0 0
M  V30 22 C -7.0366 -5.7489 0.0 0
M  V30 23 C 0.5518 -5.4729 0.0 0
M  V30 24 C 0.8738 -4.0012 0.0 0
M  V30 25 C -7.4045 -4.3231 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 4 5
M  V30 5 1 5 6
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 10 9 CFG=1
M  V30 9 1 11 9 CFG=1
M  V30 10 1 10 12
M  V30 11 1 10 13
M  V30 12 1 10 14
M  V30 13 1 11 15
M  V30 14 1 11 16
M  V30 15 2 12 17
M  V30 16 1 12 18
M  V30 17 1 13 19
M  V30 18 1 15 20
M  V30 19 1 17 21
M  V30 20 2 18 22
M  V30 21 2 19 23
M  V30 22 2 20 24
M  V30 23 2 21 25
M  V30 24 2 13 15
M  V30 25 1 16 17
M  V30 26 1 22 25
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",77086-22-7,Dizocilpine maleate,"[5R,10S]-[+]-5-methyl-10,11- dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate","MI, 12, 3451",Oxid Med Cell Longev. 2010 Jan-Feb 3(1):13-22,4/11/1979,Phase II,,Not yet attributed,H2O,,,,,,,,,,Hallucinations,,,Central Nervous System,Anticonvulsant,,,,,,,
"Homosalate
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0238 -1.4796 0.0 0
M  V30 3 O 1.2648 -2.2075 0.0 0
M  V30 4 C -1.3484 -2.2195 0.0 0
M  V30 5 C 2.5417 -1.4319 0.0 0
M  V30 6 C -1.3722 -3.7111 0.0 0
M  V30 7 C -2.6729 -1.4438 0.0 0
M  V30 8 C 2.5059 0.0954 0.0 0
M  V30 9 C 3.8185 -2.1598 0.0 0
M  V30 10 O -0.0835 -4.439 0.0 0
M  V30 11 C -2.6968 -4.439 0.0 0
M  V30 12 C -3.9975 -2.1717 0.0 0
M  V30 13 C 3.7827 0.8711 0.0 0
M  V30 14 C 5.0953 -1.3842 0.0 0
M  V30 15 C -4.0213 -3.6634 0.0 0
M  V30 16 C 5.0714 0.1431 0.0 0
M  V30 17 C 4.1645 -0.5608 0.0 0
M  V30 18 C 3.7588 2.3985 0.0 0
M  V30 19 C 6.3721 -2.1121 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 11 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 12 15
M  V30 20 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
",118-56-9,Homosalate,"(3,3,5-trimethylcyclohexyl) 2-hydroxybenzoate","MI, 13, 4759",J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1 936:80-7,3/13/1979,,,Not yet attributed,,,,,,,,,,,"Irritation, Mucosal irritation",,,Dermatology,Radioprotectant,,,,,,,
"Spaglumic acid
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -1.3336 -0.7329 0.0 0
M  V30 3 O -1.3696 -2.1866 0.0 0
M  V30 4 C -2.6672 0.036 0.0 0 CFG=1
M  V30 5 N -2.7033 1.5739 0.0 0
M  V30 6 C -4.0009 -0.6848 0.0 0
M  V30 7 C -1.4417 2.3549 0.0 0
M  V30 8 C -5.3345 0.0841 0.0 0
M  V30 9 O -1.4778 3.8928 0.0 0
M  V30 10 C -0.1802 1.634 0.0 0
M  V30 11 O -5.3706 1.622 0.0 0
M  V30 12 N -6.6682 -0.6367 0.0 0
M  V30 13 C -6.7042 -2.1025 0.0 0 CFG=1
M  V30 14 C -8.0379 -2.8354 0.0 0
M  V30 15 C -5.4427 -2.8354 0.0 0
M  V30 16 O -8.0739 -4.3013 0.0 0
M  V30 17 O -9.3715 -2.0545 0.0 0
M  V30 18 C -4.1811 -2.0545 0.0 0
M  V30 19 C -2.9196 -2.7874 0.0 0
M  V30 20 O -1.646 -2.0064 0.0 0
M  V30 21 O -2.9436 -4.2532 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 4 5 CFG=3
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 13 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 18 19
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",4910-46-7,Spaglumic acid,2-[(2-acetamido-3-carboxypropanoyl)amino]pentanedioic acid,,Allergol Immunopathol (Madr). 1997 Sep-Oct 25(5):233-7,4/15/1987,,,R01AC05,H2O,,,,Ocular,,,,,,Burning,,,"Allergology, Cardiovascular","Antiallergic, Vasodilator",,,,,,,
"Ranolazine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0244 -1.4678 0.0 0
M  V30 3 N -1.3944 -2.1772 0.0 0
M  V30 4 C 1.1742 -2.2384 0.0 0
M  V30 5 C -2.7154 -1.3454 0.0 0
M  V30 6 N 2.4463 -1.4922 0.0 0
M  V30 7 C -2.7399 0.2201 0.0 0
M  V30 8 C -4.0731 -2.0182 0.0 0
M  V30 9 C 2.4218 -0.0978 0.0 0
M  V30 10 C 3.7184 -2.2628 0.0 0
M  V30 11 C -3.9875 1.003 0.0 0
M  V30 12 C -1.3699 0.9785 0.0 0
M  V30 13 C -5.3452 -1.2476 0.0 0
M  V30 14 C -4.0976 -3.4982 0.0 0
M  V30 15 C 3.5961 0.6605 0.0 0
M  V30 16 C 4.9416 -1.5534 0.0 0
M  V30 17 C -5.3574 0.2324 0.0 0
M  V30 18 N 4.9171 0.0122 0.0 0
M  V30 19 C 6.3971 0.7705 0.0 0
M  V30 20 C 6.3727 2.2628 0.0 0 CFG=2
M  V30 21 O 7.657 3.0579 0.0 0
M  V30 22 C 5.1006 2.9967 0.0 0
M  V30 23 O 3.8407 2.2506 0.0 0
M  V30 24 C 2.5075 2.96 0.0 0
M  V30 25 C 2.483 4.5135 0.0 0
M  V30 26 C 1.1742 2.2506 0.0 0
M  V30 27 O 3.7062 5.3452 0.0 0
M  V30 28 C 1.0886 5.1495 0.0 0
M  V30 29 C -0.159 2.9845 0.0 0
M  V30 30 C 3.5961 6.8864 0.0 0
M  V30 31 C -0.1834 4.4278 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 11 17
M  V30 17 1 15 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21 CFG=1
M  V30 21 1 20 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 25 28
M  V30 28 2 26 29
M  V30 29 1 27 30
M  V30 30 2 28 31
M  V30 31 1 13 17
M  V30 32 1 16 18
M  V30 33 1 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",95635-55-5,Ranolazine,"N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide","MI, 13, 8199",Am J Cardiovasc Drugs. 2013 Feb 13(1):5-16,11/28/1984,2006,Yes,C01EB18,,,,,,,,,,1500,"Arthralgia, Constipation, Cough, Dizziness, Dyspnea, Fatigue, Headache, Nausea, Oedema",,,Cardiovascular,Antianginal,,,,,,,
"Sulfadoxine
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O -1.2134 0.9041 0.0 0
M  V30 3 O 1.1777 0.9398 0.0 0
M  V30 4 N 1.2847 -0.7375 0.0 0
M  V30 5 C -1.3085 -0.7494 0.0 0
M  V30 6 C 2.5695 0.0237 0.0 0
M  V30 7 C -2.629 0.0118 0.0 0
M  V30 8 C -1.3204 -2.2483 0.0 0
M  V30 9 N 2.5457 1.5346 0.0 0
M  V30 10 C 3.8543 -0.7137 0.0 0
M  V30 11 C -3.9376 -0.7256 0.0 0
M  V30 12 C -2.6409 -2.9859 0.0 0
M  V30 13 C 3.8305 2.2959 0.0 0
M  V30 14 O 3.8424 -2.2008 0.0 0
M  V30 15 C 5.1391 0.0594 0.0 0
M  V30 16 C -3.9495 -2.2245 0.0 0
M  V30 17 N 5.1272 1.5584 0.0 0
M  V30 18 C 5.1391 -2.9383 0.0 0
M  V30 19 O 6.4358 -0.678 0.0 0
M  V30 20 N -5.27 -2.9621 0.0 0
M  V30 21 C 6.4358 -2.1651 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 2 11 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 19 21
M  V30 21 1 12 16
M  V30 22 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
",2447-57-6,Sulfadoxine,"Amino-4 N-(dimethoxy-5,6 pyrimidinyl-4)benzenesulfonamide","MI, 13, 8991",Lancet. 2009 Oct 31 374(9700):1533-42,1/14/1974,1971,Yes,QJ01EQ13,"H2O, EtOH, MeOH","Human use, Veterinary use","Association with Pyrimethamine (Prestw-37), Cattle",,Oral,,,Liver,,,Hypersensitivity reactions,,,"Infectiology, Metabolism",Antibacterial,,,,,,,
"Cyclopentolate hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O 1.0489 -2.5747 0.0 0
M  V30 3 C 1.0251 -4.0528 0.0 0
M  V30 4 O 2.3005 -4.7799 0.0 0
M  V30 5 C -0.298 -4.7799 0.0 0 CFG=1
M  V30 6 C 3.576 -4.017 0.0 0
M  V30 7 C -1.6211 -4.017 0.0 0
M  V30 8 C -0.3218 -6.258 0.0 0
M  V30 9 C 4.8515 -4.7442 0.0 0
M  V30 10 C -1.6449 -2.4913 0.0 0
M  V30 11 C -2.9442 -4.7442 0.0 0
M  V30 12 O 0.8582 -5.3521 0.0 0
M  V30 13 C 0.882 -7.1163 0.0 0
M  V30 14 C -1.5496 -7.1163 0.0 0
M  V30 15 N 6.1269 -3.9813 0.0 0
M  V30 16 C -2.9681 -1.7284 0.0 0
M  V30 17 C -4.2674 -3.9932 0.0 0
M  V30 18 C 0.4052 -8.5229 0.0 0
M  V30 19 C -1.0966 -8.5229 0.0 0
M  V30 20 C 6.1031 -2.4555 0.0 0
M  V30 21 C 7.4262 -4.7084 0.0 0
M  V30 22 C -4.315 -2.4555 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 2 3
M  V30 2 1 3 4
M  V30 3 1 5 3 CFG=3
M  V30 4 1 4 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 7 1 6 9
M  V30 8 2 7 10
M  V30 9 1 7 11
M  V30 10 1 8 12
M  V30 11 1 8 13
M  V30 12 1 8 14
M  V30 13 1 9 15
M  V30 14 1 10 16
M  V30 15 2 11 17
M  V30 16 1 13 18
M  V30 17 1 14 19
M  V30 18 1 15 20
M  V30 19 1 15 21
M  V30 20 2 16 22
M  V30 21 1 17 22
M  V30 22 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STERAC1 ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",5870-29-1,Cyclopentolate hydrochloride,2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride,"MI, 13, 2775",Ophthalmic Physiol Opt. 1991 Jan 11(1):16-21,5/29/1951,1975,Yes,S01FA04,"H2O, EtOH",Therapeutic classification (according ATC code),Anticholinergic,,Ocular,Eye,,,,,"Confusion, Constipation, Excitation, Glaucoma, Hallucinations, Mouth dryness, Mydriasis, Occular irritation, Seizure, Somnolence, Tachycardia",,,Metabolism,,,,,,,,
"Estriol
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C 1.2731 0.7639 0.0 0
M  V30 3 C 2.5267 0.0587 0.0 0
M  V30 4 C 1.2536 2.2525 0.0 0
M  V30 5 C 3.7608 0.8226 0.0 0
M  V30 6 C 2.4876 2.9968 0.0 0
M  V30 7 C 3.7216 2.2917 0.0 0
M  V30 8 C 4.9948 0.1175 0.0 0
M  V30 9 C 4.9556 3.036 0.0 0 CFG=2
M  V30 10 C 6.2288 0.8814 0.0 0
M  V30 11 C 6.1896 2.3309 0.0 0 CFG=1
M  V30 12 C 4.936 4.5051 0.0 0
M  V30 13 C 7.4236 3.0948 0.0 0 CFG=1
M  V30 14 C 6.17 5.2494 0.0 0
M  V30 15 C 7.3844 4.5638 0.0 0 CFG=2
M  V30 16 C 9.8916 3.1144 0.0 0
M  V30 17 C 8.638 5.3082 0.0 0 CFG=2
M  V30 18 C 7.3453 6.0917 0.0 0
M  V30 19 C 9.8916 4.603 0.0 0 CFG=2
M  V30 20 O 8.6185 6.836 0.0 0
M  V30 21 O 11.1648 5.3669 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=1
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 13 16 CFG=1
M  V30 16 1 15 17
M  V30 17 1 15 18 CFG=1
M  V30 18 1 16 19
M  V30 19 1 17 20 CFG=1
M  V30 20 1 19 21 CFG=3
M  V30 21 1 6 7
M  V30 22 1 11 10 CFG=3
M  V30 23 1 14 15
M  V30 24 1 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 9 11 13 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",50-27-1,Estriol,"(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol","MI, 13, 3742",Acta Endocrinol Suppl (Copenh). 1980 233:51-6,3/22/1962,,,G03CA04Â ,"EtOH, CHCl3",,,,Oral,,,Liver,,2,"Breast pain, Menstrual disturbances, Nausea",Nuclear receptor,Estrogen receptor,Endocrinology,,,,,,,,
"(-)-Isoproterenol hydrochloride
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0 0.0 0.0 0
M  V30 2 O -0.5691 -3.9839 0.0 0
M  V30 3 C 0.7351 -4.719 0.0 0
M  V30 4 C 0.7232 -6.213 0.0 0
M  V30 5 C 2.0275 -3.9364 0.0 0
M  V30 6 O -0.6047 -6.9481 0.0 0
M  V30 7 C 2.0156 -6.9481 0.0 0
M  V30 8 C 3.3199 -4.6716 0.0 0
M  V30 9 C 3.308 -6.1892 0.0 0
M  V30 10 C 4.6123 -3.9127 0.0 0 CFG=1
M  V30 11 O 4.5886 -2.395 0.0 0
M  V30 12 C 5.9047 -4.6479 0.0 0
M  V30 13 N 7.1971 -3.889 0.0 0
M  V30 14 C 8.5013 -4.6123 0.0 0
M  V30 15 C 8.4302 -6.1063 0.0 0
M  V30 16 C 9.853 -3.9602 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 3
M  V30 2 2 3 4
M  V30 3 1 3 5
M  V30 4 1 4 6
M  V30 5 1 4 7
M  V30 6 2 5 8
M  V30 7 2 7 9
M  V30 8 1 8 10
M  V30 9 1 10 11 CFG=1
M  V30 10 1 10 12
M  V30 11 1 12 13
M  V30 12 1 13 14
M  V30 13 1 14 15
M  V30 14 1 14 16
M  V30 15 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
",5984-95-2,(-)-Isoproterenol hydrochloride,"4-[(1R)-1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol hydrochloride","MI, 13, 5237",Agents Actions Suppl. 1993 43:271-80,1/13/1959,1956,Yes,C01CA02,H2O,,,,Oral,,,Liver,,90,"Arrhythmia, Headache, Hot flushes, Hypotension, Tachycardia, Tremor",,,"Cardiovascular, Respiratory","Bronchodilator, Vasodilator",,,,,3 - 7,,
"Nialamide
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0 0.0 0.0 0
M  V30 2 C -0.0126 1.5168 0.0 0
M  V30 3 N 1.2893 2.2753 0.0 0
M  V30 4 C -1.3146 2.2753 0.0 0
M  V30 5 N 2.566 1.5421 0.0 0
M  V30 6 C -1.3146 3.8048 0.0 0
M  V30 7 C -2.6039 1.5547 0.0 0
M  V30 8 C 3.8553 2.3005 0.0 0
M  V30 9 C -2.6165 4.5632 0.0 0
M  V30 10 C -3.9059 2.3005 0.0 0
M  V30 11 C 5.132 1.5674 0.0 0
M  V30 12 N -3.9438 3.83 0.0 0
M  V30 13 C 6.4087 2.3258 0.0 0
M  V30 14 O 6.3961 3.9438 0.0 0
M  V30 15 N 7.6854 1.5927 0.0 0
M  V30 16 C 8.9874 2.3511 0.0 0
M  V30 17 C 10.2641 1.6179 0.0 0
M  V30 18 C 10.2515 0.1264 0.0 0
M  V30 19 C 11.5408 2.3764 0.0 0
M  V30 20 C 11.5281 -0.6067 0.0 0
M  V30 21 C 12.8175 1.6559 0.0 0
M  V30 22 C 12.8175 0.1516 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 11 13
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 10 12
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
",51-12-7,Nialamide,N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide,"MI, 13, 6515",Biol Psychiatry. 1992 Dec 1 32(11):1042-8,10/28/1965,,,N06AF02,H2O,,,,Oral,,,,,100,"Dizziness, Drowsiness, Fatigue, Headache, Hypertension, Insomnia, Nausea, Orthostatic hypotension, Tachycardia, Tremor",Enzyme,Monoamine oxidase,Central Nervous System,Antidepressant,,,,,,,
"Meticrane
Actelion Java MolfileCreator 2.0

  0  0  0  0  0  0              0 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0 0.0 0.0 0
M  V30 2 O 1.077 1.2718 0.0 0
M  V30 3 O -1.2031 1.3291 0.0 0
M  V30 4 C -1.2947 -0.7104 0.0 0
M  V30 5 C 1.2718 -0.7104 0.0 0
M  V30 6 C -1.3062 -2.1541 0.0 0
M  V30 7 C -2.578 0.0229 0.0 0
M  V30 8 C 1.2603 -2.1541 0.0 0
M  V30 9 C -2.5895 -2.8759 0.0 0
M  V30 10 C -0.0343 -2.8759 0.0 0
M  V30 11 C -3.8728 -0.6874 0.0 0
M  V30 12 C -3.8843 -2.1312 0.0 0
M  V30 13 S -5.1676 0.0458 0.0 0
M  V30 14 C -5.179 -2.853 0.0 0
M  V30 15 O -5.9467 -1.226 0.0 0
M  V30 16 O -4.4342 1.3176 0.0 0
M  V30 17 N -6.4394 0.802 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 9 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 8 10
M  V30 18 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
",1084-65-7,Meticrane,"6-methylthiochromane-7-sulfonamide 1,1-dioxide","MI, 12, 6220",Lille Med. 1968 Jan 13(1):Suppl:13-6,1/27/1976,,,C03BA09,EtOH/H2O:50/50,"Chemical classification (according ATC code), Therapeutic classification (according ATC code)","Sulfonamide, Low-ceiling diuretic",,,,,,,,Hypokalemia,,,Metabolism,"Antihypertensive, Diuretic",,,,,,,
